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ABSTRACT 
Immunophilins are characterised principally by their specific binding affinity to 
immunosuppressant drugs and comprise two subfamilies; the Cyclosporine A 
binding cyclophilins (Cyps) and the FK506/rapamycin binding proteins (FKBPs). 
Immunophilins also possess peptidyl-prolyl isomerase (PPIase) activity catalysing 
the slow cis-trans isomensation step of proline-peptide (Xaa-Pro) bonds in the 
folding of peptides and proteins. Immunophilins are present as components of much 
larger protein complexes. These complexes have not been fully characterised. 
This thesis describes the expression, purification, and biochemical and biophysical 
characterisation of a number of FK506 binding proteins. The main focus of the work 
is to help characterise the roles of played FKBPs thus providing a better 
understanding of their biological functions. 
Neurospora crassa FKBP22 - Expression, purification, crystallisation, and partial 
structure determination of the 22 kDa FKBP protein were carried out. The enzymatic 
PPIase activity of the N-terminal PKBP domain was characterised with the kca/Km  
value of 3.9 x 106  M 1 s 1 . Sequence analysis showed high homology of this domain to 
the 12 kDa FKBP and a highly conserved peptidyl-prolyl active site. The C-terminal 
sequence appeared to be unique among other FKBP sequences; being highly charged 
with a predicted stretch of amphipathic a-helix. The electron density for the FKBP 
domain of the structure was very clear; however, no ordered structure for the C-
terminal helical domain was visible in the electron density. A preliminary crystal 
packing analysis shows a well ordered arrangement of FKBP domains suggestive of 
dimer formation. 
Caenorhabditis elegans FKBP48 - The only immunophilin TPR protein in C. 
elegans was cloned. Three natural breakdown products of FKBP48 were purified and 
characterised: an intact full length protein, a 630 fragment missing the final 30 C- 
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terminal residues, and a ST fragment missing the C-terminal TPR domain. Results of 
small angle X-ray scattering revealed similarity of domain architecture between 
FKBP48 and FKBP51. 
A number of studies have shown that the interactions of other TPR containing 
immunophilin co-chaperones (Cyclophilin 40 and FKBP51/52) with Hsp90 are 
mediated through the TPR domain. In this study interactions between FKBP48 and 
Hsp90 (full length C. elegans DAF-21 and C-terminal human Hsp90) were 
investigated and compared with the results obtained with Cyp40, a TPR containing 
cyclophilin. Although results from co-immunoprecipitation and gel filtration of 
FKBP48 and CeHsp90 were inconclusive, the interactions of interest could be 
verified using surface plasmon resonance protein-protein interaction studies and 
NMR using FKBP48/Cyp4O with peptides of either the final 12 
(GDEDASRMIEEVD) or 5 (MEEVD) C-terminal residues of human Hsp9013. 
A genomic sequence analysis of all C. elegans TPR domain proteins was carried out 
to analyse the degree of conservation of key Hsp90 recognition sequences and to 
allow characterisation of a consensus TPR motif for C. elegans. This led to the 
identification of two putative TPR containing proteins, 016259 and Q21746, which 
may interact with Hsp90. Possible interactions of 016259 and Q21746 with Hsp90 
have been modelled. 
Caenorhabditis elegans FKBP12, Caenorhabditis elegans FKBP29, and Arabidopsis 
thaliana FKBP71 - FKBP12/29 were well expressed. The enzymatic PPIase activity 
of FKBP29 was characterised with the kca/Km value of 0.3 x 106  M's'. However 
protein yield of FKBP29 was insufficient for further studies. Purification of FKBP12 
proved problematic due to aggregation during cleavage of the fusion maltose binding 
protein. The recombinant 71 kDa FKBP protein was expressed at low levels. This 
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p(r) The pair distribution function of the protein 
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CsA Cyclosporine A 
CV Column volume 
Cyp Cyclophilin 
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ER Endoplasmic reticulum 
Fc Flow cell 
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FKBP FK506 binding protein 
FL Full length of FKBP48 
FPLC Fast protein liquid chromatography 
FRAP FK506-rapamycin associated protein 
GRASP Graphic Representation and Analysis of Surfaces Properties 
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HSB-EP 0.01 M HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% 
Surfactant P20 
Hsp Heat shock protein 
I(s) The ideal scattering intensity 
,",P(S) Experimental scattering intensity 
Igepal ca-630 Octylphenyl -polyethylene glycol 
1L2 Interleukin-2 
IL-2R Lymphokine receptor 
IMAC Immobilised metal affinity chromatography 
1P3 Inositol 1,4,5,- triphosphate 
IPTG Isopropyl 3-D-thiolgalactopyranoside 
KA The association constant 
kcal  The turnover number 
KD The dissociation constant 
kDa Kilodalton 
K, The enzyme inhibition constant 
KLC Kinesin Light Chain 
K The Michaelis-Menten constant 
LB Luria-Bertani broth 
LKR Lymphokine receptor signal 
MALDI TOF Matrix Assisted Laser Desorption Ionisation Time-of-Flight 
MBP Maltose binding protein 
MIES 2-(N-morpholino)ethane-sulphonic acid 
MHz Megahertz 
MPD (1 )-2-Methyl-2,4-pentanediol 
MPEG Methoxypolyethylene glycol 
MWCO Molecular weight cut-off 
NF-AT Nuclear factor of activated T-cells, cytoplasmic 
NF-ATn Nuclear factor of activated T-cells, nucleus 
NHS N-hydroxysuccinimide 
NMR Nuclear magnetic resonance 
NTA Nitrolotri acetic acid 
O.D. Optical density 
Par Parvulin 
PBS Phosphate buffered saline 
PBST phosphate buffered saline including 0.1% Tween 20 
PCR Polymerase chain reaction 
PDB Protein data bank 
PDEA 2-(2-pyridinyldithio)ethanilamine hydrochloride 
PEG Polyethyleneglycol 
PEX5 Peroxisome receptor 5 
PI Isoelectric point 
PLC Phospholipase C 
pNA para-nitroanilide 
PP5 Protein phosphatase 5 
PPIase Peptidyl prolyl cis-trans isomerase 
ppm Parts per million 
PST1 Peroxisomal targeting signal 1 
RAD Rapamycin-like analog 
RAPSYN Receptor-associated protein of the synapse 
Req Equilibrium response unit 
Rmax Maximal response unit 
RU Response unit 
SAXS Small angle X-ray scattering 
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SGT Small glutamine-rich tetratncopeptide 
SMART Simple Modular Architecture Research Tool 
SOS Sum of squares 
SPR Surface Plasmon Resonance 
SRP72 	Signal recognition particle 72 kDa protein 
ST The fragment comprising largely of the two FKBP domains present in 
FKBP48 (with a few additional residues from the predicted linker 
region) 
5T1 Stress-induced 1 
STIP 1 Stress-induced-phosphoprotein 
TB Terrific broth 
TCR T-cell receptor 
TEE Trifluoroethanol 
TK Tyrosine kinase 
TOR Target of rapamycin 
TPR Tetratncopeptide repeat 
UV Ultraviolet 
vo Initial velocity 
Vm Matthew's coefficient 
V.  Maximal velocity 
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1.1 AN OVERVIEW OF THE IMMUNOPHILINS 
Immunophilins are a family of conserved proteins showing high affinity 
binding to a number of immunosuppressive agents used clinically to prevent tissue 
rejection following organ transplantation. In addition, immunophilins possess an 
enzymatic activity, the so-called peptidyl prolyl cis-trans isomerase (PPIase) activity. 
This thesis focuses on FK506 binding proteins (FKBPs), a subfamily of the 
immunophilins. The background of the proteins studied in this work will be 
discussed and placed in context with other available information on this family of 
proteins. 
1.1.1 The history of immunophilins 
The discovery of cyclophilins - The first immunophilin to be identified was 
an 18-kDa protein, studied in 1985 by two independent groups. Fischer et al. purified 
and characterised a porcine kidney protein and showed that the protein possessed 
peptidyl-prolyl cis-trans isomerase activity and therefore classified it as a "PPIase" 
(E.C. 5.2.1.8) (Fischer and Bang, 1985). Meanwhile, Handschumacher et al. isolated 
and purified a protein of the same molecular weight from bovine spleen. This protein 
was isolated using a Cyclosporine A (CsA) affinity column, hence the protein was 
termed "Cyclophilin A" (Handschumacher et al., 1984). CsA is a cyclic 
undecapeptide naturally synthesised in the soil fungus, Tolypocladium inflatum 
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Gams (Figure 1.1A). The PPIase and Cyclophilin A identified above were 
subsequently confirmed by two independent groups (Fischer et al., 1989; Takahashi 
et al., 1989) to be identical proteins. Both groups showed a relationship between the 
PPIase activity and the active site of the protein cyclophilin A by use of the drug 
CsA. They found that CsA, a very highly specific ligand for Cyclophilin A, inhibited 
the enzymatic PPIase activity. In addition, the amino acid sequence of PPIase is 
identical to that of human cyclophilin (96% identity). 
The discovery of FK506 binding proteins - In 1989 another member of the 
immunophilin family was discovered through its interaction with the novel 
immunosuppressant FK506. The protein was identified as the intracellular receptor 
of FK506 by the use of an affinity matrix charged with FK506 (Harding et al., 1989) 
and radiolabeled FK506 (Siekierka et al., 1989). This protein also possessed PPIase 
activity and was termed "FK506 Binding Protein", (FKBP). FK506 is a polyketide 
produced by Streptomyces tsukubaesis (Figure 1. 1B). The catalytic domain of FKBP 
showed minor sequence homology to that of cyclophilin, however FKBP does not 
bind to CsA. FKBP, furthermore, is a common receptor for rapamycin, a structural 
analogue of FK506 (Figure 1.1C) (Fretz et al., 1991). A hydrophobic cavity for 
FK506 and rapamycin is defined by the n-strands, a-helices, and three loops as 
shown in Figure 1.3 (Van Duyne et al., 1991a; Van Duyne et al., 1991b). 
The discovery of parvulins - In 1994 a third class of PPIase proteins was 
discovered. Rahfeld et al. purified a 10 kDa protein from E. coli which was unrelated 
to any other known E. coli PPlases (Rahfeld et al., 1994). This protein, termed 
parvulin by the group, showed no significant similarity to other characterised PPlases 
whilst possessing PPIase activity. However no inhibition of this activity by either 
CsA or FK506 was detectable. Rudd et al. also identified this protein which they 
called PpiC as a new E. coli PPIase (Rudd et al., 1995). Currently the number of 
proteins containing the conserved PPIase domains can be subdivided into the three 
distinct families outlined above; 111 genes encoding cyclophlins, 128 genes 
encoding for FKBPs, and 14 genes encoding for parvulins in whole genomes of 
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organisms ranging from prokaryotes to eukaryotes. Some of these proteins have been 
well characterised in terms of biochemical, biological, and structural properties as 
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Figure 1.1. Chemical structures of the immunosuppressive drugs, A) Cyclosporine A, 
B) FK506, and C) rapamycin. The dotted circles shown in the structures of FK506 
and rapamycin indicate the binding regions for FKBPs. The arrows are pointing at 
the pipecolinyl rings which penetrate deeply into the binding pocket of FKBP. 
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1.1.2 Structural and functional classification of immunophilins 
This section describes in detail the key features of each subfamily. A number 
of well-characterised proteins belonging to each subfamily are used to illustrate the 
points discussed. Additionally, the three subfamilies are compared and contrasted to 
highlight the unique features of each subfamily. Sequence analysis reveals low 
similarity in the primary amino acid sequence between the three families mentioned 
above. However intriguingly they share an enzymatic activity involved in assembly, 
folding, and transport of cellular proteins. All the proteins studied in this work are 
members of the FKBP family; therefore, the next session will provide greater detail 
of their particular properties. 
Cyclophilins (Cyps) - The cyclophilin subfamily comprises a large number of 
proteins sharing the highly conserved CsA binding domain (Galat, 1993). 
Cyclophilins are found with a wide range of molecular weights corresponding to 
single or multiple domain(s). In the human genome, 25 cyclophilins are expressed 
and are localised in several cellular compartments e.g. the cytoplasm (Cyp A, 
Cyp40), endoplasmic reticular membrane (Cyp B), and kidney outer cortex (Cyp Q. 
All cyclophilins share sequence homology over the core domain of over 50% with 
Cyp A. Cyclophilins are involved in a diverse range of cellular pathways such as the 
immunosuppressive mechanism of CsA, folding of mitochondrial proteins (Rassow 
et al., 1995), and steroid receptor assembly (Chen et al., 1998). Cyclophilins from all 
sources bind tightly to CsA (K1 = 6 nM) (Liu et al., 1991). To date, over 60 three-
dimensional structures of cyclophilins have been solved of both unliganded and 
liganded structures. 
The prototypical cyclophilin A - Cyp A, the member of the cyclophilin family 
first identified and characterised, is a cytoplasmic protein four isoforms of which are 
found in humans. Cyp A can account for up to 0.4% of total proteins in the 
cytoplasm (Takahashi et al., 1989). Cyp A is a single domain protein of 165 amino 
acids. Human Cyp A shows PPIase activity with a kca/Km of 14.6 x 106  M 1 
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Koiron ci al.. 1991) against the tetrapeptide substrate of r\-succinyl-AIa-Ala-Pro-
Phe-p-nitroanilide (Suc-Ala-Ala-Pro-Phe-pNA). An X-ray structure of free native 
human Cyp A showed the protein fold to be that of an eight-stranded anti-parallel 13- 
 sandwich wrapping around the barrel surface with a-helices capping the barrel at 
both ends as illustrated in Figure 1.2 (Kallen et al.. 1991 -, Ke. 1991). The unique 
topology of overall 13-barrel of cyclophilin-binding domain is different from other 13- 
 barrel structures such as lactogabulin. Due to a closed 13-barrel structure, a 
hydrophobic pocket sitting on the outside of the barrel of Cyp A is mainly formed by 
highly conserved residues located on one face of the 13-sheet. whilst the hydrophobic 
cavity of lactoglobul in is lormed and located within the barrel ( Wu ci al.. 1999. 
N 
Figure 1.2. Structure at Cvclophilin A (Cvp A) from human in complex with 
Cvclosporine A (PDB code 2RMA). The single domain Cvp A composes 8 anti-
parallel fl-strands (coloured in green) which adopt a beta-barrel structure with a 
he/ices (coloured in pink) capping at both ends of the barrel. The binding site fr 
Cvclosporine A is located on the fl-sheet face. 
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FK506 Binding Proteins (FKBPs) - FKBPs are very abundant proteins with a 
wide phylogenic distribution. They also localise in various discrete cellular 
compartments (Galat, 2004). FKBP proteins from Arabidopsis thaliana for example, 
are found in many organelles (chioroplast, ER, nucleus, and cytosol) (He et al., 
2004). FKBPs exhibit PPIase activity with reported kca/Km values ranging from 0.5-
8.0 x 106  M's' against a standard substrate (Suc-Ala-Leu-Pro-Phe-pNA). The 
binding affinity for a number of different ligands (i.e. FK506 and rapamycin) has 
been calculated and has been shown to be dependent upon a key structural feature 
common to these two ligands, the pipecolenyl ring found in the FKBP binding region 
of each compound. A number of compounds replacing functional groups in the 
structure of FKBP binding compounds have been synthesised and structurally 
characterised and show the ligands binding into the same highly conserved binding 
pocket. A series of compounds replacing the ct-ketoamide moiety with a urea group 
have been investigated (Dragovich et al., 1996) and showed inhibition of activity but 
reduced affinity when compared to that seen with FK506 or rapamycin. An 
alternative approach was taken to illustrate the specificity of the interaction between 
FKBP and its ligands. In this experiment residues thought to be important in forming 
the binding pocket in yeast FKBP12 were altered. Mutation of Tyr 89 of 
Saccharomyces cerevisiae eliminated binding of rapamycin (Figure 13C) (Koser et 
al., 1993). 
In addition FKBPs have a wide variety of molecular functions significant to 
various cellular pathways including the intracellular calcium release channel (Wang 
and Donahoe, 2004), steroid receptor activation (Pratt and Toft, 1997), and gene 
transcription (Kuzuhara and Horikoshi, 2004). With a wide range of molecular 
weights, FKBPs are simply classified as low- and high-molecular-weight FKBPs 
depending on their domain composition. Most small FKBPs by definition minimally 
comprise a single typical FK506 binding (FKBP) domain. Large FKBPs have large 
modular structures with multi-FKBPs domains. Some large FKBPs can contain up to 
3-4 FKBP domains in addition to different functional domains such as the 
tetratricopeptide repeat (TPR) motif, the leucine-zipper and calmodulin binding 
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motifs. The main focus of this work is C. elegans FKBP48 which comprises two 
FKBP domains and a TPR domain which mediates protein-protein interactions. 
The well-studied FKBP12 - The slightly basic cytosolic FKBP12 was first 
cloned from cDNA (Jurkat cells) and over-expressed in E. coli as a fully active 
protein (Standaert et al., 1990). Over 36 X-ray and NIMIR structures of FKBP12 have 
been solved, both free and complexed with specific ligands, e.g. immunosuppressive 
drugs. A hydrophobic binding pocket accommodating the drugs is formed by a-
helices and the wall of the 0-sheet. Figure 1.3 illustrates the X-ray structures of 
FKBP12 from human complexed with its specific immunosuppressants, FK506 and 
rapamycin. Protein engineering together with receptor-based ligand design of 
FKBP12 have lead to a better understanding of diverse functions of the FKBP 
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Figure 1.3. Structures of hunan FKBPJ2 in complex with FK506 (A, PDB code 
JFKJ) and rapamycin (B, PDB code IFKL). FKBPI2 composes five anti-parallel 13- 
strands (coloured in green) wrapped around a short stretch of a helix at the centre 
(coloured in pink). Three loops surround and give rise to a hydrophobic pocket for 
ligand binding. Both FK506 and rapamvcin bind the same site on the FKBP domain. 
C) An alignment of S. cerei'isiae FKBPI2 against human FKBP12 showing 56% 
identity using MultiAlin. In the consensus lines, residues with red, uppercase letters 
are high/v conserved (90%). Residues with blue, lowercase letters are weak/v 
conserved (not over 50%). A position with no conserved residue (black) is 
represented by a dot. !fi)r I and V residues, $for L and M residues, %jr F and Y 
residues, and #fir B, D, E. N, Q, Z. 
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Parvulins (Pars) - The parvulin family currently contains approximate 15 
members including known homologues. Besides PPIase activity, parvulins have been 
shown to be involved in cell cycle progression (Uchida et al., 2003) and in the 
chaperone-like pathway in prokaryotes (Lazar and Kolter, 1996). Human Pin!, a 
bacterial parvulin homologue, interacts with cell cycle regulatory proteins such as 
Cdc25 via its N-terminal WW domain, subsequently altering protein conformation 
through PPIase activity. The WW domain is derived from the presence of two 
signature tryptophan residues separated 20-23 amino acids apart. The E. coli Sur A 
protein catalyses folding of outer membrane proteins in the periplasm, where 
proteins are folded in an ATP-independent manner. Currently, the Protein Data Bank 
(PDB) contains five NMR structures of parvulins: EcParlO (PDB codes 1JNT and 
1JNS), AtPinl (PDB code 1J6Y), and hPar14 (PDB codes 1EQ3 and 1FJD). 
The prototypic pan'ulin 10 (Par] 0 or PPIc) - ParlO, a small E. coli protein 
was the first parvulin to be isolated and characterised (Rahfeld et al., 1994). PPIase 
assay results for ParlO showed a high kca/Km of 16.9 x 106  M's' against the peptide 
substrate Suc-Ala-Leu-Pro-Phe-pNA, similar to those obtained for cyclophilins from 
same species. EcParlO shows a strong preference for a tetrapeptide substrate within 
which either a leucine or a phenylalanine immediately preceding the proline residue. 
This pattern of substrate specificity was similar to that seen with FKBPs. In addition, 
the enzymatic activity of ParlO was neither inhibited by CsA nor FK506. The three-
dimensional structure of EcParlO has been determined using NMR (PDB code 1JNS) 
(KUhlewein et al., 2004). It showed that the single domain of parvulin responsible for 
PPIase activity folds with three anti-parallel f-strands surrounded by three (X-helices 
as shown in Figure 1.4. A number of ParlO homologues are found in many 





l7i.,'iirc 14. An NMR structure ui LcPurl() /PDR code /.JNS, ( Auh/cueui ci (IL. 
2004)1. The conserved PPIase domain of EcParIO flds with three anti-parallel ,8-
ctiiiiids .511 i -ru! ouled with three X-/1eI!(eS. 
1.2 THE FKBP FAMILY 
This section describes in detail three important features of FKBPs: PPIase 
activity, mechanism of immunosuppression, and the three-dimensional fold of the 
core domain. A brief description of the catalysis of protein folding brought about by 
FKBP will be included the method for assaying the activity of these enzymes will 
also be outlined. When available, information relating to proteins with a well 
characterised function will be discussed. 
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1.2.1 Biochemical properties of FKBPs 
Peptidyl prolyl cis-trans isomerase activity - The intrinsic enzymatic PPIase 
(E.C. 5.2.1.8) activity shared by both immunophilins and parvulins, controls the 
cis/trans interchange of prolyl peptide bonds at various conformational states of the 
polypeptide chains within the cell. Interconversion of the cis and trans isomers of the 
proline containing peptides/proteins (Xaa-Pro) is involved in protein refolding 
(Fischer and Bang, 1985). Peptidyl proline peptide bonds naturally have a strong 
preference for the trans rather than cis conformation with an approximate ratio of 
9: 1(trans:cis) reported for protein structures deposited in the PDB (Stewart et al., 
1990). The slow cis-trans isomerisation is a rate-limiting step in the folding of small 
oligopeptides and proteins (Lang et al., 1987). FKBPs accelerate the formation of 
trans prolyl peptide bonds (Xaa-Pro) by facilitating the twisting of the amide bond 
1800  around the dihedral angle (w) as can be seen in Figure 1.5 (Schmid et al., 1993). 
In folded proteins, peptide bonds between proline and a preceding residue occur in 
the cis conformation more frequently than with any other residue, accounting for 
approximately 10% of available structures (Macarthur and Thornton, 1991). The 
possible interchange between the cis and trans conformation of proline may play an 
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Quauititaiian of PPJase activity - Fischer ci al. developed a 
spectrophotometric assay for PPIase activity (Fischer et al., 1984). The standard 
assay requires the coupling of two events: the cis-trans isomerisaton of the functional 
group of p-nitroanilide (pNA) of a peptide substrate followed by the 
conformationally specific chymotrypsin hydrolysis of the pNA group (Bang et al.. 
2000). Measurement of this isomer-specific proteolysis assay relies on two reactions; 
the reversible cis-trans isomerisation followed by the sequential irreversible cleavage 
of pNA by chymotrypsin (Kofron et al.. 1991). The isomerisation rate is measured by 
the accumulation of chromogenic product released following chymotrypsin cleavage 
of the peptide substrate (Suc-Ala-Leu-Pro-Phe-pNA) in trans conformation. The 
PPlase activity of human FKBP12 has been determined with steady-state kinetics 
value of k,/K,,, of 0.66 x 106  M 1 s' (Kofron etal.. 1991). 
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1.2.2 Biological functions of FKBPs 
FKBPS share two primary functions. In the absence of their specific drugs, 
FKBPs catalyse the slow isomerisation of cis-trans Xaa-Pro peptide bonds and 
accelerate the refolding of proline-containing polypeptides as previous described. In 
the presence of the drugs. they act as intracellular receptors for the 
immunosuppressants FK506 and rapamycin used to help prevent tissue rejection 
following organ transplantation (Wiederrecht et al., 1993h). 
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Immunosuppressive effect of FKBPs - FK506 and rapamycin bind to FKBPs 
with high affinities (Kd = 0.4 nM for FK506, Kd = 0.2 nM for rapamycin) in human 
FKBP 12 (Bierer et al., 1990). Both drugs are competitive antagonists and have 
similar common binding sites (Dumont et al., 1990). Once bound, the complex of 
FKBP-FK506/rapamycin mediates the cytotoxic effect of the drugs against the 
immune cells responsible for tissue rejection. Figure 1.7 illustrates the proposed 
signalling pathway for T-cell activation. The T-cell activation cascade is initiated by 
binding of the MHC and antigen complex (Ho et al., 1996). The first event is 
stimulation of the T-cell receptor (TCR) by foreign antigen causing TCR signal 
transduction that activates ras and the Ca2 signalling pathways (Ho et al., 1996). In 
the first mechanism, the TCR signal transducts activation of tyrosine kinase (TK) to 
phosphorylate phospholipase C (PLC) which subsequently induces an increasing of 
concentration of intracellular Ca 2 . The higher level of Ca 2,  causes calcineurin (CaN) 
activation that promotes NF-AT c translocation from the cytoplasm to nucleus where 
it combines with NF-AT. The complex enhances RNA synthesis and protein 
production of cytokines e.g. interleukin-2 (IL-2) (Gothel and Marahiel, 1999). After 
IL-2 expression, it binds to lymphokine receptor (IL-2R) on the cell surface 
(Schreiber, 1991) generating lymphokine receptor signal (LKR) signal to produce 
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Figure 1.7. Iinnunosuppressive actions  of FKBPS in the T-cell activation pathway. 
The FKBPJ 2-FK5O6 complex binds calcineurin and inhibits calcineurin activity 
required for activating and transporting NF-A T into the nucleus. This finally leads 
to no IL-2 production. On the other hand the FKBP12-rapamnvcin complex binds 
FRAP and blocks IL-2 signal transduction involved in synthesis of 1L-2. 
FKBPs inhibit early events in T-cell activation (Schreiber. 1991) that mediate 
damage of a target tissues (Wiederrecht et al.. 1993a). In the presence of FK506. the 
FKBP12-FK506 complex. in this case, binds a protein kinase calcinuerin to 
inactivate calcineurin function. This consequently leads to inhibition of production of 
a T-cell growth factor. interleukin-2 (IL-2). Although rapamycin binds FKBP12 at 
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the same site as FK506 does, the immunosuppressive mechanism that the FKBP12-
rapamycin complex effects is different. The complex binds a protein kinase known as 
target of rapamycin (TOR): FK506-rapamycin associated protein (FRAP) in humans 
or RAFT in rats, which prevents further signal transduction in the cycle of T-cell 
proliferation. 
1.2.3 Structural properties of FKBPs 
The FKBP fold - All FKBPs share a highly conserved fold of five anti-
parallel 13-strands wrapped with a short stretch right-handed a-helix at the centre, 
connected by protruding loops as illustrated previously in Figure 1.3. The 40s loop, 
the 50s loop, and the 80s loop surround and give rise to a hydrophobic pocket. The 
hydrophobic pocket is formed between the 13-strands and the cc-helices. The binding 
pocket comprises a number of conserved aromatic residues (Tyr 26, Phe 46, Trp 59, 
and Phe 99) and can accommodate the pipecolinyl ring of FK506/rapamycin as 
illustrated in Figures 1.1B and C (Wilson et al., 1995). 
A ternary complex of FKBP12-rapamycin-FRAP - FKBP/rapamycin 
Associated Protein (FRAP) formation results in the inhibition of cytoplasmic signal 
transduction cascades by blocking the Ca 2 -independent pathway as previously 
illustrated in Figure 1.7. Figure 1.8 represents the association of FKBP12-rapamycin 
with the FKBP12-rapamycin (FRB) binding domain of FRAP (Liang et al., 1999). 
The high molecular weight (289 kDa) FRAP is involved in cell-cycle progression, 
chromosome maintenance and repair, DNA recombination, and cell-cycle 
checkpoints (Keith and Schreiber, 1995). In addition, the recent structures of the 
large multi-domain FKBP51 and FKBP52 provide a better understanding of their 
additional tetratricopeptide repeat (TPR) domains with respect to potential protein-
protein interactions. FKBP51 and FKBP52 will be discussed in greater detail 





Figure 1.8. X-ray structure of a ternary complex of FKBP12-rapamvcin-FRAP 
(FKBPI2-rapamvcin associated protein) (PDB code 2FAP). Rapamvcin complexed 
with FKPI2 binds FKBPI2-rapamvcin binding domain (FRB) of FRAP to inhibit 
downstream pathways required for T-cell progression as illustrated previous/v in 
Figure 1.7. 
1.3 AN OVERVIEW OF TETRATRICOPEPTIDE REPEAT 
The retratricopeptide repeat (TPR) family is one of a number of protein 
repeats that assemble into an extended arrangement. In general. a protein repeat can 
he broadly defined as a non-overlapping region of single protein sequences. The 
repeat is likely to have occurred from duplication and recombination within a gene 
(Andrade et al., 2001). The large immunophilins (Cyp40, FKBP5I, and FKBP52) 
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containing TPR domains are well-studied examples of these proteins and will be 
discussed in the following section. 
1.3.1 The basic of TPR 
Discovery of TPRs - The TPR motif was first characterised in the literature in 
1990. Hirano et al. isolated and cloned a nuc2 gene from Schizosaccharomyces 
pombe (S. pombe) (Hirano et al., 1990). The nuc2 gene product, involved in mitotic 
chromosome disjunction, was suggested to contain two different domains; a helix-
hinge repeat domain and a DNA binding domain. The repeat unit was essential for 
the protein function. At the same time, these repeat units were also found in CDC16, 
CDC23, SSN6, and SKI3 gene products in S. cerivisiae being required for 
chromosome separation during mitosis and viral RNA replication (Sikorski et al., 
1990). The pattern of the internal tandem repeats was termed tetratricopeptide 
repeats (TPRs), each repeat was 34 amino acids long, with repeat sequences showing 
great diversity in primary sequence. A growing body of evidence shows TPRs to be 
present in a number of particular proteins with a diversity of functions. A search of 
the SMART (Simple Modular Architecture Research Tool, accession number 
SM00028) database for TPR proteins showed the rapidly growing family to comprise 
some 2,259 proteins, found in a wide variety of organisms. 
A consensus TPR fold - Using a computer-based analysis, Sikorski et al. 
further identified a consensus sequence, length of repeat unit, and repeat 
organisation. From an alignment of the TPR sequences from CDC23, CDC16, 
nuc2+, 55N16, and the SK13 gene product, a consensus sequence of the most 
common amino acid found at each position was derived from all 47 possible versions 
of the repeat (helix A: W4, L7, G8, Y1 1, helix B: A20, F24, A27, P32) as shown in 
Figure 1.9. These conserved amino acids were defined as the positions at which there 
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Figure 1.9. Diagram of the secondary structure arrangement of the 34 amino acids 
of the TPR repeat. The greatest frequencies of identities in the repeats are present in 
at least 40% of the TPRs. 
TPR arrangement - The number of TPR repeats varies from 3-16 repeats 
each of 34-amino-acid residues, with three consecutive TPR repeats being the most 
common number. In addition, individual TPR repeats can be widely distributed 
within a protein sequence. The helical segments are amphipathic subdomains, Hirano 
et al. proposed that these amphipathic helices of the TPRs could form a helix-turn-
helix (coiled-coil) arrangement as seen in Figure 1.9. Each 34 amino acid repeat 
contains two conserved residues which are important for a knob and a hole 
formation. Gly 5 on helix A and Tyr 21 on helix B. These two helices are connected 
to adjacent two helices of a following repeat with a bending loop (residues at 
positions 28-32). 
1.3.2 The structure of TPR 
The TPR topology - The TPR motif composes a repeating helix-turn-helix 
arrangement (Figure 1.10). Sequence alignment of TPR domains revealed a 
consensus sequence defined by a pattern of small and large amino acids (Sikorski et 
al.. 1990). 
N-terminus -terminus 
Figure 1.10. Topology diagram of the secondary structure of a TPR domain 
containing three repeats. Each repeat composes 2 he/ices, universal/v named A 1 and 
B1, and is connected to the next repeat by a hinge loop. The C-terminus in this 
example isfornied by a final additional long helix 
The X-ray structure of a TPR domain - The X-ray structure of protein 
phosphatase 5 (PP5) was the first such characterisation of a TPR repeat containing 
molecule (Das et al., 1998). Each of the three N-terminal TPR motifs consists of a 
pair of -helices denoted helices A 1 (cyan) and B (olive), adopting a helix-turn-helix 
fold (Figure 1. 11). Helix A, in addition, interacts with helix A' of the following TPR 
motif. The overall TPR domain of PP5, therefore, arranges itself as an overlapping 
array of these three motifs. The close single turn of helix A 1 and helix B i interacts 
with the neighbouring TPR motifs in a parallel fashion, generating a right-handed 
superhelical shape Two protein surfaces are formed: the inner surface formed by 






1. 11. The first X-ray structure of TPR domain of PP5 protein (PDB code 
1A17) showing a novel fold pattern (Das et al., 1998). The 34 amino acids of each 
repeal motif contains two anti-parallel ahelices stacking together in a parallel array 
to firni an extended domain with superhelical architecture (Main et al., 2003). 
He/ices A (cvan), he/ices B (olive). 
Comparison with other a-helical repeat Jhids - In addition to the relatively 
simple helical TPR fold, a number of other helical repeat folds exist including the 
ankyrin (ANK) and HEAT repeats (Andrade et al.. 2001: Zhang and Peng, 2000). In 
general, one motif stacks together with the adjacent motifs to form highly-conserved, 
distinctive superhelical structures (Groves and Barford. 1999). The overall structure 
of TPR domain is a right-handed superhelix of 3-16 TPR motifs as illustrated in 
Figure 1. 12A. A single TPR motif (34 amino acids) consists of a pair of anti-parallel 
helices (A i and B). The helices A and B fold together with a close interhelix angle of 














Figure 1.12. X-ray structures of repetitive domains. A) Three TPR motifs of PP5 
(PDB code JA 1 7) show an overall superhelical domain architecture (Das ci al., 
1998). B) ANK domain (5 ,notifs) is a fragment of the /3-subunit of GA-binding 
protein (PDB code ]A WC) (Batchelor ci al., 1998). C) The HEAT domain fold (15 
motifs) , a frag,neni of PR651A subunit of human protein phosphatase 2A (PDB code 
IB3U) is a hook-like structure (Groves ci al., 1999). 
Ankyrin repeats are found in a number of biologically important proteins involved in 
transcriptional regulation, cell-cycle control, and cell differentiation (Bork. 1993). A 
single motif of ANK comprises a pair of right-handed a-helices (approximately 33 
amino acids) termed A i and B. Each ANK motif is linked together via an anti-
parallel loop roughly perpendicular to the axes of the helices generating the L-shaped 
cross-section (Figure !.12B). Frequently found present in arrays of 2-7 AN  motifs, 
the overall shape of ANK is similar to the letter "L" (a long 13 loop as the base and a 
pair of a helices as the vertical arm) (Zhang and Peng. 2000). Stacking of helix-loop- 
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helix ANK motifs also provides slightly concave (inner) and convex (outer) faces. 
HEAT containing proteins are responsible for diverse functions e.g. DNA replication 
and RNA splicing. The number of HEAT motifs varies between 3 and 22. A single 
motif (approximately 40 amino acids) of HEAT is formed by a pair of anti-parallel 
helices, similarly to that of TPR with the same interhelix crossover angle of 24° 
(Figure 1.12C). Unlike TPR helices, most A and B helices of HEAT repeats are bent 
about 450  which may provide a larger volume of interhelix hydrophobic core and 
hence protein stability (Groves et al., 1999). The parallel arrangement of HEAT 
motifs as a double layer of ct-helices allows the formation of concave and convex 
surface. 
1.3.3 Biological functions of the known TPR-containing proteins 
Proteins containing TPRs are involved in a variety of biological processes, 
such as cell cycle regulation, transcriptional control, mitochondrial and peroxisomal 
protein transport, neurogenesis, and protein folding. The major role of TPRs is 
thought to be in mediating protein-protein interactions bringing together the different 
protein components of a number of molecular machinery complexes (Main et al., 
2003). The following three examples will be used to illustrate some of the better 
characterised roles played by TPR containing proteins. 
Translocase of outer membrane 20 (Tom20) - Tom20 is a mitochondrial 
protein import receptor playing an important role in protein transportation into 
mitochondria. Most mitochondnal proteins are synthesised in the cytosol and are 
imported into mitochondria by their pre-sequences. Figure 1.13 describes the domain 
architecture of Tom20 which composes a transmembrane (TM) segment, two acidic 
regions, a Q-rich region, and a single TPR motif. The TM segment allows Tom20 to 
be anchored via its N-terminus in the mitochondnal outer membrane leaving the C-
terminal domain free in the cytosol. The Q-rich region contains glutamine and 
hydrophobic residues which stabilise the interaction with the preseqeunce. The TPR 
IM 
repeat (residues 70-104) recognises the pre-sequences of mitochondrial proteins. The 
told of the Tom20 TPR repeat is similar to that of PP5 (1 repeat) as shown in Figure 
1.14 (Abe et al.. 2000). A pair of anti-parallel a helices of Tom20 stacks together 
with a 25° packing angle between their own axes (Figure 1. 14). 
1 	7 	24 	 59 79 	103 112 	140 145 
TM 	 TPIR 	0 	F 
Figure 1. 13. Schematic representatioil Lif domain organisalioli 0/ trciils/0((ise of 
outer membrane 20 (Tom20). Tom20 composes the transnzemhrwze segment (TM) 
(residues 7-24, yellow), the acidic regions (residues 59-79 and 140-145, light and 
dark violet respectively), the single TPR motif (residues 80-103, cyan), the Q-rich 
region (residues 104-112, salmon pink), and the flexible region (residues 118-133, 
light salmon pink). 
C . N 
kip 
N" 	ks 	 I ----------- t C 
Figure 1.14. NMR structure of Tom20 (PDB code 10M2). The overlaid final 
structures represent the TPR motifs of To,n20; helix A (cvan) and helix B (olive), 
interacting with a presequence peptide 1,ALDH (residues 1-22) firom aldehvde 
dehvdrogenase (balls and sticks). The other three he/ices shown in salmon jink 
represent the Q-rich region (helix C, residues 104-112) and flexible region (helix D 
and E. residues 118-124 and 128-133 respectively). 
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The pre-sequence binding groove is formed by the TPR repeat (helices A and B) and 
the Q-rich region (helix C). TPR Tom20 (residues Phe 70, Leu 71. lie 74) including 
some residues in Q-rich region (Leu 106, Val 109, Leul 10, Thr 113) recognises a 
mitochondrial presequence peptides. In addition, a number of glutamines (Gin 67, 
Gin 75, Gin 102, Gin 104, Gin 105, Gin 108, Gin 111, and Gin 112) and glutamates 
(Glu 78 and Glu 79) in Q-rich and acidic regions respectively are involved in the 
interaction. 
- The cytosolic p67h\  protein is one of the subunits that form the 
NADPH oxidase multi-enzyme complex. This complex comprises at least four 
cytosolic proteins (Rae, p40,, 47Phox and p67 °") and two membrane-bound 
components (gp910x  and p22 X) collectively known as cytochrome b588. The 
active NADH oxidase enzyme generates a superoxide anion (02) as a defence 
mechanism eliminating invading microorganisms (Babior, 1999). The key step in 
complex assembly and function is the GTP dependent interaction between Rae and 
p67x .  Rae is a small GTPase that is fully functional when bound with GTP. The 
cytosolic p67x  protein contains four N-terminal TPR domains and C-terminal SH 3 
domains (Figure 1.15).  The structure of a complex between a fragment of p67x 
including the TPR domain (residues 1-203) and Rac•GTP has been solved (Figure 
1.16)(Lapougeet al., 2000). 
3 	153 	 243 298 	460 515 
TPR 	 F 	SN3 	 SH3 
Figure 1.15. Schematic representation of p67'° domain organisation. The N-
terminal TPR domain contains four TPR mnotifs (residues 3-153, cvan), the activation 
domain (residues 199-210, hg/it orange), the pro/inc-rich region (residues 226-236, 
yellow), and the two SH 3 domains (residues 243-298 and 460-515, or(inge). 
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The Rae binding site is located on the N-terminal TPR domain of p67'. mediating 
the interaction. The P67 ph"' TPR domain consists of nine alpha helices packing 
together in a helix-turn-helix fold, with eight of the helices (A,-B 4 ) forming 4 TPR 
repeats (Figure 1.16). In addition, the TPR domain of p67 °" contains an insertion of 
?() amino acids forming two short anti-parallel 13-strands and a helical turn between 
helices B and A 4 . This additional insertion is the contact region for Rac protein. 
C. 
N 	 Rac protein 
GTP"SS . 






TPR domain of P67prlox 
	& 
Figure 1.16. X-ray structure of the RacGTP1p67" complex (PDB code 1E96). The 
structure represents the TPR domain (he/ices A 1 -A 4, cvan, and B 1 -B 4, olive) of 
interacting with Rac protein (gold) in complex with GTP (balls and sticks). 
The two short anti-parallel sheets (red) are inserted between the third and forth TPR 
motifc to for,,i the GTPase binding site with additional stabilisation of the final C-
terminal helical extension. 
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1/eLI! shock protein 70/9() orga1li.i/lg protein (Hop) 	Hop, also known as 
STI 1, is one of the TPR containing co-chaperones of heat shock proteins 70 and 90 
(Hsp70/90). Hop provides specific binding sites for both molecular chaperones 
(Scheufler et al., 2000) and is able to differentiate between binding motifs (Odunuga 
Ct al.. 2003). The next section will describe l-lsp90 in more detail, in particular its 
association with TPR containing proteins will be discussed and available structural 
information presented. Briefly, the molecular chaperones. Hsp70/90 are involved in 
protein folding and conformational regulation. The TPR domain of Hop mediates the 
formation of a stable complex of Hsp70/Hsp9O/Hop formed to promote the Hsp70/90 
activation of client proteins. Hop comprises nine evenly distributed TPR motifs, as 
illustrated in Figure 1.17. The N-terminal TPR domain, TPRI, interacts with Hsp70 
whilst the C-terminal TPR domains, TPR2AI2B interact with Hsp90 (Scheufier et al., 
2000). Once Hop binds to Hsp70. Hsp70 is then able to deliver client proteins to 
Hsp90. TPR domains of Hop recognise the C-terminal resides EEVD of both heat 
shock proteins. Figure 1.18 represents the X-ray structures of Hop TPR1 complexed 
with the C-terminal residues GASSGTPIEEVD of Hsp70 (Figure 1. 18A) and Hop 
TPR2a complexed with the residues MEEVD of Hsp90 (Figure 1. 18B). 
4 	118 130 169 223 	352 353 	477 492 531 
TPR1 	STI TP}R2A TPR28 STI 
Figure 1.17. Schematic representation of the domain organisation of Hop. Hop 
composes two clusters of TPR domains, TPRI (residues 4-118), TPR2 (residues 223-
352 for TPR2A and residues 353-477 for TPR2B) and two stress-induced (STI) 










iiure 1.18. X-r(1v structures a! Hop TPR (/OlflULllS in cOfll/)leX with the C-terminal 
residues of heat shock proteins. A) HOP TPRI in complex with the final 12111er 
(IASSGTPIEEVD of Hsp70 (PDB code IELW). B) HOP TPR2A in complex with the 
/iiial 5,,zer MEEVD of Hsp9O (PDB code IELR). 
The TPR-peptide complexes reveal that the peptide binding grooves of TPRs are 
formed on the inner surfaces of the first helices of each motif (Figure 1 .8. coloured in 
cyan). This work focuses on TPR-Hsp90 interactions. Results from studies into the 
interactions between Hsp90 and the TPR domain of FKBP48 from C. elegans are 
compared and contrasted with those seen with the large well characterised 
immunophilin Cyp40 and Hsp90, are described in Chapters 6 and 7. 
1.4 HEAT SHOCK PROTEIN 90 (HSP90) 
Hsp90 is one of the members of the heat shock protein family which play 
many roles in the cell. Under normal conditions Hsp90 functions as a molecular 
chaperone, folding both newly synthesised proteins and refolding denatured proteins. 
It is also required for viability under conditions of physical and chemical stress 
(Caplan et al., 2003). High levels of Hsp90 expression permit S. cerevisiae growth at 
higher temperatures (50°C) normally a non-permissible temperature (Borkovich et 
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al.. 1989). In addition. Hsp90 is required for cell viability in Drosophila (Van der 
Straten 1997) and C. elegans (Birnby et al.. 2000). Hsp90 primarily composes a 25-
kDa N-terminal domain, a short linker, a 33-k- Da middle domain, and a 15-kDa C-
terminal domain (Figure 1.19) (Pearl and Prodromou. 2000). 
Ct 
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JR signal 	 ...KDEL 
Mitochondrial Hsp9O 
Figure 1.19. Domain organisations of threc' diffrrent isoforms of Hsp90 found in 
higher eukarvotes. Each iso form contains at least 3 identifiable, Junctional domains. 
The N-terminal domain contains a nucleotide-binding pocket. The function qf the 
middle domain is as vet unclear, but tends to be the binding site qt client proteins. 
The C-terminal domain incorporates the dimerisation domain. Particular sequences 
at the extreme carboxv terminus of the protein have been attributed particular 
functions. MEEVD (the terminal residues in the human cvtosolc proteins) fur 
instance has been shown to be critical for TPR binding. 
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1.4.1 The genetics of Hsp90 
Human Hsp90 - Two isoforms of the gene encode for human cytoplasmic 
Hsp90 (Hsp90cand Hsp90,6) and are very similar with a high degree of conservation 
(86% identity) (Hickey et al., 1989). In addition, other Hsp90 isoforms localised in 
the ER and mitochondria are also found in higher eukaryotes (Chavany et al., 1996; 
Ishii et al., 1999). Hsps are highly conserved with yeast (S. cerevisiae) and 
Drosophila Hsp90 being 61% and 78% identical to human Hsp903, respectively 
(Rebbe et al., 1987). Under non-denaturing conditions, Hsp90 was isolated as a 
dimer (Welch and Feramisco, 1982). The homodimers (a:(x and 1E:13) are formed 
more dominantly than the heterodimers (a:I3and 13:(x) (Perdew et al., 1993). 
An Hsp90 homologue in C. elegans - The highly conserved Hsp90 protein 
can be found across species including C. elegans. Three proteins in C. elegans are 
found to be Hsp90 homologues; DAF-21, T05E11.3, and R151.7 (moe, Takamura et 
al. 2003). The DAF (dauer larva formation) proteins are involved in formation of a 
third larval form known as dauer larva. Dauer larvae can be produced in response to 
conditions of stress including the level of food, temperature, and a constitutively 
secreted pheromone. DAF-21 is the name given to the C. elegans cytosolic Hsp90, 
which shows high homology to other Hsp90s as can be seen in Figure 1.20: human 
Hsp90 (58%), Drosophila (60%), and yeast (S. cerevisae) (62%). A daf-21 gene 
encoding the DAF-21 protein contains heat shock element (HSE) and consensus 
sequences for heat shock transcription. Localisations of daf-21 niRNA and DAF-21 
protein are rather different. moe et al. reported daf-21 mRNA was detected in 
germline cells whilst the protein was localised both in germline cells and somatic 
cells (Inoue et al., 2003). RNA interference (RNA I) experiments showed the gene to 
be essential as knockouts were early embryonic lethal (Piano et al., 2000). The 
MEEVD residues which are required for TPR recognition are conserved in C. 
elegans DA-F-21. In this work, the interactions of large immunophilins and C. 
elegans Hsp90 are focused upon and will be described in Chapters 6 and 7. 
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Figure 1.20. An alignment (#'C. elegans DAF-21 with a number of its homologues 
including human (58%), Drosophila (60%), and S. cerevisae (62%). The align,nent is 
produced using Mu/tA/in (Corpet, 1988). In the consensus lines, residues with red, 
uppercase letters are highly conserved (90%). Residues wi th blue, lowercase letters 
are weak/v conserved (not over 50%). A position with no conserved residue (black) 
is represented hr a dot. !for I and V residues, $for L and M residues, % for F and Y 
residues, and #fhr B, D. E, N, Q, Z. 
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1.4.2 The 3D structure of Hsp90 
The N-terminal domain - The highly conserved N-terminal domain of Hsp90 
contains the nucleotide-binding pocket as depicted in Figure 1.21. The first structure 
of this domain was published in 1997 by Stebbins and co-workers who determined 
the structure of human Hsp90 (residues 9-232) in complex with geldanamycin, an 
anti-tumour agent Figure 1.21B (Stebbins et al., 1997). The overall structure of 
human Hsp90 composes two faces of a nine-a helix folding against eight anti-
parallel P strands with a+13  sandwich. At the centre of the helical face, geldanamycin 
occupies a 15 A deep hydrophobic-binding pocket. Geldanamycin upon binding to 
Hsp90 retards cell proliferation with growth inhibition (G150) at a concentration of 13 
nM (Supko et al., 1995). The rate of tumour progression is consequently reduced, 
due to inhibition of the Hsp90-mediated conformational maturation/refolding 
reaction and the subsequent degradation of misfolded Hsp90 substrates (Doong et al., 
2003). 





Figure 1.21. X-ray structures qt Hsp9O N- terminal domains: A) the yeast N-domain 
was solved in complex with ATP (PDB code ]AM]), B) the human N-domain in 
complex with geldanamnycin (PDB code 1 YET. The overall structure of the N-
terminal domain consists of a high/v twisted eight-stranded ,8 sheet covered on one 
face by nine a he/ices. A 15A deep pocket is formed at the centre qt the helical ftice 
with a# sheet as its base. with three he/ices and ci loop forming the wall. 
ATP invo/i'emneizt in Hsp90 functions - A number of lines of evidence 
showed a requirement for the involvement of ATP in Hsp90 functions (Nemato et al.. 
1995: Prodromou et al.. 2000). However the ATP dependence/independence of a 
number of Hsp90 mechanisms was the subject of great debate for several years 
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(Jakob et al., 1996). In 1997 Prodromou and colleagues determined the structures of 
the N-terminal domain of yeast Hsp90 (residues 1-220), in complex with both ATP 
and ADP (Figure 1.21A) (Prodromou et al., 1997), thus proving conclusively the 
involvement of ATP in Hsp90 functions. In each case the co-crystal structures 
revealed the adenine nucleotide occupied the same deep pocket as that occupied by 
geldanamycin in the human structure. Yeast Hsp90 is a homologue of human Hsp90 
(61% identity). At the quaternary level the yeast N-terminal domain of Hsp90 is 
found as a dimeric molecule (Prodromou et al., 1997) which contrasts with the 
human protein which exists as a monomer. In yeast the last C-terminal 0 strands of 
each N-terminal monomer cross over on each other forming a rough cylindrical 
channel resembling a clamp structure (Figure 1.21A). As previously reported when 
ATP fits into the pocket, the conformation of Hsp90 changes (Csermely et al., 1993). 
Prodromou and his team, therefore, proposed that the conformation of this molecular 
clamp could be flexible between a closed and open form (residues 160-168) in the 
presence of ATP (Prodromou et al., 1997). 
The charged linker - Eukaryotic Hsp90s are frequently found to contain 
charged linkers (approximately 50 residues long) which flexibly connect the N-
terminal to the middle domains and help maintain the open conformation of the N-
terminal domains in relaxed states (Meyer et al., 2003). The linkers are found to be 
of different lengths and compositions between both different species and isoforms 
(Pearl and Prodromou, 2001). HtpG, a bacterial homologue to human Hsp9013, 
contains a significantly shorter linker. This charged linker seems to play a simple 
role in connecting the N-terminal domain to the rest of the protein. Louvion et al. 
found that Hsp90-dependent cell survived in the absence of this linker (Louvion et 
al., 1996). 
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The middle domain of HspY() - Recent studies suggested that the Hsp9() 
middle domain acts as a binding site for client proteins including protein kinase 
B/Akt (Sato et al., 2003), tumour suppressor p53 (Sepehrnia et al.. 1996), and 
cytoplasmic steroid receptor (Joab et al.. 1984). The X-ray structure of this domain 
of yeast Hsp90 (residues 273-560) was recently solved and allowed further 
characterisation of the binding region for client proteins (Meyer et al., 2003). This 
middle domain itself comprises 3 district domains with an aI3a sandwich domain 
located at both the N- and C-termini connected by a small a-helical domain (Figure 
1,22). The N-terminal aI3u domain (residues 273-409) contains a loop which is 








Figure 1.22. X-ray structure of the yeast Hsp90 middle domain (PDB code JHK7). 
The Hsp90 N-terminal domain alone shows very little detectable ATPase activity 
requiring contributions from other regions in the protein to promote enhanced 
activity. Accompanied by the catalytic ioop, the outermost phosphate (y) of ATP is 
positioned to undergo the nucleophilic attack of water that causes hydrolysis (Meyer 
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et al., 2003). Next to the catalytic loop centred on F349, an additional loop is formed 
by residues 342-352. V348 and F349 from this neighbouring loop are the key 
residues in the hydrophobic patch proposed to interact with the final helix of the N-
terminal domain in the putative closed conformation. This led to the suggestion that 
the patch acts as an interdomain communicator (Meyer et al., 2003). Mutational 
analysis in the patch region (F349A and F349Q) in yeast resulted in a lower rate of 
growth at 30° and 37°C and also a substantial decrease in in vitro ATPase activity. 
The third domain (residues 435-525) at the C-terminus seemingly folds with an c4ct 
architecture (Meyer et al., 2003). The final 35 amino acids (residues 526-560) of this 
middle domain were not visible in electron density. 
The C-terminal domain of Hsp90 - Two regions with distinctly defined 
functions have been identified in the C-terminus of eukaryotic cytoplasmic Hsp90s. 
Firstly, an inherent dimerisation region (Young et al., 1998). C-terminal domain 
dimerisation is necessary for Hsp90 functions as discussed earlier with the formation 
of the carboxylate clamp. Secondly, this region provides an interaction domain which 
mediates the binding of TPR-containing proteins, the so called TPR-domain co-
chaperones. The large immunophilins including Cyp40 and FKBP5 1/52 are members 
of this group. The nature of the interaction between Hsp90 and the TPR co-
chaperones has been investigated functionally and structurally. The specificity of the 
interaction between the C-terminus of Hsp90 and the TPR-containing proteins was 
first characterised in 1996 with studies on protein phosphatase 5 (PP5), a modulator 
of protein phosphorylation, (Chen et al., 1996). The requirement for the C-terminal 
motif MEEVD (from the extreme C-terminus of the protein) for TPR binding was 
then determined and subsequently confirmed with Cyp40 (Carrello et al., 1999; Chen 
et al., 1998). This particular region is universal for TPR interactions (Owen-Grillo et 
al., 1996). 
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1.5 OVERALL OBJECTIVES AND SELECTION OF TARGET FKBPs 
Understanding FKBP functions - The main focus of this work is to address 
the role(s) of FKBPs thus providing a better understanding of their various biological 
functions. To achieve the goals of the proposed study, five different FKBPs from 
three experimentally and genetically well characterised model organisms were 
focused upon (three from C. elegans, one from N. crassa and one from A. thaliana). 
These proteins were selected to fall into two major categories, thus providing 
examples of single and multi domain FKBPs which are described more fully in the 
following sections. 
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FKBPI2 from Caenorhahditis elegans - Among 8 genes (fkhI-fkb8) in C. 
elegans.fkb-2 encodes an immunophilin FKBP12, a homologue of human FKBP12. 
Figure 1.23 shows an alignment of C. elegans FKBPI2 against its human and 
Drosophila homologues: C. elegans FKBP12 shares 59% and 61% homology with 
human and Drosophila FKBP12 respectively. The cytosolic C. elegans FKBPI2 is 
108 amino acids long with a single ligand binding domain (Figure 1.23). An RNA1 
experiment revealed that disruption of jkb-2 gene results in a reduced brood size 
(Antony Page, personal communication). Details of the expression and purification 
of this protein will be presented in Chapter 3. 
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Figure 1.23. Schematic representation of the domain organisation of C. elegans 
FKBPI2 and an alignment against FKBP12 from human and Drosophila 
mnelanogaster. The levels of homology between CeFKBPI2 and hFKBP12 and 
DmFKBPJ2 are 59% and 61% respectivel. The alignment was made using which 
programme Mu/tA lit? (Carpet, 1988). In the consensus lines, residues with red, 
uppercase letters are high/v conserved (90%). Residues with blue, lowercase letters 
are weak/v conserved (not over 50%). A /)osi!iOn with no conserved residue (black) 
is represented by a dot. .P for I and V residues. $fr L and M residues, f7c .for F and Y 
residues. and #for B. D, E, N, Q. Z. 
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I KBP2Y /roiii Cae,iorluththtis eIcgwis - C. cleans FKBP29 encoded by the 
10-3 gene is a secreted protein expressed in the C. elegans hypodermis. The 
presequence (16 amino acids) at the N-terminus suggested that CeFKBP29 is 
synthesised as a precursor (261 amino acids in length). The mature protein is 
predicted to contain two FKBP domains (residues 17-139 for FKBP domain 1 and 
residues 140-257 for FKBP domain 2) as shown in Figure 1.24. The extreme C-
terminal residues KEEL are an ER-retention signal which suggested that FKBP29 
might be a part of the ER system. Disruption of fkh-3 shows no effect (Antony Page, 
personal communication). Protein production and characterisation will be described 
in Chapters 3 and 4 respectively. 
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Figure 1.24. Schematic representation of the doinauz organisation of C. elegans 
FKBP29. FKBP29 composes two clusters of FKBP domains: FKBP1 (residues 39-
131, broken underlined), FKBP2 (residues 157-251, red thin underlined). Most like/v 
cleavage site is between positions 16 and 17 (underlined, CWA-AN). The final C-
terminal KEEL residues represent an ER-retention signal. 
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FKBP48 firoin Caenorhahditis elegans - FKBP48 is the only large 
immunophilin in C. elegans. The protein composes three separate domains: FKBP 
domains 1 and 2 and a TPR domain (Figure 1.25). The first FKBP domain has been 
solved recently (PDB code 1R9H). The overall structure of this domain is similar to 
FKBPI2. Its TPR domain is believed to have the same function with that of Cyp40. 
FKBP5I, and FKBP52. These three proteins have been well-characterised as the 
Hsp90 co-chaperones via their TPR domains. Therefore this work mainly focuses on 
investigations of interactions between CeFKBP48 and Hsp90 which will be 
explained in Chapters 6 and 7. 
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Figure 1.25. Schematic representation of the domain organisation of C. elegans 
FKBP48. FKBP48 comprises of two clusters of FKBP domains (residues 24-118 for 
FKBPI, broken underlined and residues 141-234 for FKBP2, red thin underlined) 
and additional TPR domain (residues 254-370, pink letters). 
This protein encoded by the ftb-6 gene is expressed in neuronal cells. Disruption of 
fkb-6 results in vulva] defects with an accompanying reduction in brood size (Antony 
Page, personal communication). 
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FKBP22fro,n Neurospora crassa - NFKBP22 is synthesised as a precursor 
protein in cytoplasm and imported into the ER via its cleavable 20 amino acids 
presequence, flanking the N-terminus (Solscheid and Tropschug. 2000). Figure 1.26 
illustrates the domain arrangement of this protein. The FKBP domain (residues 21-
129) is located N-terminally and shows a degree of conservation with human 
FKBP12 (37%) and human FKBP22 (22%) as shown in Figure 1.26. 
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Figurel.26.Scheinatic representation of FKBP22 firoin N. crassa. The levels of 
homology between NcFKBP22 and hFKBPI2 and hFKBP22 are 37% and 22% 
respective/v. The alignment was made using programme Mu/IA/in. In the consensus 
lines, residues with red, uppercase letters are high/v conserved (90%). Residues with 
blue, lowercase letters are weak/v conserved (not over 50%). A position with 110 
conserved residue (black) is represented by a dot. !fir I and V residues, Sfor L and 
M residues, %fr F and Y residues, and #for B, D, E, N, Q, Z. 
I Me 
The NcFBP22 FKBP domain also possesses PPIase activity with k,"/K m of 6.94 x 
i05 M 1 s' and is inhibited by both FK506 (K1 = 4.5 nM) and rapamycin (K1 = 6.2 
nM) (Solscheid and Tropschug, 2000). The C-terminus (residues 136-217) is likely 
to compose a novel domain which may adopt an amphipathic a-helical fold (residues 
136-209). This unique C-domain of NcFKBP22 shows no homology to any other 
known FKBP and contains a high number of polar residues: glutamine (14), aspartate 
(5), and lysine (10). The final C-terminal residues HNEL are an ER-retention signal 
which acts as a recognition site for target protein. This suggested that NcFKBP22 is 
an ER protein involved in protein folding and/or transport of certain proteins into the 
ER (Solscheid and Tropschug, 2000). Protein production, characterisation, and 
structural studies of this protein will be covered in Chapters 3, 4, and 5 respectively. 
FKBP71 from Arabidopsis thaliana - FKBP71 is one of the 17 FKBPs and 
FKBP-like proteins found in A. thaliana: 11 are found as low-molecular-weight 
proteins in the range of 12-27 kDa, 6 as high-molecular-weight proteins in a range of 
42-71 kDa) (Harrar et al., 2001). PAS1 encodes the 71-kDa immunophilin-like 
protein similar to FKBP. FKBP71 is constitutively expressed in plants, except that 
PASJ is up-regulated when plants are grown in the presence of cytokinins (a class of 
phytohormones) (Vittorioso et al., 1998). This protein has a sequence similarity with 
FKBP52 from several mammals such as human and Mus musculus (Faure et al., 
1998). PAS1 regulates cell proliferation and differentiation. Mutagenesis of allele 1 
of the PAS1 (PASJ-1) gene shows a pronounced alteration in development. 
Disruption of PAS1-1 affects cell division with defects in cell proliferation in all 
tissues apart from roots. Sequence analysis shows that FKBP71 contains three FKBP 
domains, and one TPR domain as illustrated in Figure 1.27 (Harrar et al., 2001). The 
additional cluster of the TPR domain might have been acquired over time for plant-
specific structural determinants. Details of the expression and purification of this 
protein will be presented in Chapter 3. 
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Figure 1.27. Schematic representation of the domain organisation of A. thaliana 
FKBP7I. FKBP7I composes three clusters of FKBP domains: FKBPJ (residues 42-
144. broken underlined), FKBP2 (residues 166-257, red thin underlined), and 
FKBP3 (residues 285-380, red thick underlined), and additional TPR domain 
(residues 400-516, pink letters). 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 INTRODUCTION 
This chapter provides details of all the experimental methods used throughout 
the duration of this work. The methods were divided into 2 broad areas; general and 
specific procedures and will be discussed accordingly. The general procedures 
include the conventional techniques of cloning, protein expression/production, 
purification, and crystallisation. These techniques are well known and consequently 
will not be described in great detail. The specific procedures address the 
characterizations of target proteins including for example, protein-protein interaction 
studies by BlAcore. These techniques are not so well established and will therefore 
be described in greater detail. 
2.2 GENERAL PROCEDURES 
2.2.1 Molecular cloning 
Using recombinant DNA technology, genetic information of a desired gene 
can be engineered and transferred from one organism to the other. The particular 
gene is isolated from genomic DNA or a cDNA library, amplified using the 
polymerase chain reaction (PCR) technique, and inserted into an appropriate vector. 
The recombinant plasmid is then introduced into competent cells. Screening of the 
-77- 
gene insert is carried out with the blue/white colony selection. To get the protein 
expressed, the particular gene is excised and inserted into an expression vector. 
Sequencing analysis is carried out to confirm the correct insertion. 
For all cloning experiments described in this work the techniques for plasmid 
DNA minipreps, gel extraction, competent cell preparation and transformation of the 
plasmid DNA into the competent cells were as outlined in the QIAGEN handbooks 
(the QlAprep® Miniprep, QlAquick® Spin, and the QlAexpressionistTM). 
Plasmid DNA miniprep - This technique was routinely used to extract 
plasmid DNA from host cells. The bacterial cells were grown overnight at 37°C in 
10 ml LB broth, supplemented with ampicillin (100 tg/ml). The cells were pelleted 
for 10 minutes at 4°C, 6,000 x g. The cell pellet was resuspended in 250 tl Buffer P1 
(50 mM TrisCl, 10 mM EDTA, 100 j.tg/ml RNAse, pH 8.0) and transferred into a 
sterile eppendorf tube. 250 p1 of Buffer P2 (200 mM NaOH, 1% SDS) was then 
added into the cell suspension and gently mixed. 350 p1 of Buffer N3 (3 mM 
potassium acetate, pH 5.5) was added followed by gentle mixing. The cells were 
pelleted at 10,000 x g for 10 minutes. The supernatant was pipetted onto the QlAprep 
column. After a short spin, the flow-through was discarded. The column was washed 
with 750 .tl Buffer PE. The additional spin was repeated to remove residual ethanol 
from Buffer PE. The plasmid DNA was eluted from the column with 100 j.il Buffer 
EB (10 mM TrisCl, pH 8.5). Small aliquots of the DNA were stored at 4°C. 
Gel extraction - This technique was used to obtain pure DNA from the 
plasmid stocks. DNA was cleaved from plasmids with the appropriate restriction 
enzymes and run on a 1% agarose gel. The band of appropriately sized DNA was 
precisely excised from the gel and placed in a clean preweighed sterile eppendorf 
tube. Three volumes of Buffer QG were added to one volume of the gel slice 
followed by incubation for 10 minutes at 50°C (or until the gel piece had completely 
dissolved). One volume of isopropanol equivalent to one volume of the gel slice was 
then added, mixed, and transferred to a QlAquick spin column. After a short 
spinning, the column was washed with 750 .tl Buffer PE and spun twice at 10,000 x 
g for 1 minute. The desired DNA was eluted with 50 pi Buffer EB and spun at 
10,000 x g for 1 minute. 
Preparation of competent cells - The cells were plated out on a LB-
kanamycin agar (25 .tg/ml) and grown overnight at 37°C. A single colony of the 
cells then was picked, inoculated into 10 ml LB-kanamycin broth (25 pg/ml), and 
grown overnight in a shaker at 37°C. One ml of the overnight culture was diluted 100 
times into the prewarmed fresh LB-kanamycin. After reaching the O.D. 600 reached 
approximately 0.5, the culture was cooled down on ice for 5 minutes. The cells were 
harvested at 4,000 x g, 4°C for 5 minutes, re-suspended in 30 ml cold TFB I buffer 
(100 mM RbC1, 50 mM MnC12, 30 mM potassium acetate, 10 mM CaCl 2, 15% 
glycerol, pH 5.8, sterile-filtered). The suspension was incubated on ice for 90 
minutes and centrifuged as above. The pellet was re-suspended in 4 ml cold TFB II 
(10 mM MOPS, 10 mM RbC1, 75 mM CaC12, 15% glycerol, pH 6.8, sterile-filtered). 
The cell suspension was transferred into 100 j.tl aliquots, quickly frozen in liquid 
nitrogen, and stored at -80°C. 
Transformation of competent cells - 2 tl of plasmid DNA was pipetted into a 
sterile eppendorf tube and placed on ice. The 50 tl aliquot of competent cells was 
thawed on ice, gently resuspended, mixed up with the plasmid DNA, and placed on 
ice for an additional 20 minutes. The mixture was then heat shocked at 42°C for 90 
seconds. 500 p1 Psi broth (LB broth, 4 mM MgSO4, 10 mM KCI) was added and the 
cells were shaken at 220 rpm, 37°C for 60 minutes. 50 and 100 p1 aliquots were 
spread onto LB agar plates containing both 100 pg/ml ampicillin and 25 pg/ml 
kanamycin. The plates were allowed to dry and finally incubated overnight at 37°C. 
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2.2.2 Protein expression 
Expression in Escherichia coli (E. coli) - Production of foreign proteins in E. 
coli is relatively easy and inexpensive. Moreover, rapid duplication of bacteria leads 
to large quantities of protein produced in a short time. A number of E. coli host 
strains are widely used nowadays. Compatibility between expression plasmids and 
host strains are of great importance when designing an experiment. Most of the 
proteins of interest described in this work were expressed under T5 promoter 
transcription-translation system. The candidates were M15(pREP4) and 
SG13009(pREP4). These strains can stabilise the T5 promoter-based plasmids and 
repress the lac operon. Optimizing the conditions of cell growth is another key factor 
to help succeed with high-level expression of the target proteins. Conditions 
producing the optimum levels of the desired target proteins can therefore be a 
combination between a number of factors including the growth media used, 
temperature and the concentration of IPTG used. 
Growth media - Three different media were used for expression trials: Luria-
Bertani broth (LB) (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl), 2XYT broth 
(16 g/L tryptone, 10 g/L yeast extract, 10 gIL NaCl), and terrific broth (TB) (12 g/L 
tryptone, 24 g/L yeast extract, 4 ml glycerol, 12.5 g/L potassium phosphate 
monobasic, 2.3 g/L potassium phosphate dibasic). 
Antibiotics and chemical inducer - Stock solutions of ampicillin (100 
mg/ml), kanamycin (25 mg/ml), and isopropyl 3-D-thiolgalactopyranoside (IPTG) 
(1M) were freshly prepared in sterile-filter water. 
Small-scale expression - The following factors were optimised to obtain high 
levels of target protein expression; media, temperature, a concentration of IPTG, and 
time. A single colony of the cloned cells was selected and inoculated into 10 ml of 
each of three different trial media (LB, 2XTY, and TB). The media for MiS growth 
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contained 200 pg/ml of ampicillin and 25 Jtg/ml of kanamycin; whilst those for 
XL10 cells contained only 200 pg/ml of ampicillin. Different requirements for 
antibiotics were due to the use of different expression systems. In the QlAexpress 
system used for FKBP22/48/71 expressions, pREP4 plasmids express lac repressor 
proteins which bind the lac operon of the host cells and regulate the expression of the 
target proteins. Growing the MiS cells, therefore, additionally requires kanamycin 
supplement to maintain the pREP4 repressor plasmids. These cultures were 
incubated overnight at 37°C in a shaking fermentor. The overnight cultures were 
diluted 50 times in 100 ml of fresh media supplemented with the appropriate 
antibiotics. The cells were allowed to grow under strong agitation until the desired 
cell density reached 0.6 (O.D. 600). A 1-ml sample from each culture was taken at this 
time and immediately spun down. The cell pellets were resuspended in lx SDS-
PAGE sample buffer and stored at -20°C until required. The temperature of the 
culture was adjusted to the temperatures under test of 18°, 24°, 30°, and 37°C. IPTG 
at a final concentration of 1 mlvi was added to each culture set. The cultures were 
further agitated for 4 hours, with samples being taken every hour post induction to 
monitor protein expression levels over the induction period. After four hours, the 
cells were centrifuged at 4,000 x g, 4°C for 10 minutes. 
Large-scale expression - Following the Optimisation of expression 
conditions, the production of the target proteins was scaled up. The final level of 
target protein expression from each of the constructs helped determine the volume of 
culture required to produce crystallographic quantities of highly purified target 
protein. One litre of a prewarmed medium was routinely inoculated with 20 ml of an 
overnight culture. The optimal conditions for each protein expression (as determined 
from pilot experiments) were also used in the large scale cultures. Following 
induction, the cells were harvested at 9,000 x g for 10 minutes, the supernatant 
discarded and the pellets resuspended in lysis buffer and frozen at -20°C. 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) - 
The Miniprotean II gel electrophoresis system (Biorad) was routinely employed for 
SDS-PAGE analysis. The gels were freshly prepared (12% resolving gels for 
FKBP12IFKBP22 and 15% gels for the rest of proteins). The protein samples were 
loaded onto the gels under buffer, a molecular weight marker track (prestained 
protein marker broad range, New England biolabs, cat. no. P7707S) was included to 
allow a quick comparison between the bands seen on the gel and well characterised 
proteins of defined molecular weight. The gels were electrophoresed with the 
following settings 200 volts (V), 400 milliampere (mA) for 45 minutes. The proteins 
were visualized by coomassie blue staining of the gel followed by destaining with a 
solution of acetic (10%), methanol (10%) in water. 
2.2.3 Protein purification 
Purification of target proteins of interest in this work was achieved using 
affinity and ion exchange chromatography. The target proteins were expressed with 
either a "carrier" protein or a relatively small affinity tag to facilitate purification, 
dependent upon the choice of vector used in cloning. The use of such fusions of 
target protein with another protein i.e. MIBP have been shown in some cases to help 
with the solubility of target proteins. In these cases, the proteins of interest were very 
soluble. Additionally, using the affinity tag, protein purification can theoretically be 
achieved in one-step. Two recombinant protein/fusion systems were used in this 
work, maltose binding protein (IMIBP) and polyhistidine (His6). MBP was encoded by 
the malE gene at the upstream position from the multiple cloning site of pMALTM c2 
vector. It acted as the signal protein enhancing protein expression in E. coli 
cytoplasm (Kapust and Waugh, 1999). His-tagged fusion can be placed as an 
extension to either the N-terminus or C-terminus of the particular protein as required. 
Special ligation of additional proteins adjacent to the His tags can be used for 
expressions of small proteins (QIAGEN). 
MBP fusion system - As expressed by the pMAL expression system, FKBP12 
and FKBP29 were purified using a maltose gradient elution. The MBP-based fusion 
proteins generally bind tightly amylose immobilised on an otherwise inert matrix. At 
low concentration of maltose, both proteins bound to amylose specifically. Protein 
elution depended on increasing maltose concentration. The elution occurred when the 
concentration of maltose increased sufficiently to displace the MIBP fusion proteins 
previously bound. Cleavage of MBP from the target proteins was carried out using 
factor Xa. This protease specifically recognised Ile-GlulAsp-Gly-Arg. The cleavage 
occurred preferentially after the arginine residue. Separation of the target proteins 
from MIBP was achieved by an anion exchange chromatography. 
His-tagged system - The immobilised metal affinity chromatography (IMAC) 
method was used to purify FKBP22, FKBP48, and FKBP71. This technique is 
principally based on the binding property of amino acid side chains to metal ions 
(Porath et al., 1975). These three proteins were expressed under the pQE expression 
system that carries the sequences encoding for six histidine residues (6xHis) at the N-
terminus. This hexapeptide tag has strong affinity for transition metal ions. To form 
the interactions, the transition metal charges (Ni 2 ) were chelated to chromatographic 
matrices. The matrices used in this work were synthesized with nitrolotri acetic acid 
(NTA). This adsorbent matter generated tighter coordination of 6 chelating Ni 2 . On 
the basis of tetradentrate chelating technology, the ligand interaction sites were 
occupied by four of six Ni 2 ions (Figure 2.1). The other two ions were free to 
capture the His-tagged target proteins. The chemical structure of histidine composes 
an imidazole ring that can bind to immobilised Ni 2 . At physiological pH 8.0, 
histidines bind by sharing electron density of the imidazole nitrogen with the 
electron-deficient orbitals of Ni 2 . The recombinant polyhistidine-tagged proteins 
were eluted when the concentration of imidazole in the eluion buffer is increased to 







Figure 2.1. Representative diagram of interaction of nickel ion with nitrotriacetic 
acid in Ni-NTA matrices. Diagram based on one in the QlAexpressionist handbook. 
2.2.4 Protein quantitation 
UV absorption at 280 nm (A280) - This technique was developed from the UV 
absorption properties of the aromatic amino acids. The protein concentration (mg/ml) 
is directly proportional to the protein absorbance at 280 nm. Each protein was 
solubilised in a buffer similar to a blank. To determine the protein concentration, the 
A280 of protein already subtracted from the A280 of blank was divided by the 
Extinction coeffiecient (cm 1 M 1 ) as illustrated in equation 2.1 
c = A280/cb 
	
(2.1) 
where c = concentration of protein (M), A 280 = absorbance reading at 280 nm, E = 
extinction coefficient (cm'M'), b = path length (cm). The Extinction coefficients for 
each given protein (CeFKBP12/29/48 = 8,250, 31,960, and 39,640 cm'M 1 
respectively, NcFKBP22 = 12,210 cm'M 1 , and AtFKBP71 = 53,700 cm- 'M-1 ) were 
IM 
determined from their protein sequences using the ProtParam calculation programme 
(http://www.expasy.org/tools/protparam).  
Ultrafiltration - Purified proteins were concentrated by ultrafiltration. A 
number of ultrafiltration devices are commercially available. The devices essentially 
compose membranes of specified pore size, each providing a defined molecular 
weight cut-off (M\VCO). As a rough guide, the appropriate MWCO to use is one-
third of the molecular size of the target protein. The protein of interest is 
concentrated as the sample is centrifuged as particles smaller than the MWCO pass 
through the membrane whilst the protein molecules are retained. 
2.3 SPECIFIC PROCEDURES 
A variety of techniques were used mainly to characterise the proteins of 
interest. These techniques can be grouped into three broad classes. Biochemical 
techniques verified the enzymatic activities of the proteins. Biophysical techniques 
addressed the physical characteristics of the proteins, e.g. molecular weight, protein 
structures. Molecular modelling/Protein-protein interactions used available structural 
data and surface plasmon resonance studies to provide insight into possible protein 
functions. 
2.3.1 Biochemical techniques 
2.3.1.1 Peptidyl prolyl cis-trans iosomerase (PPlase) assay 
This assay measures the catalytic rate of conversion of the cis-trans 
isomerisation reaction of proline peptide (Xaa-Pro) bonds. The isomerisation rate is 
determined by the accumulation of chromogenic dye released following 
chymotrypsin cleavage of the standard peptide substrate (succinyl-Ala-Xaa-Pro-Phe-
p-nitroanalide) which occurs only when the substrate is in the trans conformation. 
The accumulation of the 4-nitroanilide (pNA) is observed on a spectrophotometer 
over the time course of the experiment. 
Chemicals, solvents, and buffers - The specific substrate (Suc-Ala-Leu-Pro-
Phe-p-NA, Bachem) for FKBPs was dissolved as a 100 mM stock solution in 470 
mM LiCl/trifluoroethanol (TFE) (Kofron et al., 1991). A stock (0.1 MM) of 
chymotrypsin (Calbiochem, cat. no. 230832) was prepared in an assay buffer (50 
mM HEPES, 100 mM NaCl, pH 8.0). The enzymatic activities were performed on a 
lambda 20 spectrophotometer (Perkin Elmer) with temperature controller, PTP- 1 
Peltier Sytem. 
Assay techniques - PPIase activities of target FKBPs were assayed as 
described (Fischer et al., 1984) with modifications by Kofron (Kofron et al., 1991). 
The proteins were prepared as a stock (30 j.tM) in the assay buffer. 865 tl of an assay 
buffer and 10 j.il of protein stock were mixed in a 1 ml cuvette and incubated on ice 
for 30 minutes. 100 j.tl of the chymotrypsin stock was also added and then 
equilibrated in the thermostated cell holder until the temperature was steady at 4°C. 
The assay reaction was then started by adding 25 ptl substrate followed by rapid 
mixing. Chymotryptic cleavage of pNA was observed at 390 nm for 10 minutes. The 
proteins were assayed with a series of substrate concentrations (100-600 tM). 
Steady-state kinetic parameters for PPIase substrate were determined using nonlinear 
least-squares Optimisation of Km and V,, in the Michaelis-Menten equation; 
V = Vrnax[S1I([S]+Km) 	 (2.2) 
where v = velocity, V 	= maximal velocity of the enzymatic reaction, [5] = 
concentration of substrate, Km = the substrate concentration resulting in half-maximal 
velocity. 
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2.3.2 Biophysical techniques 
2.3.2.1 Mass spectroscopy 
The protein solutions were characterised on a mass spectrometer (Applied 
Biosystems Voyager DE-STR MALDI-TOF mass spectrometer) to verify the precise 
molecular weights of target proteins. Thanks to Dr. Andrew Cronshaw and 
colleagues, Institute of Structural and Molecular Biology (ISMB), University of 
Edinburgh for the mass spectrometric analysis. 
2.3.2.2 Dynamic light scattering 
Dynamic light scattering (DLS) is a widely used technique with a broad range 
of applications. It is a useful tool in predicting success in the crystallisation of 
proteins (Zulauf and D' Arcy, 1992). This technique determines the size of particles 
by correlating changes in scattering of monochromatic beam of laser. Therefore, 
proteins can be distinguished as a monomer or dimer. 30 out of 35 proteins 
characterised with monodisperse profiles were successfully crystallised (D' Arcy, 
1994). In this work, homogeneity of the purified proteins of interest in solutions was 
seen before crystallisation trials commenced. 
Experimental aspects - The diagram below shows the theoretical background 
of the technique. A beam of monochromatic light is passed through the sample 
solution. The electric field of the light induces oscillation of the particles in the 
sample which results in the scattered light. These particles are assumed to have a 
spherical shape with random movement (Brownian motion) in the solution. The 
fluctuations of the intensity of the scattered light are detected and amplified by the 
photomultiplier. The signal is then transformed to electronic pulses. The pulses are 
read by an analysis package which counts the number of photons detected in each 
time period. Correlation of the change of incoming light and the size of particles is 
determined as estimated molecular weights of particles, the spread of particle size 
(polydispersity), and the quality of fit of monomodal analysis (baseline and sum of 
square). 
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Figure 2.2. Diagram of common instrumental setup of dynamic light scattering. 
Data interpretation - Three main parameters are normally considered when 
analysing dynamic light scattering results. First, the polydispersity value indicates 
the standard deviation based on the mean radius measurement measured. Any 
polydispersity value below 15% of hydrodynamic radius signifies a negligible 
polydispersity or a monodisperserse solution. A value over 15% represents a 
polydisperse sample. Second, the baseline parameter represents the completeness of 
fit to the autocorrelation function. Baselines between 0.997-1.001 represent a 
monomodal distribution. A baseline greater than 1.005 suggests a polydisperse 
distribution. Third, the sum of squares (SOS) parameter represents the amount of 
residual noise or error associated with the autocorrelation function. Any SOS 
parameter around 1.0-5.0 is negligible error/low noise. The SOS values in the range 
of 5.0 to 20.0 are somewhat significant background error due to a small amount of 
polydispersity. SOS values greater than 20 are reflective of signal noise/error due to 
high polydispersity in size distribution. 
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Materials - All the trials were carried out at 4°C using a DynaPro 801 from 
ProteinSolutions, Inc. The machine was fitted with a microsampler system which 
was used to enable the analyses to be carried out on very small sample volumes. 
Methods - The purified proteins were prepared at several concentrations (1-5 
mg/ml). 20 tl of filtered protein sample at each concentration was applied into a 
quartz cuvette and placed into the sample chamber. The sample was first briefly 
examined to see if it was suitable for further analysis. To get reliable data from this 
system the particle count rate must be very stable and fall within established 
parameters. A number of preliminary experiments may be required to determine the 
optimum protein concentration to use in the analysis. 
2.3.2.3 Protein crystallisation 
Attempts were made to characterise the proteins of interest using 
crystallographic techniques. The method involves obtaining quality protein crystals. 
To obtain suitable crystals, proteins are precipitated from their liquid states. The 
crystals are placed in an X-ray beam for diffraction screening. The data from 
diffracting crystals are collected and processed. 
Handling of protein samples - Protein samples for crystallisation should be 
very highly purified (>95%) and concentrated (normally at least 10 mg/ml). A 
number of studies (Cudney and Patel, 1994; Giege et al., 1994) have shown a strong 
correlation between the degree of purity of a protein and the likelihood of it being 
crystal successfully. Proteins should be dissolved in a well characterised buffered 
solution. Small aliquots of proteins were stored at 4°C until required. 
Initial screening - It is very difficult to predict conditions which will 
crystallise any given protein, however there are a number of parameters that can 
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easily be investigated during the initial screening process. These parameters include 
temperature, protein concentration, pH, additives, degree of purity/homogeneity of 
the target molecule and the nature of the precipitants used. Proteins are brought to 
their solid states (supersaturation) by gradually increasing the concentration of 
precipitant(s) in the drop. Figure 2.3 illustrates the solubility curve for proteins 
against increasing precipitant concentration. Crystals of proteins can successfully 
grow in the metastable zone when low levels of supersaturation are present. A high 
degree of supersaturation (the labile zone) favours the formation of nuclei which may 
become small crystals. Typical precipitants are salts, polyethyleneglycol (PEG), and 
their derivatives. By salting-in or salting-out, the concentration of proteins are 
increased which gradually leads to hydration of molecules of proteins and salts. 
Formation of the protein crystals commences. If conditions are favourable, the small 
molecules may develop into a crystal lattice. pH and temperature are very important 
variables when considering the growth of protein crystals. There are a number of 
commercially available screening kits which adopt a 'sparse matrix" approach and 
allow rapid screening of the solubility of a protein against a wide range of pH's and 
precipitants. In addition to the kits, preliminary crystallisation trials should also 
incorporate simple screens with ammonium sulphate or PEG against a broad pH 
range to determine a solubility curve for each protein. 
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Figure 2.3. Schematic diagram of solubility curve of proteins. Supersaturation is a 
function of the concentration of proteins in the Y-axis against parameters affecting 
its solubility (pH, precipitant, temperature, etc). Supersaturation accommodates 
crystallisation in two different zones: labile (higher) and metastable (lower) zones. 
Labile zone supports nucleation and growth. Metastable zone supports crystal 
growth only. No crystal formation and growth is found in the stable zone. Diagram 
based on Figure 1 (Saridakis et al., 1994). 
Optimisation - Following close examination of crystallisation trials, 
conditions that lead to the growth of crystals or a useful precipitate are sequentially 
refined to improve crystal quality/grow crystals. To achieve this, the initial 
conditions are modified. This might include incremental changes in pH, protein and 
precipitant concentration, and temperature. Different buffers, addition of additives, 
and the use of microseeding technique might also prove useful in producing crystals 
of sufficient quality for X-ray diffraction studies (Cudney and Patel, 1994). 
Preparation of crystals for data collection - Protein crystals are fairly fragile 
and require gentle handling and manipulation to minimize damage. All data 
collections were carried out on frozen crystals as flash cooling the crystals to -196°C 
has been shown to reduce radiation damage and hence prolong crystal life in the X-
ray beam (Garman, 1999). Crystals were transferred from mother liquor into freezing 
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solution using an appropriately sized cryoloop (Teng, 1990), incubated in freezing 
solution for approximately 5 seconds, and flashed in liquid nitrogen. Routinely 
crystals were screened by taking one image to determine the quality of the diffraction 
pattern seen; well diffracting crystals were then used to collect a full dataset. 
Materials - 24-well Linbro plates an alpha-numeric template, 22 mm round 
glass siliconised coverslip and paraffin wax were required for crytallization trials 
using the hanging drop technique. 
Crystallisation technique - The crystallisation trials in this work were carried 
out using the hanging drop technique, a vapour diffusion method. This technique 
depends on diffusion of volatile agents or water between a droplet of mother liquor 
and a large reservoir solution. The first step in each vapour diffusion experiment was 
to prepare and clearly label a 24 well Linbro plate. The tops of each well were 
covered with a thin layer of paraffin wax. Each component of the final mother liquor 
well was then added to the well followed by mixing. A 2 pA droplet of protein at the 
required concentration was pipetted onto a siliconised coverslip. An equal volume of 
mother liquor was added to the protein droplet and mixed well. The coverslip was 
then inverted and sealed onto the top of the appropriate well. The drops were 
immediately examined under a microscope. Any change in the appearance of the 
drops was closely monitored by microscopic examination of the plates at regular 









Figure 2.4 Sche,natic diagran of hanging drop vapour th/Jision crystallisation 
process. A crvstallisation drop made U %i'ith ci mixture o.tpro(ein  and mother liquor 
is placed over a reservoir of mother liquor. The drop normally contains a lower 
concentration of reagent than the reservoir. Water there tre vaporises and ends up 
in the reservoir to produce equilihriumn. As water leaves the drop, the concentration 
of protein sample and reagent increases to relative supersaturation that could 
produce crvstallisation of the protein. 
2.3.2.4 Small angle X-ray scattering (SAXS) 
This technique was used to determine the preliminary structure of FKBP48 in 
solution. 
SAXS theory - Small angle X-ray scattering has developed from advances 
made in the technology behind X-ray optics and detectors and provides an 
opportunity to probe a wide range of polymeric molecules including biological 
macromolecules. These molecules basically have the abilities to scatter 
electromagnetic radiation at certain wavelengths. In SAXS. X-rays disturb electronic 
charges in the molecules under observation (Figure 2.5). The exciting charges then 
scatter the light. From different sample positions exposed to X-ray, the molecule 
provides different scattered intensities. Thus, scattering data is analyzed to predict 
the molecular shape (radius of gyration) and the distance between atoms (p(r)). High 
energy X-rays are not scattered much, so data can only be collected at low angles 
(lower than 15 degrees). The intensity of scattered beam is recorded on a detector. 
This technique can also be useful in determining structures of proteins which are 
difficult to crystallise. In addition, SAXS can be applied to crystallised proteins, and 
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the resultant data can be used to compare conformational differences between their 
solution and solid state forms. 
Figure 2.5. Schematic diagram of a basic instrument of small angle X-ray scattering; 
1: X-ray generator, 2: monochromator, 3: vacuum flight tube, 4: vacuum sample 
chamber, 5: goniometer and sample, 6: vacuum flight tube, 7. beam stop chamber, 8: 
detector. 
Materials - Investigation into the structure of FKBP48 using SAXS was 
performed by Miri Hirshberg. Data was collected at station 2. 1, SRS, Daresbury. 
2.3.2.5 Co-immunoprecipitation 
The rationale behind this immunological technique is the formation of a 
complex of the target antigen (protein) with an antibody which has been specifically 
raised against it. The resultant immune complexes are then pulled down (or out of 
solution) in a second step by addition of the appropriate antibody binding protein 
(protein A/G, dependent upon the antibody used) followed by centrifugation and 
extensive washing to remove any unbound contaminating proteins. SDS-PAGE 
analyses followed by Western blotting were the techniques subsequently utilised to 
characterise the proteins isolated in this way. 
Materials - Monoclonal immunoglobulin G 1 (IgG 1 ) antibody (AC88, 
Stressgen Biotechnologies) raised against mouse was used in the 
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immunoprecipitation series. The Cyp40 antibody was a gift from Dr. T Ratajczak, 
Australia. 2X IF buffer was made up with 30mM NaCl, 20mM Tns pH 7.4, 2mM 
EDTA, 2mM EGTA pH 8.0, 0.4mM sodium orthovanadate, 2% triton X-100, and 
1% IGEPAL CA-630. For comparison, the co-precipitation of bCyp40 with Hsp90 
was also examined. Protein A and protein G Sepharose were from Sigma. 
2.3.2.6 Western blot 
Western blot technique - The Semi-dry technique was used for protein 
transfer in this series of experiments. Briefly, the nitrocellulose membranes and SDS 
gels were soaked in transfer buffer (25 mM Tris, 190 mM glycine, and 20% 
methanol). Electrical transferring was performed at 15 mV for 30 minutes. The 
membranes were then soaked in blocking buffer (137 mM NaCl, 0.27 mM KCI, 1 
mM Na2HPO4, 0.2 mM KH2PO4, 0.1% Tween 20, 0.5% milk powder) for 1 hour at 
room temperature and incubated with the primary antibody at 4°C for at least 3 
hours. Following an additional incubation with the secondary antibody, visualisation 
of the immunological bands was achieved by alkaline phosphatase reactions. 
2.3.2.7 Gel filtration 
Gel filtration 	chromatography 	technique 	- 	Separation 	of 
CeHsp90/CeFKBP48 complex was performed on Sephacryl 16/60 S-300 HR column 
(Amersham Biosciences) connected to the semi-automated BioCad system 
(Perceptive Biosystems). The Sephacryl 16/60 S-300 HR column has a separation 
range of 10-1,500 kDa and bed volume of 120 ml. The column was equilibrated with 
1 column volume of running buffer (50 mM Tris, 150 mM KCI, 5 MM  MgC1 2 pH 
7.5) at 0.5 ml/min. The mixture of CeHsp90/CeFKBP48 was prepared at 30°C for 30 
minutes. 1 ml of the mixture was injected to the column (same flow rate). All eluent 
fractions were collected automatically. The peak fractions were analyzed on SDS-
PAGE. In addition, three control runs of CeHsp90 alone, CeFKBP48 alone, and 
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molecular weight standards (Gel Filtration LMW Calibration Kit ranging between 
14-2,000 kDa, Amersham Biosciences) were carried out. 
2.3.2.8 Surface plasmon resonance (SPR) 
Surface Plasmon Resonance (SPR) spectroscopy is a quantitative method that 
is used to measure the interactions of biomolecules. When polarised light hits a gold 
film under analyte-free condition, the light is then reflected (Figure 2.6A). Analyte is 
injected into a continuous flow of running buffer. Using the advanced microfluidics 
system in the BlAcore X and 3000 models, analyte passes over the coupled dextran 
layer. The ligand captures the analyte based on a specific affinity which in turn 
changes the angular reflection of light. This change is represented as an SPR signal 
in arbitrary units. The trace of the signal is called a sensorgram and represents matter 
happening when the two molecules were in contact (Figure 2.6B). Before addition of 
an analyte the response signal is at baseline. When an analyte is passed over the 
surface, the signal increases if an interaction occurs, eventually reaching a steady 
state. The signal then decreases as the concentration of available analyte diminishes. 
The complex then finally dissociates. 
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Figure 2.6. Schematic diagram of surface plasmon resonance technology A), and the 
resulting output, the "sensorgrain '', B), 1: equilibration, 2: association phase, 3: 
dissociation phase. 
Sensor chip chemistry — The interactions between bio-molecules take place in 
real time on the sensor chip surface. Under BlAcore manufacturing, a sensing gold-
coated surface carries a self-assembled monolayer of alkanethiols to avoid self-
adsorption to proteins. The back of a thin gold film is a reflection site absorbing and 
converting incident light into an electron density wave called plasmon. In the chip 
most frequently used for the series of experiments described in Chapter 6. 
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carhoxymethylated dextran is covalently attached to the other side of the conductive 
film. One molecule of the pair to be analyzed (the ligand) is coupled onto the dextran 
surface (Figure 2.7). The other molecule (the analyte) is passed over the ligand 
bound to the dextran. If the two interact the analyte is specifically captured during 
the association phase of the experiment. 
coo 	COO coo- COO • COO 
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Dextran layer 
Gold-coated h iii 
Figure 2.7. Diagram of a cross-section through a CM5 hiosensor chip. The CM5 
chip composes a gold-coated .tulmn  and a carboxvmeth rioted dextran surface. The 
gold layer  provides the chip with a surftice with a high conductivity. The dextran 
surftice is rich in negative charges and provides a surface to which a ligand can be 
coupled under acidic conditions. 
Using SPR technology, the analysis of bio-molecular interactions is not limited to 
protein-protein interactions only. Interactions between DNA-DNA, DNA-protein, 
lipid-protein, and protein-small-molecules can also be studied. Choosing the 
appropriate chip type and a coupling chemistry for studies of biomolecular 
interactions is the primary consideration. In this work, the CM5 sensor chip was 
chosen for all SPR experiments and used standard amine coupling chemistry to 
attach the ligand molecule to the dextran surface of the chip. 
Ligand coupling chemistries - Several covalent immobilisation techniques 
have been developed to support this system. Well-established techniques are amine (-
NH2), thiol (-SH). aldehyde (-COH). and streptavidin/biotin coupling. The difference 
between the techniques is the reactive groups present on the modified dextran 
surfaces. Crucial in determining which chip/coupling chemistry to use for an 
experiment is the nature of the ligand to be attached, different approaches will be 
required for different ligands including nucleic acids, peptides, proteins, or 
polysaccharides. A ligand can be captured onto a chip surface in two ways, 
permanently (direct attachment to a surface) or temporary immobilisation 
(attachment to another capturing molecule bound to the surface). As with the 
majority of biophysical techniques it is useful to integrate all that is known about the 
ligand into the experimental plan i.e. ligand size, amino acid composition, p1, and pH 
stability are useful in determining an appropriate immobilisation method. The 
diagram in Figure 2.8 illustrates the standard amine coupling chemistry used on 
dextran surfaces. A more comprehensive discussion of the practical detail behind the 
coupling chemistries can be found in BlAapplication handbook supplied by BlAcore. 
EDC/NHS  
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Figure 2.8. Diagram showing the chemical modification of standard amine coupling 
required to enable a variety of coupling chemistries to be used to attach the ligand 
molecule to the surface of the CM5 chip. This coupling technique was used 
throughout this series of experiments. 
Amine coupling is the technique typically recommended as a good starting point due 
to its simplicity. N-hydroxysuccinimide esters are methylated to the carboxymethyl 
groups using EDCINHS (1 -ethyl-3 (3-dimethyaminopropyl)-carbodiimide 
hydrochloride/N-hydroxysuccinimide). The ester groups then spontaneously form 
covalent bonds with amine groups on ligands. Therefore, this technique is generally 
suitable for most macromolecules (used as ligands) containing amine groups. 
Technically, the method is quick and straightforward (no modification of the ligand 
required). Nevertheless, this chemistry is of limited use when ligands are very acidic 
(p1 < 3.5) or are amine-rich in the binding pocket. An amine rich analyte binding 
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pocket is problematic due to likelihood the protein will orientate binding pocket 
down onto the chip surface. 
Kinetic studies - Determination of kinetic parameters of biomolecular 
interaction can be carried out using SPR techniques. In this work, the interaction 
scheme was simply described with the assumption of a 1:1 binding ratio as illustrated 
in equation 2.3: 
ka  
L+A 	 LA 	 (2.3) 
kd 
where L = ligand, Hsp90, A = analyte, FKBP48, ka = association rate constant (s 1 ), 
kd = dissociation rate constant (M-'s- I  ). With a fixed concentration of ligand, Hsp90 
on the chip surface, the quantities of target complex the equilibrium were defined. 
The raw data was fitted to a simple ligand binding model as described in equation 
2.3. The dissociation constant (KD) and the association constant (KA ) of FKBP48-
Hsp90 interactions were determined SigmaPlot with the following equation 2.4: 
Req 	= 	(Rmax [A])! (KD + [A]) 	 (2.4) 
where Req = equilibrium response value, KD = the dissociation constant, [A] = 












Figure 2.9. A plot of the equilibrium dissociation constant (KD) estimation. The KD 
value can be estimated at where a half of the equilibrium response units is reached. 
The curve of Req against the concentrations of free analyte was plotted to evaluate 
how well the raw data fitted to the model (Figure 2.9). The maximum signal (RMax) 
was read when the response plateaued. The value of KD was determined as the 
concentration where half RMax  was seen. This meant 50% of CeHsp90 binding sites 
were occupied with that amount of FKBP48. 
Materials - Full length C. elegans Hsp90 (CeHsp90) and the C-terminal 
domain of human Hsp90 (hHsp90-530_724) were employed as ligand molecules. 
Full length Hsp90 was originally cloned by Dr. A. P. Page. The group of Dr. T. 
Ratajczak, Western Australian Institute for Medical Research, University of Western 
Australia, cloned the C-terminal domain of hHsp90-530_724. The measurements of 
binding were on the basis of real-time BIA technology developed by BlAcore. The 
coupling kit, sensor chips CM5 (research grade), and HSB-EP running buffer (10mM 
HEPES, 150mM NaCl, 0.1mM EDTA, 0.005% surfactant P20 pH 7.5) were also 
manufactured by BlAcore. Binding measurements of CeFKBP48 and the two forms 
of Hsp90 were characterised at 25°C. CeFKBP48 binding to the hHsp90-530 
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fragment were measured on a BlAcore 3000, a fully automated system. All other 
studies were carried on a semi-automated BlAcore X installed at the laboratory of 
Professor Alastair Aitken, School of Biomedical and Clinical Laboratory Sciences, 
University of Edinburgh. There were three main steps of operation, immobilisation, 
association/dissociation, and regeneration. 
Immobilisation - To determine the proper conditions for immobilisation of 
each of the ligand proteins to the sensor chip, the pre-concentration technique was 
used. From among these different coupling buffer pH's, the one at which the best 
level of immobilisation was seen was chosen for the experiments. The ligand was 
then directly coupled onto the chip surfaces by standard amine coupling chemistry. 
Association and dissociation - Association and dissociation occurred during 
the interval of analyte diffusion. In continuous flow mode, the association phase 
began when an analyte started encountering the surface. The dissociation started after 
the sample diffusion stopped. 
Regeneration - In real-time biomolecular interaction studies, complete 
regeneration of the chip surface is necessary. This requires a step in the protocol that 
is used to remove remaining analyte still bound to the chip surface after the 
dissociation phase of the experiment. Complete regeneration would therefore return 
the observed RU to that seen prior to application of the analyte, ensuring the ligand 
binding sites were once again free and available for interaction prior to application of 
the next analyte. Thus effective regeneration reproduces the original surface binding 
capacity of the chip allowing direct comparisons between analytes tested on the same 
chip. The dextran surfaces to which high acidic or high salt solution are applied were 
regenerated at the end of each sample application. 
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2.3.2.9 Nuclear magnetic resonance (NMR) 
Nuclear magnetic resonance techniques utilise the phenomenon of the 
intrinsic nuclear spin of protons to determine chemical structures of biological 
molecules in dynamic environments under almost physiological conditions. 
Electrostatic particles (proton, neutron, and electron) holding together in an atom 
have physical properties for charge, mass, and spin. When a proton spins, it produces 
a small magnetic dipole along the spin axis (Figure 2.10) called the nuclear magnetic 
moment. In a presence of a magnetic field (130), the nuclei become aligned either 
with or against the field. 
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Figure 2. 10. A schene of magnetic moment rearrange,nents in an applied magnetic 
field. Without an applied field, alignments of nuclei spins are rando,n. When the 
nuclei are placed in the magnetic field applied, their spinning axes are rearranged 
either reinforcing (+112) or opposing (-112) to the applied filed. During the 
experiment, rathofrequencv pulses are applied and absorbed by the nuclei. If the 
radiofrequency is at the same energy as the difference between the 2 energy levels, 
the nuclei then reorient and release the energies, refrrred to a resonance. 
NMR spectroscopic techniques rely upon NMR phenomena to study the 
biological, chemical, and physical characteristics of molecules. Resulting spectra, 
showing line positions, intensities, line widths, multiplicities, and transitions (in 
time-dependent studies) can be interpreted as molecular structures, conformations, 
motions, and kinetics. Currently a number of NMR spectroscopic techniques are 
specified ranging from basic to advanced. All NMR studies carried out in this work 
were based on a simple ID technique, proton spectroscopy. Some fundamental 
principles related to the experiments performed in this study are given below. 
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Chemical shift - Under an external magnetic field (B 0), electrons circulating 
around a nucleus bring on a second magnetic field which opposes the external field. 
The opposite circulation of electron magnetic field against the applied field is called 
nuclear shielding. The magnitude of the opposing field is typically 10 -6 times that of 
the static field and is dependent upon the chemical environment of the nucleus. The 
chemical shift is used to monitor nuclei in different chemical environments by 
comparing to the resonance frequency of each nucleus to the standard (e.g. TMS) in 
units of parts per million (ppm). 
Proton ('H) chemical shifts - When the same nucleus is placed in different 
chemical environment, it provides a different proton chemical shift. For example, 
electronegative group bonded to a 'H deshields the electron distributions surrounding 
the nucleus and gives rise to a chemical shift value for that proton shifting downfield 
(to higher ppm values). The diagram in Figure 2.11 shows the range of 'H chemical 
shifts as types of compounds. 
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Figure 2.11. The correlation ranges qt h drogen-bonded proton. 
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Aromatic ring currents - Electron distributions in aromatic molecules can 
induce magnetic shielding and deshielding (Juselius and Sundholm. 2000). Proton 
chemical shifts of aromatic rings are strongly influenced by electron motion in the 
ring currents (Morao and Cossio, 1999) (Figure 2.12). The ring currents are produced 
by the conjugated it-electron system. The it-system causes a non-uniformity of a 
magnetic field (anisotropy). Hydrogens located above and below the plane of the ring 
are shielded and therefore appear at the lower ppm values, whilst ones on the planar 




Figure 2.12. Diagrammatic representation of aromatic ring currents produced by a 
benzene ring. The circulation of individual electrons (in orange) opposes the 
external field (B0). Except for the peripheral hydrogens (in green with stars), their 
electron circulations align with the external field (deshielding), which reinforces the 
external field. 
Relaxation - In the NMR process, relaxation is the process by which nuclei 
return to their ground states after excitation by the radiofrequency pulses. The excess 
energies are lost or dispersed to the environment. A timescale of nuclear relaxation 
can be indicated from spectral line widths (Full-width-half-height of a peak). 
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Proton NMR spectroscopy - The proton or hydrogen ( ' H) spectroscopy is a 
routine process to excite nuclei of hydrogens with a single radiofrequency pulse then 
detect the free induction decay (FID). The FID is finally Fourier transformed to a 
resulting spectrum of frequency versus energy absorption. 
NMR instrumentation - The diagram seen below (Figure 2.13) represents the 
overall instrumental arrangement. A typical NMR spectrometer is assembled from 4 
primary units (a sample compartment. a surrounding superconducting magnet, a 
radiofrequency (RF) generator, and an RF detector. 
A sample 
compartment 








Figure 2.13. An NMR spectrometer diagram. 
The sample tube is placed within the superconducting magnet where the 
external magnetic field is generated. Radiofrequency pulses then are sent through the 
circuit to excite the sample nuclei. The excited nuclei reemit the absorbed energies at 
the characteristic frequencies, which induce the radio signals. The actual signals are 
transformed as an NMR spectrum in the output-computerized detector. 
Materials - The MacMillan group, School of Chemistry. University of 
Edinburgh provided two synthetic peptides. MEEVD and GDEDASRMEEVD. The 
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unfolded-synthetic peptides were derived from the final resides of human Hsp90f. 
The shorter peptide named 5mer had molecular weight of 664 dalton whilst the 
longer 12mer weighed 1394 dalton. Dr. Julia Richardson carried out the NIvIIR 
experiment. All NMR studies were performed on machines located at the EPIC 
centre, University of Edinburgh. The machines, operating at frequencies of 600 and 
800 MHz for 'H, were from Bruker Nonius, Germany. Proteins (approximately 60 
mg/ml) and peptides (1 mg/ml) were maintained in PBS buffer made up from tablets, 
Sigma (cat. no. P4417). Following the instructions, one tablet was dissolved in 200 
ml distilled, degassed water to obtain 10mM Na 2PO4, 2.7mM KC1, 137mM NaCl, pH 
7.4. 
2.3.3 Molecular modelling techniques 
2.3.3.1 Comparison of protein sequences 
Similarity and variability of protein sequences within their families or 
between difference species leads to insight into evolutionary and structural 
relationships of proteins. Multiple sequence alignment, thus, is a prequisite approach 
for further analyses (Notredame et al., 2000). Basically, sets of nucleotide or amino 
acid sequences which are most closely related are first aligned followed by entire 
alignment of these groups. 
CLUSTAL X - This programme is a new version in the CLUSTAL series 
widely use for multiple sequence alignment and phylogenetic tree preparation 
(Jeanmougin et al., 1998). The programme provides high quality in alignment 
analysis with marking low-scoring segments. In this work, multiple sequence 
alignment was carried out to study homology of TPR domains in C. elegans. The 
conserved residues involved in interaction with heat shock protein 90 (Hsp90) were 
illustrated for further studies. This part of the project will be described in greater 
detail in Chapter 7. 
ffiflam 
2.3.3.2 Generation of modelled structures 
In this work, modelling studies were carried out in an attempt to better 
understand both the functions and potential interactions of the target protein, 
CeFKBP48. The following packages were used to generate a modelled structure and 
the further downstream analysis of the model with its putative partner proteins. 
Further details in the programmes and methods employed will be described in 
Chapter 7. 
SWISS-MODEL - The SWISS-MODEL server is designed for automated 
comparative modelling of 3D protein structures (http://swissmodel.expasy.org ) 
(Schwede et al., 2003). Sequences of target protein are threaded in the Protein Data 
Bank (PDB) database to select suitable templates. This server generates 3D models 
of target proteins from their amino acid sequences using a comparative modelling 
approach. This approach compares a significant amino acid sequence identity of at 
least one experimentally solved 3D structure (template) to the target sequence. A 
structural alignment is produced to line up the identical sequences and subsequently 
optimised for placement of insertions and deletions. The backbone of a model 
including side chains is generated followed by energy minimisation using the 
ProModfl programme. This programme allows detection of the parts of the model 
with conformational error. 
Graphic Representation and Analysis of Surfaces Properties (GRASP) - This 
graphics programme is used to construct electrostatic surfaces (molecular or 
accessible display) of macromolecules according to charges within molecules 
(Nicholls et al., 1991). 
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INSIGHT II— This package programme from Acceirys integrates a molecular 
graphic interface with tools and applications for biomolecular engineering, 
modelling, and stimulations. Additional features (visualiser, builder, analysis, 
spreadsheet, and docking) are also integrated to allow manipulations of molecules, 
data analysis including annotations, and molecular interaction 
(http://www.accelrys.com/insight).  
2.3.3.3 Preparation of 3D structures 
BobScript - All the figures of 3D structures presented in this thesis were 
prepared using BobScript (Esnouf, 1999). PDB coordinate files of the given proteins 
were prepared as input files which were converted to Raster3D format. The Raster3D 
files were finally saved as image files e.g. file.jpg. 
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CHAPTER 3 
CLONING, EXPRESSION, AND PURIFICATION OF TARGET 
FKBP PROTEINS 
3.1 INTRODUCTION 
This chapter describes the production of target proteins. Cloning of Jkb-6 
encoding for FKBP48 was carried out as a part of this work. The rest of proteins 
were cloned and supplied by collaborating groups as mentioned in Table 3.1. All the 
resultant recombinant proteins were then expressed and purified in-house. 
Table 3.1 summarises all the genes coding for each FKBP related to this 
work. The genes were initially isolated from natural sources by collaborating groups 
(as summarised in Table 3.1). Dr. Antony P Page and his colleagues (Wellcome 
Centre for Molecular Parasitology, University of Glasgow) originally prepared the 
cDNA libraries of the Jkb genes from C. elegans. They also cloned Jkb-2 and Jkb-3 
(encoding for FKBP12 and FKBP29 respectively) into the given vectors and 
provided the expression cells, XL10 (Stratagene). The Jkb-6 gene was sub-cloned in 
this work. The cloned cells containing FKBP22 from N. crassa were supplied by 
Professor Maximilian Tropschug (Institut für Biochemie und Molekularbiologie, der 
Universität Freiburg). The PAS1 gene encoding for FKBP71 in Arabidopsis thaliana 
was cloned and supplied by Dr. Jean-Denis Faure (Institut National de la Recherche 
Agronomique, Paris, France). 
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Table 3.1 Summary of the sources and cloning details of each target protein 
P r o t e i n S o u r c  Expression vector Expression host 
FKBP]2 C. elegans pMAL'C2 XL 10-Gold® 
FKBP29 C. elegans pMAL/C2 XL 10-Gold® 
FKBP48 C. elegans pQE30 M15(pREP4) 
FKBP22 N. crassa pQE32 M15(pREP4) 
FKBP71 A. thaliana pQE32 M15(pREP4) 
3.2 MATERIALS AND METHODS 
3.2.1 Molecular cloning of fkb-6 encoding FKBP48 from C. elegans 
Buffers and restriction enzymes - PCR buffer was prepared in 11. 1X stock 
concentration (2 M Tris pH 8.8, 1 M (NH 4)2SO4, 1 M M902, mercaptoethanol, 10 
mM EDTA pH 8.0, 100 mM dATP, 100 mlvi dCTP, 100 mM dGTP, 100 mM dTT'P, 
10 mg/ml BSA) and diluted 11.1 times in 50 p1 PCR master mix to the final working 
concentration. Replication enzymes (Pfu, Taq, and Vent) and restriction enzymes 
(Sph I and Sal I) were purchased from New England Biolabs. 
Primers, vectors, and host cells - pPCR-ScriptTM (Stratagen) and pQE30 
(QIAGEN) were used as cloning and expression vectors respectively. The forward 
(cggcatgcatgtccggcgaaaagatcgatatc) and reverse primers 
(gcgtcgacctaagcattggaagtagagcttcc) were synthesised by Sigma. The E. co/i strains, 
XL-10 (Stratagen) and M15(pREP4) (QIAGEN), were used. All the cloning kits 
were manufactured by QIAGEN. 
-114- 
Cloning techniques - The mixed stage N2 cDNA library of C. elegans Jkb-6 
constructed by Dr. Page was cloned. To amplify the Jkb-6 fragments, 1 jtl of cDNA 
was mixed with polymerase enzymes. Both primers added were to be hybridised at 
Sph I (cggcatgcatgtccggcgaaaagatcgatatc) and Sal I 
(gcgtcgacctaagcattggaagtagagcttcc) recognition sites to 5' and 3' ends respectively. 
After repetitive cycles, the PCR products were cleaned up, ligated to pPCR-Scriptmt, 
and transformed into competent XL10 cells. Colonies were screened by blue/white 
colony selection technique for vectors with the Jkb-6 inserts. In the digestion 
experiment, miniprep DNA was cleaved by Sph I and Sal I, purified from 1% 
agarose gel, ligated into pQE30, and re-introduced into XL10. The pQE30/Jkb-6 
plasmids were prepared from the positive colonies and finally introduced into 
competent M15 cells for expression. 
3.2.2 Expression of FKBP proteins 
The standard protocol adopted throughout the duration of this work was 
followed (See Chapter 2, section 2.2.2). The optimal conditions for each protein 
expression (as determined from pilot experiments) were also used in the large scale 
cultures. Overnight cultures were diluted 50 times in one litre of pre-warmed fresh 
media supplemented with the appropriate antibiotics. The cells were allowed to grow 
under strong agitation at 37°C until the desired cell density reached 0.6 (O.D. 600). 
The cells were induced with 1 mM IPTG, added to initiate production of the 
heterologous proteins. After a 4-hour induction period, the cells were then harvested 
at 16,000 x g, 4°C for 10 minutes, the supernatant discarded, and the pellets were 
resuspended in lysis buffer and frozen at -20°C. 
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3.2.3 Cell lysate preparation 
Lysis buffers and lysozyme - As recommended by the manufacturer, the lysis 
buffers were prepared and applied to the appropriate cells. The cells containing 
MBP-tagged proteins were lysed with column buffer (20 mM Tris, 200 mM NaCl, 1 
mM EDTA, 10 mM 3-mecaptoethano1 (p3-ME), pH 7.4). The cells expressing His-
tagged proteins were lysed with 50 mM NaH 2PO4, 300 mM NaCl, 10 mM imidazole, 
pH 8.0. Except for those expressing FKBP48, lysis buffer was made up from 50 MM 
Tris, 100 mM NaCl, 1 mM EDTA, pH 7.4 to improve its solubility. Lysozyme 
(Sigma, cat. no. E-6876) was added to the cell suspension to a final concentration of 
0.1% w/v. Protease inhibitor cocktails, mini-complete EDTA-free inhibiting a 
multitude of proteases, including serine proteases, cysteine proteases and 
metalloproteases (Roche, cat. no. 1836173), were also used. 
Preparation technique - The frozen cells were thawed in ice-cold water for 
15 minutes. Lysis techniques routinely used combined chemical (lysozyme) and 
mechanical (sonication) methods. The cell pellets were re-suspended in 3 ml lysis 
buffer per gram wet weight. The lysis buffer also contained a cocktail of protease 
inhibitors. After re-suspension, 0.1% w/v lysozyme was added. The suspension was 
incubated at 4°C for 20 minutes. The cells were then sonicated on ice (10 sec pulse 
on and 10 sec pulse off at 180 JVIIHz for 10 cycles). The cells were pelleted at 13,000 
x g, 4°C, 30 minutes. The supernatants, called cell lysates, were stored at -20°C for 
purification. Solubility of both proteins was determined by SDS-PAGE. 
3.2.4 Purification of MBP-FKBP12 and MBP-FKBP29 
Chromatographic materials - Amylose resins (New England Biolabs) and 
ionic exchange resins (Source® 30Q and 30S, Amersham Bioscience) were packed 
into XK16/26 columns. Chromatographic equipment was manufactured by 
Amersham Bioscience. Purification was undertaken on a Gradifrac system, a fast 
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protein liquid chromatography (FPLC)-based machine. Factor Xa (cat. no. 69037-3) 
was purchased from Novagen. 
Buffers - Of both proteins, column buffer (20 mM Tris, 200 mM NaCl, 1 mM 
EDTA, 10 mM f3-mecaptoethanol (13-ME),  pH 7.4) and Elution buffer (column 
buffer + 20 mM maltose pH 7.4) were prepared for the first step purification on 
amylase columns. Buffers A and B were also prepared for the second step: Buffer A 
(50 mM HEPES, 1 mM EDTA, and 20 mM 13-ME, pH 7.4), Buffer B (Buffer A + 
500 mM NaCl) for FKBP12 on a MONO S column and Buffer A (20 mM bis-Tris, 1 
mM EDTA, 1 mM DTT, pH 6.3), Buffer B (Buffer A + 500 mM NaCl) for FKBP29 
on a MONO Q column. 
The first step, affinity chromatography - After column packing, the amylose 
resin was equilibrated with 2 CV of column buffer. The cell lysate was loaded to the 
column in the same buffer at 1 ml/min flow rate. Another 2 CV column buffer was 
further applied to wash off any unbound materials. The target proteins were eluted 
with increasing maltose concentrations. All the fractions were collected and analysed 
by SDS-PAGE analysis. 
MBP cleavage - MJ3P is a relative large molecule therefore it was necessary 
to cleave this fusion protein prior to further characterisation and crystallisation trials. 
The constructs contained a Factor Xa cleavage site, a number of pilot experiments 
were carried out to determine the optimum cleavage conditions. Variable tests 
included protease concentrations, length of incubation period, and temperature. With 
three variable parameters, the optimal condition of MIBP cleavage from FKBP12 was 
determined. In a 1 ml reaction, 100 j.tl of 0.1 mg fusion protein, 20 pi of Factor Xa 
(0. 1, 0. 2, 0.5U*),  100 gl of 1 O cleavage buffer (500 mM Tris, 1 m NaCl, 50 MM 
CaCl2, pH 8.0), and 780 tl of sterilised water were mixed and incubated at 4°C and 
room temperature for 24 hours, with samples being taken at a particular time (2, 4, 6, 
-117- 
8, 10, 12, 16,18, 24) after mixing to monitor degree of cleavage over the incubation 
period. 
(*. U is an activity unit of Factor Xa generally sufficient for cleavage of 50 ,ugfusion 
protein in lx cleavage buffer at 20 °Cfor 16 hours as suggested by Novagen.) 
The second step, ion exchange chromatography - This chromatographic 
technique was used to separate the target proteins from MBP. FKBP12 was captured 
on cationic exchanger (source® S) at pH 7.5 whereas FKBP29 was bound to anionic 
exchanger (source® Q) at pH 6.3. The proteins were eluted by changing the ionic 
strength using a gradient of NaCl. The peak fractions were analysed by SDS-PAGE. 
3.2.5 Purification of FKBP22, FKBP48 and FKBP71 
Chromatographic materials - Nickel superfiow resin (QIAGEN) and 
Source® 30Q (Amersham Bioscience) were used for first and second step 
purification respectively. 
Buffers - Wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 
pH 8.0) and Elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, 
pH 8.0) were prepared for the first step purification of all proteins. Buffers A and B 
were also prepared for the second step on MONO Q columns: Buffer A (20 MM bis-
Tris, 1 mM EDTA, and 20 mM 3-ME, pH 7.4), Buffer B (Buffer A + 500 MM NaCl) 
for FKBP22 and Buffer A (20 mM Tris, 1 mM EDTA, 1 mM DTT, pH 6.4), Buffer 
B (Buffer A + 500 mM NaCl) for FKBP48. 
The first step, affinity chromatography - The resin was first equilibrated with 
Wash buffer (2 CV). The cell lysate was loaded to the column with the same buffer 
at 1 ml/min flow rate. Unbound molecules were washed through the column with 
another 2 CV of Wash buffer. The target proteins were eluted with immediately 
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increased concentrations of imidazole (step-gradient elution). All the fractions were 
collected and tested for SDS-PAGE analysis. 
The second step, anion exchange chromatography - FKBP22 and FKBP48 
were further applied to anionic column (MONO Q). The proteins were bound to the 
resin at pH 7.2 (FKBP22) and pH 6.4 (FKBP48). The proteins were released by 
gradually increasing the concentrations of NaCl. The peak fractions were further 
loaded on SDS-PAGE. Further purification of FKBP71 was not attempted due to 
severe proteolytic cleavage seen after the first step. 
3.3 RESULTS AND DISCUSSION 
3.3.1 Expression and purification of CeFKBP12 
FKBP12 expression - The optimal conditions for FKBP12 expression were 
with 0.1 mM IPTG (final concentration) at 37°C for 4 hours post induction. At 37°C, 
the bacterial host cells containing Jkb-2 genes expressed the gene products well in 
both 2XYT and TB broth respectively when compared with the expression level seen 
with LB broth, as can be seen in Figures 3.1A-C. Although each growth medium 
facilitated expression of the protein to a high level, the degree of solubility of the 
target protein produced was also an important consideration in selection of an 
appropriate growth media. Lanes 9 and 10 of Figures 3.1A-C illustrate the existence 
of FKBP12 in soluble and insoluble forms respectively. Over 50% of the protein 
expressed was as a soluble protein (lanes 9 of each). This could result from an 
enhancement of protein solubility due to the fusion between the highly soluble MBP 
and the target protein. Among the three media, the target protein in soluble form 
seemed to be produced most using LB broth (lane 9A). The temperature trials 
revealed that the host cells, in this case, preferred a high temperature, 37°C to 
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express the target protein as can be seen in Figure 3. IF. Figures 3.2D-E show the 
target protein is produced in greater amounts at high temperature. 
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Figure 3.1. Expression trials of recombinant MBP/FKBPI2, 57 kDa, from C. elegans 
showing optimisation of two parameters. A)-C) Effects of tarring growth media: LB 
broth. 2XYT, and TB broth respective/v. 1&3: supernatants before and after IPTG 
induction, 2&4-7: pellets before and after induction for 1, 2, 3, and 4 hours, 8-9: cell 
Irsatesainples, 10: an insoluble pellet. D)-F) Effects of varying temperatures during 
the cell inductions: 18°, 25°, and 37°C. 1&3: supernatants before and after IPTG 
induction, 2&4-8: pellets before and after 5-hour induction, 9-11: cell irsate 
samples, 12: an insoluble pellet. 159'c SDS gels were used throughout. 
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FKBP12 purification - The MIBP/FKBP12 fusion protein was eluted from the 
amylose resin with 12 mM maltose (Figure 3.2A, lanes 5, 6, 9-11). The positive 
fractions were pooled and concentrated to 2 mg/ml for MBP cleavage trials, which 
were subsequently scaled up proportionally from the optimal conditions determined 
in the pilot experiments. After a series of small scale digestions, the optimum 
conditions of IvIBP cleavage from FKBP12 were incubating the fusion protein with 
0.2U Factor Xa at 4°C for 24 hours. The protein mixture was concentrated to 2 
mg/mi before further purification. The concentrated sample was then loaded onto a 
MONO S column where MIBP and FKBP12 were separated. FKBP12 was found to 
be eluted at 200 mM NaCl as assumed from the relative peak on the chromatogram 
(data not shown). However, none of the desired protein was detectable as expected at 
12 kDa relative to the markers (Figure 3.211, lanes 8-11). This could result from low 
amounts of the target protein and hence protein loss during running through the 
column. Therefore purification of FKBP12 requires large amounts of initial fusion 
protein and special handling during the MBP cleavage step. Protein aggregation was 
occasionally seen when the cleavage reactions were scaled up to milligram 
quantities. This may explain why no FKBP12 could be observed. 
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Figure 3.2. Three stages of C. elegans FKBPI2 purification. A) First-step 
purification on the amvlose column from which MBP/FKBP12 was eluted with 12 
mM maltose. 1&2: flow-through. 3-4: wash fractions, 5-11: eluted MBP/FKBPI2 
fractions migrating on a SDS-gel (15%) at approximate/v 60 kDa relative to 
markers. B)-G) MBP cleavage trials varied the concentration of Factor Xa and 
temperatures over time-course. 1: MBP/FKBP 12 uncleaved sample, 2-10: cleaved 
mixtures incubated for 2, 4, 6, 8, 10, 12, 16, 18, and 24 hours. H) Second-step 
purification on the MONO S column to separate FKBPI2 from cleaved MBP protein. 
1-4: starting cleavage mixture, 6-7: elution fractions of MBP, 8-11: FKBPI2 
fractions eluted at 200 mM NaC/. a: fusion MBP/FKBPJ2 protein, h: MBP, C: 
FKBPJ2. 15'7c SDS gels were used. 
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3.3.2 Expression and purification of NcFKBP22 
FKBP22 expression - The optimal conditions for FKBP22 expression were 
with 0.1 mM IPTG (final concentration) at 30°C for 4 hours post induction. 
Recombinant FKBP22 was over-expressed under the control of the pQE expression 
system. The composition of the growth media used tended to have no effect on the 
levels of protein produced as shown from the results of the expression trials (Figures 
3.5A-C). FKBP22 was expressed using LB, 2XYT, and TB broth with approximately 
the same level of expression (lanes 4, 6, 8, and 10 of Figures 3.3A and B in case of 
2XYT broth and lanes 4, 6, and 8 of Figures 33C in case of TB broth). High level of 
the target protein expression can be achieved either at normal temperature (37°C, 
Figure 3.5E) or at lower (30°C, Figure 3.5D). Reducing the temperature to 30°C 
during the induction, however, improves protein solubility (lanes 10 and 11 of 
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Figure 3.3. Expression trials of recombinant FKBP22 from N. crassa showing 
optimisation of two parameters. A)-C) Three diflrent growth media were used: LB 
broth, 2XYT, and TB broth respectiveI. 1,3,5,7,9: supernatants before and after 
IPTG induction, 2,4,6,8,10: pellets before and after 4-hour induction. D)-E) 
Different temperatures during the cell inductions: 30° and 37C. 1&3: supernatants 
befbre and after IPTG induction, 2&4-7: pellets before and after 4-hour induction, 
8-10: cell lvsate samples, 11: an insoluble pellet. 12% SDS gels were used. 
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FKBP22 purification - At the beginning of the study, purification of FKBP22 
seemed to be achieved with a one-step affinity purification (> 95% purity) with 
immobilised nickel on the chromatographic matrix (Figure 3.4A). After a number of 
repeat purifications, some contaminants were also eluted in the same fraction of 
FKBP22 as can be seen in Figure 3.4B (lanes 7 and 8). Therefore further purification 
was required. The protein retrieved from the first column was then applied to an 
anion exchange column, MONO Q (Amersham Bioscience). FKBP22 approximately 
90% pure was eluted with 250 mM NaCl (Figure 3.5C, lanes 6-10). In addition to the 
Ni-NTA purification, a different metal immobilised matrix resin (cobalt ion) was 
also tried in an attempt to improve purity of the target protein. However using cobalt 
in the IMAC step offered no significant advantage over nickel resin in the final 
degree of protein purity (Figure 3.4D). Further purification on a MONO Q column 
was still required to achieve a sufficient degree of purification of the target protein 
(Figure 3.4E, lanes 9-11). 
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Figure 3.4. Two steps of N. crassa FKBP22 purification. A) A 12% SDS gel 
illustrating a representative purification of FKBP22 on Ni-NTA column. The protein 
was eluted with 200 mM imidazole. 1&2: flow-through, 3-10: eluted FKBP22 
fractions at approximate/v 30 kDa relative to the MWT markers. B) First-step 
purification of FKB22 on Ni-NTA column showing some contaminants. 1-4: flow-
through, 5-6: wash fractions, 7-12: elution fractions of FKBP22. C) Second-step 
purification on MONO Q column. 1-2: flow-through, 3-5: elution fractions of 
contaminants by a NaCl gradient, 6-10: FKBP22 fractions eluted at 200 mnM NaCl. 
D) A trial of first-step in the purification using a (Co 2 ) Talon column showing 
FKBP22 eluting with some contaminants. 1-3: flow-through, 4-12: elution fractions 
of FKBP22. E) Second-step purification after D) on MONO Q column: 1-4: flow-
through, 6-7: elution fractions of contaminants. 8-11: elution fractions of FKBP22. 
15% SDS gels were used fr B)-E). 
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3.3.3 Expression and purification of CeFKBP29 
FKBP29 expression - FKBP29 was grown and expressed under similar 
conditions, except for growth temperature, as those found optimal for FKBP12; 0.1 
mM IPTG (final concentration) at 30°C for 4 hours post induction. The preference of 
the cells for different growth media remained similar to that seen with FKBP12, in 
decreasing order of usefulness LB > 2XYT > TB at 37°C as can be seen in Figures 
3.5A-C. Nevertheless the target protein expressed seemed to be more insoluble as 
most of the protein was in the insoluble fraction (Figures 3.5A-C, lanes 11). 
Expression trials at lower temperatures were carried out in an attempt to improve 
solubility of the target protein (Figures 3.5D-F). The degree of solubility of the target 
protein expressed at 30°C and 37°C were approximately similar, however a large 
amount of FKBP29 was insoluble as illustrated in Figure 3.5E, lane 11. Therefore, to 
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Figure 3.5. Expression trials of recombinant C. elegans MBP/FKBP29. 67 kDa, 
showing optimisation of iwp parameters. A)-C) Three dzfft-'rent growth media: LB 
broth, 2XYT, and TB broth respective/v. 1,4,7: supernatants beftre and after IPTG 
induction for 2 and 4 hours respective/v. 2,3,5,6,8: pellets before and after induction 
fir 1, 2, 3 and 4 hours respectively, 9-10: cell lvsate samples. 11: an insoluble pellet. 
D)-F) Trials of different temperatures during the cell inductions to improve protein 
soluhthtv: 17°, 23°, and 37°C. D) 1,4,7: supernatants before and after IPTG 
induction for 2 and 4 hours respective/v. 2,3,5,6,8: pellets before and after induction 
ft.r 1, 2, 3 and 4 hours respectively, 9-11: cell lvsate samples, 12: an insoluble pellet. 
E)-F) I &3: supernatants before and after IPTG induction, 2&4-7: pellets before and 
after 4-hour induction, 8-10: cell lvsate samples, 11: an insoluble pellet. 12% SDS 
gels were used .for A), B), C), and D). 15% SDS gels were used for E) and F). 
MWEIR 
FKBP29 purification - The MBP/FKBP29 fusion protein was eluted with 20 
mM maltose (Figure 3.6A, lanes 7-10). MBP was cleaved from FKBP29 using 
Factor Xa followed by a second purification step on a MONO Q column. The target 
protein was eluted with 100 mM NaCl (Figure 3.6B. lanes 9-10). Figures 3.6C to 
3.6E illustrate a series of MBP cleavage trials which were designed in the same way 
to those of FKBPI2 cleavage previously illustrated. The optimum conditions in this 
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Figure 3.6. Three stages of C. elegans FKBP29 purification. A) First-step affinity 
chromatography on MBP column from where MBP/FKB29 was eluted with 20 mM 
maltose. 1&3: flow-through, 4-5: wash fractions, 7-10: eluted MBP/FKBP29 
fractions migrate on an SDS-gel (15%) at approximately 72 kDa relative to the MW'T 
markers. B)-D) MBP cleavage trials used the following concentrations of Factor Xa 
0. 1, 0. 2, and 0.5U. Two temperatures, 4° and RT, were tested. Samples for SDS- 
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PAGE (12% SDS gel) analysis were taken over the time-course of the experiment. 
1&5: MBP/FKBP29 uncleaved sample, 2&6. cleaved mixtures incubated for2, 4, 8, 
12, 16 hours. E) Second-step purification on a MONO Q column to separate 
FKBP29 from cleaved MBP protein (15% SDS gel). 1: starting uncleaved sample, 2: 
starting cleaved mixture, 3-6: flow-through, 7-8: MBP fractions eluted at 100 mM 
NaCl, 9-10: FKBP29 fractions eluted at 200 mM Na Cl. a: fusion MBP/FKBP29 
protein, b: MBP, c. FKBP29. 
3.3.4 Cloning, expression, and purification of CeFKBP48 
Isolation, amplification, and insertion of fkb-6 - Different polymerase 
enzymes were screened in an attempt to isolate fkb-6 (Figure 3.7A, Taq: lanes 1-3, 
Pfu: lanes 4-5, Vent: lanes 6-8). Between these three enzymes, Taq and Vent 
enzymes were equally effective whilst the Pfu enzyme seemed to have no effect. The 
DNA of interest was then precipitated and ligated into pPCR-ScriptTM vectors. 
Blue/white colony screening allowed for selection of the inserts of flcb-6 which were 
then recovered. Positive colonies were identified by PCR (Figure 3.7B, lanes 3, 5, 7, 
8, and 9). The genes of interest were excised from pPCR-ScriptTM and purified 
(Figure 3.7C). Pure Jkb-6 was precipitated followed by ligation into the pQE30 
vector. The pQE30/Jkb-6 plasmids were amplified (Figure 3.7D). Expression cells, 
M15(pREP4) were transformed with pQE3O/Jkb-6 plasmids (Figure 3.7E). To ensure 
the presence of the DNA inserts, pQE30/Jkb-6 were extracted from the XL-10 cells 
and subsequently digested with Sph I and Sal I. The sequencing data (not shown) 
confirmed the presence of no errors in the cloned Jlcb6 sequence. 
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Figure 3.7. Molecular cloning of fkb-6 froni C. elegans. A) Isolation of fkb-6 with 
different polymerase enzymes (lanes 1-3: Taq, lanes 4-5: P/li, lanes 6-8: Vent), B) 
Amplification of the gene from the positive XL-101pPCR-ScriptTM1Jkh-6 colonies, C) 
Digestion of the gene (lower) from pPCR_Script'FM (top), D) Preparation (t the 
purified gene for ligation, E) Amplification of the gene froin the positive 
M15(pREP4)1pQE301fkh-6 colonies. I agarose gels were used. 
CeFKBP48 expression - The optimal conditions for FKBP48 expression 
were with 0.1 mM IPTG (final concentration) at 30°C for 4 hours post induction. The 
recombinant C. elegans FKBP48 was highly expressed. At the beginning of the 
study, the expressed protein accumulated in inclusion bodies (Figures 3.8A-C. lanes 
12). This could result from its high level of over-expression. Several trials were then 
carried out to improve solubility of the protein. Expression trials with three different 
media showed TB broth to be the most useful (Figure 3.8C). Fermentation was 
performed at low temperatures after induction (Figure 3.8D. 17°C and Figure 3.8E. 
- 131 - 
30°C). Concentrations of IPTG were tested and varied in the range of 0.2-1 .0 MM. 
The shaking speed was also reduced to 180 rpm. Under optimisation of the 
combinations of these parameters, the solubility of the target protein was finally 
improved with a high level of expression. 
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Figure 3.8. Expressions of recombinant FKB48 from C. elegans showing 
optimisation of growth medium and temperature. A)-C) Three difl' rent growth 
media: LB broth, 2XYT, and TB broth respectively. 1,4,7: supernatants hefrre and 
after IPTG induction for 2 and 4 hours respectively, 2,3,5,6,8: pellets hefhre and 
after induction jhr 1, 2, 3 and 4 hours respectiL'elv, 9-10: cell l%'sate samples, 11: 
soluble supernatant, 12: an insoluble pellet. D)-F) Different temperatures during the 
cell inductions (17°, 30°. and 37°C) showing successful improvement of protein 
soluhility at 30°C. D)-E) 1,4,7: supernatants before and after IPTG induction for 2 
and 4 hours respectii'elv. 2,3,5,6,8: pellets be/bre and after induction for 1, 2. 3 and 
4 hours respectively. 9-10: cell lvsate samples. 11: an insoluble pellet. F) 1&3: 
supernatants before and after IPTG induction, 2&4-6: pellets before and after 3- 
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hour induction, 7-8: cell lysate samples, 10: an insoluble pellet. 12% SDS gels were 
used 
FKBP48 purification - FKBP48 was eluted from a nickel column by a 
concentration of 200 mM imidazole with two obvious co-purifying contaminants as 
illustrated in Figure 3.9A. Separation of the target protein from these contaminants 
was achieved on a MONO Q column with slow flow rate (0.5 ml/min). At 100 mM 
NaCl, FKBP48 was eluted from the anion exchanger. The contaminant migrated at 
about 46 kDa with respect to the molecular weight markers, and was more tightly 
bound to the resin and eluted at low concentration of NaCl (approxiamtely 50 mm) 
as can be seen in Figure 3.9B, lanes 4-6. The other contaminant migrating at about 
30 kDa did not bind to the resin and was found in flow-through (Figure 3.9B, lane 9). 
Pure samples of these two contaminants were also collected and further characterized 
using mass spectroscopy. Separation of these proteins using the anion exchanger 
became more difficult over the period of study as shown in Figure 3.9C. The 
properties of the 46 kDa contaminant seemed very close to those of FKBP48 such as 
molecular weight and isoelectric point (p1). Gel filtration chromatography was also 
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Figure 3.9. Two step purification of FKBP48. A) A 12% gel SDS gel representing 
purification of FKBP48 on Ni-NTA column rom where the protein was eluted hi' 200 
mM injidazole. 1&3: flow-through, 4-11: eluted FKBP48 fractions at approximate/v 
49 kDa relative to markers. B) Second-step purification on a MONO Q column (12% 
SDS gel). 1-2: elution fractions at low NaCl concentration (5 mM), 4&7: elution 
fraction of contaminant, a, at approximately 50 mM NaCl, 6&8: eluiion fraction of 
FKP48 at 100 mM NaCl, 9: elution fraction of contaminant, b, 10: a reference 
fraction after Ni-NTA. C) A result (15% SDS gel) of unsuccessful separation of 
FKBP48jr0m contaminants on a MONO Q column. 1-5: protein fractions from Ni-
NTA column, 6-13: elution fractions of FKBP48 with contaminants. 
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3.3.5 Expression and purification of AtFKBP71 
FKBP7I is expressed as a mild/v toxic protein - Expression levels of 
FKBP7I were low with 0.1 mM IPTG (final concentration) at 37 °C for 4 hour post 
induction using LB broth as the growth media (Figure 3.lOA). Recombinant FKBP7I 
tended to be mildly toxic to the host cells. Although expression was carried out using 
a M I 5(pREP4) strain which was a recommended bacterial cell for the expression of 
toxic proteins, low yields of the target protein were recovered. Different growth 
media slightly improved the expression level of the target protein (Figures 3.10B and 
3.I0C). Among the three media, expressing FKBP7I in 2XYT and TB broth 
provided higher levels of protein yields. 
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Figure 3.10. Expression of FKBP7I .1roni A. thaliana in three different growth 
media: A) LB broth, B) 2XYT broth, and C) TB broth. 1,3,5,7,9: supernatants before 
and after IPTG induction at 1, 2, 3, and 4 hours, 2.4,6,8.10: pellets before and after 
induction at 1, 2, 3, and 4 hours. 
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FKBP7I purification - FKBP71 was eluted at 200 mM imidazole from the 
nickel column with a high level of contaminants (Figure 3.11. lane 7). These 
contaminants could be degradation fragments of FKBP7 I or background proteins 
from host cells. A trial using protein inhibitors was carried out to in an attempt to 
prevent deg 
2









Figure 3.11. One step purification of A. thaliana FKBP71 purification. A 12% gel 
SDS gel representing purification of FKBP7I on Ni-NTA colunn from where the 
protein was eluted at 200 mM imidazole. / &5: flow-through, 6-8: elution fraction of 




Optimisation of expression conditions for all the target FKBP proteins was 
determined in this work. The target recombinant proteins, except FKBP71, were 
over-expressed under the optimized conditions determined. A fundamental 
requirement for crystallisation trials is the production of large quantities of soluble, 
active protein (typically a minimum of 200 .tl of protein at 10 mg/ml for an initial 
screen). The solubility of the proteins of interest was rather high. However, lower 
levels of expressed FKBP48 were noticed at 37°C. Lowering growth temperatures 
produced the obvious improvements on the degree of solubility (Figures 3.3B, 3.4B, 
and 3.5B). Reducing IPTG concentration to 0.2 mM seemed to have a little effect on 
the expression level of FKBP48 at low temperature (data not shown). Furthermore, 
the trials of different host strains for FKBP29 and FKBP48 showed slight effects 
(data not shown). Production of FKBP12/29/7 1 was problematic and provided 
insufficient proteins for further studies throughout this work. Expression results 





This chapter describes the biochemical and biophysical characterisation of the 
target FKBP proteins studied in this work. The various techniques used were outlined 
previously in Chapter 2. The key techniques utilised were the PPIase assay, mass 
spectrometry, dynamic light scattering, and crystallisation. Basically, all the purified 
target proteins were subject to a panel of experiments utilising the above techniques, 
except for CeFKBP12 and AtFKBP71. The level of expression of these two proteins 
was such that insufficient quantities of material could be obtained for the planned 
experiments. In addition to the biochemical and biophysical characterisation of N. 
crassa FKBP22, structural studies were also carried out on this protein and will be 
further described in Chapter 5. 
4.2 MATERIALS AND METHODS 
4.2.1 The measurement of PPIase activity 
Experimental assay of PPIase activity - FKBP22, FKBP29, and FKBP48 
were purified and prepared as described in Chapter 3, sections 3.2.3 and 3.2.4. The 
experimental setup including the reagents used for this assay was outlined in Chapter 
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2, section 2.3.1.1. The proteins were diluted in assay buffer to a stock concentration 
(30 .tM). In a 1-ml cuvette, 865 tl of an assay buffer stock and 10 p.1 of protein stock 
were mixed up and pre-incubated on ice for 30 minutes. 100 p.1 of chymotrypsin was 
then added and further equilibrated in the thermostated cell holder until temperature 
was steady at 4°C. The assay reaction was then started by adding 25 p.1 substrate 
followed by rapid mixing. Chymotryptic cleavage of pNA was observed at 390 nm at 
4°C for 10 minutes using a lambda 20 spectrometer interfaced to a UV lambda 20 
data collection programme. The proteins were assayed with a series of substrate 
concentrations (100-600 p.M). The readings produced are plotted and represented by 
the so-called spectral progress curves. 
Data analysis - Steady-state kinetic parameters for PPIase substrate were 
determined using the SigmaPlot programme with nonlinear least-squares 
optimisation of Km and V,, in the Michaelis-Menten equation; 
V = Vrnax[S1I([S]+Km) 	 (4.1) 
where v = velocity, V, = maximal velocity of the enzymatic reaction, [5] = 
concentration of substrate, Km = the substrate concentration resulting in half-maximal 
velocity. 
4.2.2 Mass spectrometry 
Matrix Assisted Laser Desorption lonisation Time-of-Flight (MALDI TOF) - 
For a typical MALDI analysis, 0.5 p1 protein of interest (approximately 10 M) and 
0.5 p1 matrix solution, sinapinic acid (approximately 10 mM) was premixed in a 
small eppendorf tube and then applied to small wells of a sample plate. The plate was 
delivered into the instrument (Applied Biosystems Voyager DE-STR MALDI-TOF 
mass spectrometer) for data analyses. 
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4.2.3 Dynamic light scattering 
The purified protein for crystallisation trials was prepared as described 
previously in Chapter 3. Homogeneity of the protein was determined using dynamic 
light scattering. The protein was filtered through a 0.1 lam Whatman AnotopTM 
immediately prior to analysis to remove unwanted dust or particles giving false 
readings. The experimental analysis of the purified protein was carried out on a 
DynaPro80l with Microsampler attachment, Protein Solutions, Inc. 
4.2.4 Crystallisation 
Crystallisation trials were carried out on both IVIBPIFKBP29 and FKBP48 
from C. elegans using following the crystallisation agents; Crystal screen TM and 
Crystal Screen 2 T (Hampton Research), Structure Screen 1TM  and JJTM  (Molecular 
Dimension), an ammonium sulphate screen, and polyethyleneglycol 4000 screen. In 
addition, co-crystallisation trials between CeFKBP48 and a pentapeptide (MEEVD, 
corresponding to the final C-terminal residues of Hsp90) were carried out. Further 
characterisation of CeFKBP48 and Hsp90 will be illustrated in Chapters 6 and 7. 
4.3 RESULTS AND DISCUSSION 
4.3.1 PPIase activity of FKBPs of interest 
Assay for peptidyl prolyl cis-trans isomerisation - Observations of 
chymotrypsin cleavage of the C-terminal amide bond only in trans conformers of 
substrates (Suc-Leu-Pro-Phe-pNA for FKBP22/48 and Suc-Ala-Ala-Pro-Phe-for 


























































Figure 4.1. Representative spectrometric progress curves for the PPIase-caialvsed 
cis to trans isolnerisalion Wit/i thflerent starting concentrations (100-600 Ø"í) of 
substrates: A) NcFKBP22, B) CeFKBP29, and C) CeFKP48. Measurements were 
carried out in 50 mM HEPES, 100 ,nM NaC1, pH 8.0 at 4°C. The curves represent 
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accumulation of the chromogenic product (pNA) released from only the trans 
conformers of substrates over the time course of the experiment. 
Determination of steady-state kinetic parameters for PPIase substrates - 
From the progress curves (Figure 4.1) the slopes of the linear plots of absorbance 
were derived as initial velocities (vo). Initial velocities refer to PPIase-catalysed cis to 
trans isomerisation of the substrates. The results were analysed by nonlinear least-
squares optimisation of Km and V in the Michaelis-Menten equation 4.1 using 
SigmaPlot. In addition, turnover numbers (kcal)  were calculated from the 
concentrations of FKBPs and the values of Vmax . Kinetic values were therefore 
obtained by extrapolation. Representative plots of velocity versus substrate 
concentrations for FKBP22, FKBP29, and FKBP48 are shown in Figures 4.2A-C 
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Figure 4.2. Michaelis-Menten plots of the reaction velocities of PPIase-catalysed 
cis-trans isomerisation: A) NcFKBP22, B) CeFKBP29, and C) CeFKBP48. The solid 
lines represent the nonlinear least-squares best fit to the Michealis-Menten equation, 
VU = Vni[S]I([S]+Km). 
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hFKBP12 hFKBP51 °  NcFKBP22 CeFKBP29 CeFKBP48 
K,(j.iM) 520 N.S. 200 3,181 232 
V. (iMJs) 4.5 N.S. 9.4 36.5 7.8 
kcat(5 1 ) 344 N.S. 783 913 312 
kca/K,n(M1S) 0.7 x 106 0.5 x 
106 3.9 x 106 0.3 x106 1.3 x 106 
Table 4.1. Steady-state kinetic parameters of the target FKBPs in comparison to 
those of FKBP12 and FKBP51 from human. (*.. Data from (Kofron et al., 1991), •. 
Data from (Yeh et al., 1995), N.S. = not specified). 
Substrate specificity - Results from PPIase assays confirmed that FKBPs 
have a strong substrate specificity (Rahfeld et al., 1994). FKBPs normally prefer the 
presence of leucine immediately preceding the proline in the tetrapeptide substrates 
(Xaa-Pro). With the exception of FKBP29 all kinetic values on FKBPs (Table 4.1) 
were obtained with the specific substrate, Suc-Ala-Leu-Pro-Phe-pNA, for FKBPs. In 
contrast, FKBP29 tagged with MBP was assayed with the non-specific substrate of 
Suc-Ala-Ala-Pro-Phe-pNA and provided high K,,, (3,181 jiM) and high maximal 
velocity (V,) of approximately 37 seconds. Fusion with MBP could affect the 
conformation of the whole molecule and hence disrupt substrate accessibility into the 
binding pocket. Therefore these could result in higher K,,, value of FKBP29 than 
those of other FKBPs determined in this study. 
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4.3.2 Mass spectrometric analyses 
Mass spectrometric analyses showed the relationships between the theoretical 
and experimentally derived molecular masses for the target FKBP proteins. 
Molecular weights calculations of three target FKBPs including their N-terminal 
fusion tags were carried out using the ProtParam tool from the EXPASY server. 
Figures 4.3 and 4.4 represent the accurate masses of FKBP22 and FKBP48 
determined using the MALDI -TOF technique. 
Accurate mass of FKBP22 - A theoretical mass of FKBP22 (residues 1-217) 
was calculated at 22,915 Da which was very close to the observed mass (Figure 4.3). 
This could be explained by post-translational processing where the N-terminal His 
tag was cleaved from the mature FKBP22. 
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Figure 4.3. Mass spectrum of N-terminal His-tagged FKBP22 showing a molecular 
mass of 22,919 Da. The calculated mass of the sequence is 22,915 Da, including the 
N-terminal presequence (residues 1-20). 
- 145- 
Masses of FKBP48 and its breakdown products - A theoretical mass for 
FKBP48, including the hexa-histidine tagged residues, was 49,631 Da which was 
approximately 180 Da smaller than the experimentally determined mass of 49,812 
Da. The increasing mass could result from the post-translation modification. 
However the nature of this modification is unknown. 
Results of the FKBP48 purification illustrated earlier in Chapter 3, section 3.3.4 
revealed two co-purifying proteins migrating on an SDS-gel at 46 and 30 kDa 
(shown as an inset in Figure 4.4). Mass spectrometric analysis of these two proteins 
shows the accurate masses to be 46,576 and 30,725 Da respectively (Figures 4.413 
and 4.4C). Peptide sequencing suggested that these two proteins were the breakdown 
products of FKBP48 (data not shown) (see protein sequence in Figure 6.5). Further 
characterisation of full length FKBP48 including its breakdown fragments will be 
illustrated in Chapter 6. Each fragment shown in an inset of Figure 4.4 corresponds 
to accurate molecular masses of 49,812, 46,576, and 30,725 Da respectively. Further 
characterisation of the two smaller fragments (2 and 3) was carried out. Peptide 
sequencing revealed that these two fragments are degradation products of FKBP48. 
The calculated mass of the full sequence is 49,631 Da. Throughout this work, the 
fragment missing approximately 30 amino acids from the C-terminus and providing 
the molecular mass of 46,576 was named the 630 fragment as shown in Figure 4.413. 
The smallest fragment showing the molecular mass of 30,713 was known as the short 
fragment (Figure 4.4C). 
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Figure 4.4. Macs spectra oJN-terminal His-tagged FKBP48. A) Full length frag,nent 
(residues 1-431), B) the b30 fragment (residues 1-400), C) the short fragment 
(residues 1-234). The two dominant fragments shown as an inset were also co- 
puritied. 
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4.3.3 Dynamic light scattering analyses 
Data output - The data output from the DynaPro analysis software 
(Dynamics) graphically represents the numbers of photon count rates (measured as 
thousands per second) and the hydrodynamic radii of the molecules in solution 
(measured as nm). Tables 4.2 and 4.3 present the results obtained from 
measurements taken at 4°C for FKBP29 at 1.0 mg/ml (without MBP) and FKBP48 at 
















1 0.570 464 5.2 2.7 158 1.002 8.664 
2 0.560 463 5.3 1.4 166 1.002 5.925 
3 0.562 475 5.2 1.9 155 1.001 3.514 
4 0.029 298 8.2 5.5 478 1.002 0.115 
5 0.019 314 7.8 2.0 421 1.000 0.035 
6 0.015 353 6.9 5.3 317 1.000 0.090 
7 0.015 332 7.4 2.7 372 1.000 0.069 
8 0.014 372 6.6 4.3 281 1.000 0.075 
9 0.014 361 6.8 4.0 300 1.001 0.104 
10 0.017 415 5.9 0.0 217 1.000 0.036 
11 0.020 487 5.0 1.2 146 1.000 0.060 
12 0.024 471 5.2 2.4 159 1.000 0.077 
Mean 
values 
0.155 400 6.3 2.8 264 1.001 1.564 
Table 4.2. A data series from an analysis of the size distribution of CeFKBP29. A 
total of 12 measurements were taken, the mean for each parameter was calculated 
and is shown above. 
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Meas Ampi Diff Rad Polyd Est MW Base SOS 
no. Coef (nm) (nm) (kDa)  line error 
1 0.650 354 4.0 1.0 85 1.023 3.557 
2 0.646 385 3.7 0.9 70 1.000 2.949 
3 0.664 332 4.3 1.9 100 1.045 5.036 
4 0.672 398 3.6 1.2 64 0.999 5.482 
5 0.655 357 4.0 1.5 82 1.010 6.685 
6 0.651 386 3.7 0.9 70 1.001 3.139 
7 0.662 398 3.6 0.8 64 1.000 2.296 
8 0.677 383 3.7 1.1 70 1..005 5.331 
9 0.672 390 3.7 1.5 - 68 1.003 7.560 
10 0.661 389 3.7 1.2 68 1.000 8.074 
11 0.675 395 3.6 0.6 65 1.003 6.757 
12 0.671 392 3.6 1.2 66 0.999 4.475 
13 0.671 406 3.5 1.1 61 1.002 4.376 
14 0.680 382 3.7 0.8 71 1.009 4.817 
Mean 0.660 381 3.8 1.1 72 1.006 4.654 
values 
Table 4.3. A data series from an analysis of the size distribution of CeFKBP48. A 
total 25 measurements were taken, of which 14 are illustrated above. The mean was 
calculated from all the data points taken. 
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Interpretation of FKBP29 data - Table 4.4 summarises the important 
parameters indicating size distributions of the protein samples in monomodal and 
bimodal modes of analysis. Monomodal analysis of FKBP29 suggested high 
polydispersity (44% of the average radius) based upon the actual size distribution 
(baseline at 1.001) and SOS value of 1.564. Bimodal analysis of the data suggested 
the majority of FKBP29 had an estimated molecular weight of 108 kDa, with a small 
proportion present as high molecular weight aggregate (28,976 kDa) as shown in 
Table 4.4. The light scattering results therefore suggest that FKBP29 exists as a 
multimer of between tetramers and octamers, though some aggregation also happens 
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Monomodal 12 0.155 400 6.3 	2.8 264 100 1.001 1.564 
Bimodal 
analysis: 
Monomodal 1 0.017 415 5.9 	0.0 217 --- 1.000 0.036 
Bimodal 1 11 0.072 778 4.0 	---- 108 95 1.000 0.809 
Bimodal2 0.100 205 45.1 28976 5 
Table 4.4. A summary of the mean values obtained from both monomodal and 
bimodal dynamic light scattering analysis of FKBP29. 
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Data interpretation of FKBP48 - The protein sample of FKBP48 was found 
to be polydisperse (29%) with high baseline values (1.006). Bimodal analysis 
suggested the majority of FKBP48 had an estimated molecular weight of 65 kDa, 
which is slightly over the actual mass of 49 kDa. The higher estimated molecular 
weight could result from a high baseline value of 1.004. Both monomodal and 
bimodal analysis suggested that FKBP48 may be predominantly monomeric. 
Mean MeasAmpi 01ff Rad Polyd Est % Base SOS 
values no. Coef (nm) (nm) MW mass line error 
Monomodal 
analysis: 
Monomodal 25 0.660 381 3.8 1.1 72 100 1.006 4.654 
Bimodal 
analysis: 
Monomodal 1 	0.675 395 3.6 0.6 	65 	1.003 6.757 
Bimodal 1 24 	0.195 1327 1.7 ---- 	16 	87 	1.004 2.620 
Bimodal2 0.478 309 5.1 194 	13 
Table 4.5. A summary of mean values from monomodal and bimodal analysis of 
FKBP48. 
Dynamic scattering analysis of NcFKBP22 will be illustrated in Chapter 5, section 
5.2.3. 
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4.3.4 Crystallisation analyses 
Crystallisation of FKBP29 - Due to an insufficient yield of native FKBP29 
no crystallisation trials could be set up for this particular construct. However 
sufficient quantities of MBP fused FKBP29 was available for a series of 
experiments. Despite extensive trials no protein crystals were produced. The protein 
appeared to precipitate very easily; this effect could be seen in many of the screens 
used (as outlined in Section 4.2.4). 
Crystallisation of FKBP48 - Crystallisation trials of both full length 
CeFKBP48 and the 830 fragment were carried out. It was anticipated that 
crystallisation of the full length protein would be difficult to achieve due to inherent 
instability of the protein. Up until now, no protein crystals have been obtained from 
any of conditions mentioned in section 4.2.4. Co-crystallisation experiments with the 
30 fragment and the peptide MEEVD provided a few promising precipitates which 
were produced by 30% MPD and 0.2 M magnesium acetate at pH 6.5. Further 
optimisation of conditions with a broad pH screen (pH 4.5-8.5) was subsequently 
tried, however once again refinement around the promising precipitate conditions did 
not produce any protein crystals. 
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4.4 CONCLUSION 
Catalytic efficiency of the target FKBPs - With the specific substrate (Suc-
Ala-Leu-Pro-Phe-pNA), NcFKBP22 and CeFKBP48 showed higher catalytic 
efficiency kca/Km relative to that of FKBP12 (6- and 2-fold higher respectively). 
FKBP29 showed specificity of binding to a different substrate (Suc-Ala-Ala-Pro-
Phe-pNA) when compared with that seen with the standard substrate, as illustrated in 
section 4.3.1. The higher K,,1 of FKBP29 (Table 4.1) could result from a number of 
factors including low substrate specificity, changes in protein conformation when 
fused to MBP protein, and the presence of two binding pockets. Sequence analysis 
showed some degrees of sequence identity of the two FKBP domains of FKBP29 to 
that of human FKBP12 (20% and 37%). The high Km of FKBP29 suggested that 
either of the two FKBP domains could be active. Similarly only one of two FKBP 
domains of FKBP48 (53% and 25% identity to FKBP12 respectively) seems 
functional with a Km as same as that of NcFKBP22. This agrees well with previous 
PPIase studies of human FKBP5 1/52 which share 43% and 47% identity to FKBP 
domains of CeFKBP48 (Barent et al., 1998). The paper reported that the second C-
terminal FKBP domain of both FKBP5 1/52 showed minimal activity due to lack of 
conservation of the residues essential in formation of the binding pocket. 
Crystallisation problems - To date crystallisation of FKBP29 and FKBP48 
has not been achieved. The main factor is likely to be protein homogeneity, as 
illustrated by the dynamic light scattering data, section 4.3.3. The amount of pure 
FKBP29 produced decreased considerably (by over 50%) after cleavage of the MIBP 
fusion protein. Therefore this could be problematic for additional steps in 
purification as each subsequent step also results in some loss of protein. Protein 
stability is another key factor for CeFKBP48. The protein was found to degrade 
rapidly after the first step of purification as shown in Chapter 3, section 3.3.4. In 
addition, further degradation of the purified protein (full length and fragments) was 
also noticed after storing at 4°C and -20°C for 1-2 weeks (data not shown). However 
promising precipitates have been obtained from co-crystallisation experiments. 
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CHAPTER 5 
STRUCTURAL STUDIES OF N. crassa FKBP22 
5.1 INTRODUCTION 
Expression, purification, and PPIase activity of N. crassa FKBP22 have been 
characterised in Chapter 3, section 3.3.2 and Chapter 4, sections 4.3.1 and 4.3.2 
respectively. Further studies of FKBP22 were carried out. This chapter will describe 
the characterisation techniques to determine the preliminary X-ray structure of N. 
crassa FKBP22. 
5.2 PROTEIN X-RAY STUDIES 
5.2.1 Dynamic light scattering 
Dynamic light scattering has been discussed in Chapter 2 and is known to be 
a useful technique to predict success in crystallisation trials. Homogeneity of 
FKBP22 was determined prior crystallisation trials commenced. The protein was 
filtered through a 0.1 lam Whatman AnotopTM prior to remove unwanted dust or 
particles which can give false readings. The experimental analysis of the purified 
protein was carried out on a DynaPro801 with Microsampler attachment, Protein 
Solutions, Inc. 
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5.2.2 Light scattering suggests FKBP22 is a dimeric protein 
The data output collected shown on the analysis software, Dynamics, gives 
the numbers of photon count rates (measured in thousands per second) and the 
hydrodynamic radii of the molecules in solution (measured in nm). Table 5.1 
presents the major parameters analysed from the measurements at a protein 
concentration of 3.5 mg/ml at 4°C. The sample was slightly polydisperse. Bimodal 
analysis of the data suggested the majority of the protein had an estimated molecular 
weight of 23 kDa, with a small proportion present as high molecular weight 
aggregate. Results from monomodal analysis raise the possibility that the protein 
may however be dimenc as this gives an estimated molecular weight of 46 kDa 
(Table 5.2). Further evidence in support of FKBP22 forming dimers comes from 
FPLC gel filtration experiments of microsomal luminal fractions of N. crassa where 
free NcFKBP22 moved as a dimer and was also identified as a component of a 300 
kDa complex with BiP (the ER Hsp70) and other chaperone proteins, the first FKBP 
to be found in a protein folding/maturation supercomplex (Dirk Tremmel and 
















1 0.718 456 3.1 0.0 45 1.002 3.285 
2 0.695 475 3.0 0.0 42 1.004 4.225 
3 0.692 437 3.3 1.3 .52 1.003 8.279 
4 0.701 401 3.6 0.9 63 1.017 6.891 
5 0.674 464 3.1 0.8 44 1.003 6.037 
6 0.685 463 3.1 0.9 45 1.005 4.813 
7 0.669 467 3.1 0.8 44 1.001 4.913 
8 0.459 452 3.2 0.9 47 1.023 4.644 
9 0.687 454 3.2 0.6 47 1.002 5.887 
10 0.673 435 3.3 0.7 52 1.001 3.152 
11 0.678 426 3.4 0.5 55 0.998 5.211 
12 0.690 452 3.2 1.0 48 1.003 10.956 
13 0.672 451 3.2 1.2 .48 1.006 11.175 
14 0.679 383 3.8 1.5 71 1.041 7.148 
Mean 
values 
0.668 446 3.2 0.8 50 1.005 6.025 
Table 5.1. A data output for size distribution analysis of NcFKBP22. The key 
parameters are calculated from individual measurement, total 29 measurements, but 
















1 0.718 456 3.1 0.0 45 1.002 3.285 
2 0.695 475 3.0 0.0 42 1.004 4.225 
3 0.692 437 3.3 1.3 52 1.003 8.279 
4 0.701 401 3.6 0.9 63 1.017 6.891 
5 0.674 464 3.1 0.8 44 1.003 6.037 
6 0.685 463 3.1 0.9 45 1.005 4.813 
7 0.669 467 3.1 0.8 44 1.001 4.913 
8 0.459 452 3.2 0.9 47 1.023 4.644 
9 0.687 454 3.2 0.6 47 1.002 5.887 
10 0.673 435 3.3 0.7 52 1.001 3.152 
11 0.678 426 3.4 0.5 55 0.998 5.211 
12 0.690 452 3.2 1.0 48 1.003 10.956 
13 0.672 451 3.2 1.2 48 1.006 11.175 
14 0.679 383 3.8 1.5 71 1.041 7.148 
Mean 
values 
0.668 446 3.2 0.8 50 1.005 6.025 
Table 5.]. A data output for size distribution analysis of NcFKBP22. The key 
parameters are calculated from individual measurement, total 29 measurements, but 
only 14 of them are shown. 
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Mean 	MeasAmpl Diff Rad Polyd Est % Base SOS 
values 	no. 	Coef (nm) (nm) MW mass line error 
Monomodal 
analysis: 
Monomodal 29 0.668 446 3.2 0.8 50 100 1.005 6.025 
analysis: 
Monomodal 8 0.679 459 3.1 0.4 46 	--- 1.001 5.706 
Bimodal 1 21 	0.357 1971 2.0 	---- 23 93 	1.003 3.830 
Bimodal2 0.324 271 13.1 20229 7 
Table 5.2 A summary of dynamic light scattering values from inonomodal and 
bimodal analysis of FKBP22. 
5.2.3 Crystallisation of FKBP22 
The hanging drop vapour diffusion method was used to grow crystals in 24-
well Linbro plates. Crystals were readily obtained at both 4°C and 18°C. Thin plate 
crystals were grown by equilibrating a 4 micro-litre drop against a 1 ml well solution. 
The well solution consisted of 600 p.1 methoxypolyethylene glycol (MPEG) 5000, 
100 .tl 1M 2-(N-morpholino)ethane-sulphonic acid (MES) at pH 6.1, 30 p.1 saturated 
ammonium sulphate, 10 p.1 dimethyl suiphoxide (DMSO) and 260 p.1 water. The drop 
consisted of 2 p.1 protein solution and 2 pA of well solution. The protein solution 
consisted of protein at 12 mg/ml in phosphate buffered saline at pH 8.0. Crystals 
grew as very thin plates which compose multiple layers of thin sheets. A number of 
additives were used to modify crystal growth and some moderate improvement in 
crystal form was found using glycerol and DMSO (up to 5% w/v). The best crystals 
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grew as plates up to 0.5 mm across, but were still less than 0.01 mm thick (Figure 
5.IA). The morphology of the crystals in most drops was poor with most crystals 
growing in layers on top of each other. Small fragments of the sheets could be cut 
from the larger sheets and these were transferred from the hanging drop using an 
appropriately equal-sized cryo-loop into a cryo-protectant solution containing mother 
liquor plus 20% glycerol. Crystals were removed from the cryo-protectant solution 
after 5 seconds and mounted in a cryo-loop and flash frozen in liquid nitrogen. 
Co-crystallisation of FKBP22 and RAD, a rapamycin-like analog, was also 
carried out. A needle crystal (Figure 5. 1B) was grown by equilibrating a 3 micro-litre 
drop against a 1 ml well solution. The well solution consisted of 360 tl polyethylene 
glycol (PEG) 4000. 100 .tl IM citric acid at pH 5.5, and 540 .tl water. The drop 
consisted of 1.5 .tl protein solution and 1.5 p1 of well solution. The protein solution 




1 mm 	 1 mm 
Figure 5.1. Crystal morphology of FKBP22. A) Thin plate crystals of the native 
protein growing with 600 pI MPEG 5000, 100 p1 IM MES at pH 6.1, 30 p1 saturated 
ammonium sulphate, 10 p1 dunethvl sulphoxide (DMSO) and 260 p1 water. B) A 
needle crystal of the FKBP221RAD complex growing with 360 pl PEG 4000, 100 p1 
1 M citric acid at pH 5.5, and 540 p1 water. 
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5.3 X-RAY CRYSTALLOGRAPHIC STUDIES OF FKBP22 
All computational work described in this section was carried out by Dr. Paul 
Taylor and Professor Malcolm D Walkinshaw. 
5.3.1 Data collection 
X-ray data (Table 5.3) were collected at lOOK using a MAR image plate and 
processed using DENZO and SCALEPACK (Otwinowski and Minor, 1993). 
Synchrotron data was collected on station ID-14, EH3 at the ESRF facility Grenoble 
and station 9.6 at the SRS Daresbury. 
5.3.2 Crystallographic data for NcFKBP22 
X-ray crystallographic data of FKBP22 were collected from the crystal 
shown in Figure 5.1A. However no diffraction was collected from the needle crystal 
of FK113P22 in complex with RAD (Figure 5.1B). Table 5.3 summarises the statistics 
of crystallographic data for FKBP22. The merging R factor is 10.6% and the data are 
87% complete to a resolution of 2.6 . The molecular replacement solution was 
found using MOLREP (Vagin and Teplyakov, 1997) using data to a resolution of 3A 
and FKBP12 (PDB code 1FKL) as the starting model (Wilson et al., 1995) (Residues 
2 to 104 as can be seen in Figure 5.3). 
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Resolution A 	 30.0-2.6 
a A 	 70.83 
b A 	 32.23 
c A 	 77.10 
00 	 106.29 
Rmerge 	 0.106 (0.281) 
Completeness % 	 87.0 (0.82) 
No. observations 	 20652 
No. unique reflections 	9372 
Table 5.3. Crystallographic data for FKBP22 from N. crassa 
The X-ray images showed diffraction patterns from two or more of the 
composite crystals (Figure 5.1A). Despite the composite ("twinned") diffraction 
pattern it was possible to separate out reflections corresponding to one single crystal 
(Table 5.3) belonging to space group P2, with unit cell dimensions a = 70.83, b = 
32.23, c = 77.10 A and P = 106.290. Assuming a molecular weight of 22,919 Da, the 
calculated Matthew's coefficient (V m) for one molecule per asymmetric unit is 3.7 
A3/Da whilst for two molecules per asymmetric unit V m is 1.9 A3/Da with a low 
solvent content of 67%. 
A self rotation function gave a very strong (non-crystallographic) peak with 
Rf/sigma = 11.1 and x = 1800 (next strongest peak 3.9) indicating that the asymmetric 
unit consists of a 2-fold dimer. A cross-rotation search using FKBP12 (PDB code 
1FKL) as a search model gave two strong peaks (Rf/sigma 5.4 and 5.2 with the next 
highest peak at 4.7). These peaks are related to each other by rotation of 179 0 and are 
consistent with the results from the self rotation search. These two cross-rotation 
function peaks also provide a clear solution in the translational search with an R- 
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factor of 0.56 (next best 0.6) and a correlation coefficient of 0.28 (next best 0.19). 
Rigid body refinement using the human FKBPI2 model with side chains modelled to 
the NcFKBP22 sequence gave an Rr ee value of 0.5 1 and a Figure of merit of 0.32. 
The packing arrangement of this rigid body refinement is shown in Figure 5.2. 
I i uie 5.2. (r\.s11/ JkI(k1Ii 	f the IA'BP JHlluii/l Of \'IK/?P22. T/u' unit 	I/ is 
shown in green. 
- 163- 
5.4 CONCLUSION 
The electron density for the FKBP domain of the structure is very clear. 
though the quality of the data did not allow an unambiguous chain tracing extending 
into the C or N terminal regions. These preliminary structural results show that the 
N-terminal domain of NcFKBP 22 is a typical FKBP domain (Doman et al., 2003). 
The highest homology of NcFKBP 22 is with the cytosolic/mitochondrial NcFKBPI3 
(55%). All residues important for PPIase activity and FK-506 binding are conserved 
in the FKBP domain of NcFKBP22 (Figure 5.3). 
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Figure 5.3. An alignment of N. crassa FKBP22 against human FKBPI2 and N. 
crassa FKBPJ3 showing high degree of conservation (37% and 55% identity 
respectit'elv) of the FKBP-binding domain (residues 21-129 of FKBP22). Residues 
with red highlights represent high conservation. In the consensus lines uppercase 
letters, lowercase letters, and dots represent residues with 907, 50%, and 09c 
identity respectively. #for B, D. E, N, Q, Z. Arrows and coils represent secondary 
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structures of /3-strands and a-helices respectively. Blue dots represent the position of 
the C-terminal helix. The alignment was produced using the ESPript programme. 
The C-terminal domain of the protein (residues 136-217) is unlike any other 
FKBP characterised to date. The extreme carboxy-terminus has a clear bias for 
alanine, glutamate, lysine and valine residues. This domain is also very acidic and is 
likely to adopt an amphipathic helical conformation as predicted by PSIPRED 
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Figure 5.4. A two-dimensional graphical representation of secondary structure 
prediction of FKBP22 using the PSIPRED sen'er (McGuffin et al., 2000) showing 
the predicted helical structure of the C-ter,ninal sequence (residues 116-197 in 
mature protein equivalent to residues 136-217). 
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BLAST (Altschul et al., 1990) searches using the C-terminal domain revealed a low 
sequence similarity to short regions from late embryogenesis abundant (LEA) 
proteins from a number of different species. These LEA proteins are thought to 
protect cells from stress associated with dehydration and have been shown to have an 
osmoprotective role (Garay-Arroyo et al., 2000). The extreme C-terminal sequence 
(HNEL) is an ER retention signal suggesting that NcFKBP22 may be involved in 
protein folding in the ER, with the charged C-terminal domain acting as a 
recognition site for target proteins. It is suggested that the C-terminal domain of the 
N. crassa FKBP22 could act either as a substrate binding domain or as a dimerisation 
domain analogous with the Mip structure (Riboldi-Tunnicliffe et al., 2001). 
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CHAPTER 6 
STUDIES ON FKBP48 STRUCTURE AND FUNCTION 
6.1 INTRODUCTION 
As mentioned previously, among all the immunophilins found in C. elegans 
including 18 cyclophilins and 8 FKBPs, FKBP48 is the only large immunophilin to 
contain a TPR domain. To date, a number of TPR-containing proteins, including 
large immunophilins, have been shown to bind to Hsp90 to facilitate its function 
(Owen-Grillo et al., 1996). These heteroprotein interactions were mediated through 
TPR domains. Therefore, it was postulated that CeFKBP48 was a likely binding 
candidate for Hsp90. This chapter details how this assumption was investigated 
through employing several different biophysical techniques to characterise the 
protein-protein interactions. 
6.1 .1 The identification of large immunophilins as Hsp9O-binding 
proteins 
The interactions of large immunophilins with Hsp90 were revealed in the 
1990's (Callebaut et al., 1992; Ratajczak et al., 1990; Tai et al., 1986). FKBP52 from 
rabbit was the first large immunophilin characterised (Nakao et al., 1985). The 
interaction with Hsp90 was noticed by coincidence whilst the authors investigated 
interactions with steroid receptors. No direct interactions between the immunophilins 
and the steroid receptor formed. Renoir and his team found from the cross-linking 
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study that FKBP52, in the unactivated steroid receptor, bound only Hsp90, but not 
the steroid receptor (Renoir et al., 1990). Up until now, a number of lines of 
investigation have shown interactions between members of the large immunophilin 
family with Hsp90. In 1994 Radanyi showed that the tetratricopeptide repeat (TPR) 
domain of FKBP52 mediated binding to Hsp90 (Radanyi et al., 1994). Then in 1995, 
Hoffmann showed the TPR domain alone from human Cyp40 was sufficient to 
enable Hsp90 binding (Hoffmann and Handschumacher, 1995). 
Interactions between immunophilins binding Hsp90 - Three large two 
domain immunophilins have been widely studied, FKBP5 1, FKBP52, and Cyp40. In 
terms of the Hsp90-binding proteins, they can be classified as the Hsp90 co-
chaperones; mainly influencing interactions of Hsp90 with nuclear receptors, i.e. 
steroid receptors (Pratt and Toft, 1997). High molecular weight immunophilins were 
first characterised from studies of a number of steroid receptors. In attempts to 
prepare a monoclonal antibody against the rabbit progesterone receptor, rabbit 
FKBP52 was also detected (Faber and Tai, 1985). Whilst attempting to purify the 
oestrogen receptor, Ratajczak and his team found a co-purifying protein of 
approximately 40 kDa (Ratajczak et al., 1990). This protein was subsequently 
characterised as Cyp40 (Kieffer et al., 1993; Ratajczak et al., 1993). The high 
resolution crystal structures of Cyp40 (Taylor et al., 2001), FKBP51 (Sinars et al., 
2003), and FKBP52 (Wu et al., 2004) have recently been determined. Domain 
organisations of FKBP5 1 and FKBP52 are similar with two consecutive FKBP 
domains at the N-terminus and one C-terminal TPR domain. 
TPR mediation of Hsp90 interactions - A number of lines of evidence shows 
that TPR repeats are required for Hsp90 binding (Hoffmann and Handschumacher, 
1995; Radanyi et al., 1994). A TPR repeat is a degenerate 34 amino acid sequence 
present in tandem arrays of 3-16 motifs which mediates protein-protein interactions. 
General background on the TPR repeat was described in Chapter 1, section 1.3. The 
C-terminal TPR domains of FKBP51, FKBP52, and Cyp40 share a great deal of 
structural similarity at the interaction site with Hsp90 (Carrello et al., 1999; 
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Ratajczak et al., 1993). The interaction between Cyp40 and the extreme C-terminal 
residues from Hsp90 was modelled. Using the model and data available from the X-
ray structure of Hop in complex with MEEVD (Scheuffer et al., 2000) a mutational 
analysis of residues from Cyp40 was carried out to determine those critical in the 
interaction with Hsp90. Six out of 24 key mutant residues (K227, N231, F234, N278, 
K308, and R312) mutated from the C-terminal TPR domain of Cyp40 had the most 
dramatic impact on Hsp90 binding, effectively eliminating any interaction between 
the two proteins. Mutation of other residues, e.g. F234A and S274L significantly 
reduced Hsp90 binding compared to binding level of the wild types (Ward et al., 
2002). Finding single point mutants capable of eliminating binding was somewhat of 
a surprise due to nature of protein-protein interactions. The recent X-ray structure of 
the FKBP52 TPR domain in complex with the final five residues (MEEVD) from 
Hsp90 (Wu et al., 2004), corroborated the site-directed mutagenesis studies of Cyp40 
with residues N324, K354 and R358 of FKBP52 (equivalent to N278, K308 and 
R312 in Cyp40) interacting with the Hsp90 MEEVD peptide. Two novel interactions 
were identified by the X-ray structure of the FKBP52 TPR domain complexed with 
the MEEVD peptide, namely K282 and M328. The equivalent positions in the Cyp40 
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Figure 6.1. Sequence alignment of CeFKBP48, FKBP5I152 from human against 
bCvp40. Conserved residues required tar Hsp90 binding are shown highlighted 
boxed in black. The X-ray structure of the C-terminal FKBP52 (residues 145 -459) in 
complex with the pentapeptide MEEVD (PDB code IQZ2) revealed two additional 
residues, K282 and M328, important for binding shown in black circles. The 
alignment is produced using MultAlin. in the consensus lines, residues with red, 
uppercase letters are high/), conserved (90%). Residues with blue, lowercase letters 
are weak1' conserved (not over 50%). A position with no conserved residue (orange) 
is represented by a dot. !for I and V residues, $fbr L and M residues, %for F and Y 
residues, and #fr B, D. E, N, Q, Z. 
6.1.2 The well-characterised Hsp90 binding TPR proteins 
FK506-hinding protein 51 and -52 (FKBP5J and FKBP52) - The structural 
architecture of FKBP5 I and FKBP52 is very similar with 70% sequence identity 
whereas their relative domain orientations are different (Sinars et al., 2003: Wu et al., 
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2004). The structural data show each protein contains two consecutive FKBP 
domains and one TPR domain (Figure 6.2). The FKBP domains of FKBP12: 
FKBP51 FK1 and FK2 domains display 48% and 26% identity with FKBP12 FK1 
and FK2 domains, respectively; and FKBP52 FK1 and FK2 domains display 49% 
and 28% identity with FKBP12 Fl and F2 domains, respectively. The FKBP 
domains (FK1 and FK2) of both proteins share sequence identities to FKBP12 (48% 
and 26% for FKBP51 and 49% and 28% for FKBP52). Each FKBP domain 
comprises five anti-parallel 13  strands wraparound a central a helix. Although these 
two domains are structurally similar, their enzymatic activities are significantly 
different. FK1 domain shows higher PPIase activity (k,,'/Km = 0.48 x 106  M 1 s' for 
FKBP51 and 1.5 x 106  M's 1 for FKBP52). The FK2 domain shows minimal activity 
(Barent et al., 1998; Pirkl et al., 2001) which can be explained by the lack of 
sequence conservation in the binding pocket of FKBP. The TPR domains of FKBP5 1 
and FKBP52 corresponds to those of PP5 (Das et al., 1998), Hop (Scheuffer et al., 
2000), and Cyp40 (Taylor et al., 2001). Three TPR repeats and an additional long C-
terminal helix are included in each of these domains. The TPR motif comprises a 
sequence of 34 amino acids, within which no residues are completely conserved. The 
resulting structure is made up of a pair of anti-parallel a helices. Between TPR-
containing proteins, the angle at which the additional C-terminal helix (if present) 
protrudes from the final helix shows some variation (Sinars et al., 2003; Wu et al., 
2004). The following chapter will compare and contrast a number of TPR domain X-
ray and modelled structures in greater detail. 
The final C-terminal helical extension seen in Cyp40 has been proposed to be a 
binding site for calmodulin. However, the presence of a calmodulin-binding site in 
both FKBP5 1 and FKBP52 remains controversial. Massol et al. found calmodulin-
sepharose resin retained rabbit FKBP52 in the presence of Ca 2+  (Massol et al., 1992). 
The opposite effect was observed in a series of experiments carried out in the Smith 
laboratory, Hsp90 failed to bind to FKBP in the presence of calcium chelators 
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Figure 6.2. X-ray structures of human FKBP51 (A, PDB code JKTI) and hunan 
FKBP52 (B, PDB codes IQJC fbr the N-terminal domain, residues 1-260, and JP5Q 
ftr the C-terminal domain). The overall structures of both proteins compose 2 FKBP 
domains (FKJ shown in grey, residues 33-138 for both, FK2 shown in pink, residues 
147-251 fbr FKBP51 and 149-253 tbr FKBP52) and 1 TPR domnain shown in (.-van 
and olive, residues 268-384 .16r FKBP51 and 270-386 .16r  FKBP52) fbi/owed by a 
final long helix (can). 
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Cyclophilin 40 (Cyp40) - Both the Cyp40 gene and gene product have been 
extensively studied over the last decade in terms of its genetics, biochemistry, and 
structure. Several Cyp40 homologues were identified, i.e. Cpr6 and Cpr7 in S. 
cerevisiae (Duina et al., 1996a) and SQUINT in Arabidopsis thaliana (Berardini et 
al., 2001). Cyp40 possesses PPIase activity with kca/Km = 1.9 X 106 M 1 s' using the 
substrate Suc-Ala-Ala-Pro-Phe-pNA (Kieffer et al., 1992). X-ray structures of bovine 
Cyp4O were recently solved from two crystal forms, monoclinic and tetragonal, the 
TPR domain differs greatly between the two structures (Taylor et al., 2001). The two 
structures are illustrated in Figure 6.3, and show the protein comprises two main 
structural domains, the cyclophilin domain (residues 1-183) and the TPR domain 
(residues 222-340). The TPR domain adopts alternative conformations between the 
monoclinic and tetragonal crystal forms. 









Figure 6.3. X-ray structures of bovine Cvp40 solved from the monoclinic crystal 
for,,i (A, PDB code JIHG) and the teiragonal crystal fhrm (B, PDB code hiP). The 
overall structures of both proteins compose 2 distinct domains (the cyclophilin 
domain shown in grey, residues 1-183 and the TPR domain shown in cyan and olive, 
residues 222-340 fillowed by the final helix ((yan). in the tetragonal crystal form 
only the first four he/ices of the TPR domain are visible in electron density. The two 
helices oft/ic second TPR inotif stretch to form an extended helix. 
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Both structures share a great deal of similarity of overall domain organisation. The 
N-terminal domain, an 18-kDa PPIase domain, shares enzymatic and structural 
similarity to Cyp A (65%). The PPIase domain composes eight strands of anti-
parallel 0 barrel capped at either end by two x helices (Kallen et al., 1991). The 
structure of the cyclophilin domain differs from that of human Cyp A as it contains a 
divergent loop of eight additional residues (residues 60-67) as can be seen in Figure 
6.3A. The cyclophilin and TPR domains are connected by a 30-residue linker 
(residues 184-213) which includes negatively charged residues (D200. D204) to form 
the salt bridges with the positively charged residues (K244. K245. K248, R251) of 
the helix "B 1 " of the TPR domain (Figure 6.4). 
16 	183 222 	340 431 
CYP 	TPR 
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CGEL. EDi FPIDI.)SHPDFPEDD'JDLI D1DJLLTSEDLKNIGNTFFK5QNWE 
MAIKXYTKVLRYVEGSRAAAEDADGAKLQPVALSCVLNIGACKLKMSDWQGAVDSCLEAL 
	
EIDPSNTKLYRRAQGWQGLKEYDQALADLKKAQEIAPEDK' I 	 I !A,F L' -. 
Figure 6.4. Schematic representation of the domain organisation of bovine 
cvclophthn 40. Cvp40 composes two clusters of c clophilin domain (residues 16-183, 
green letters) and additional TPR domain (residues 222-340, pink letters). Bold, 
underlined letters in orange and pink represent negative/v and positive/v charged 
residues forming salt bridges between a linking ioop and TPR domain respective/v. 
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The C-terminal domain contains a TPR motif and a putative calmodulin binding site 
(residues 353-370) at extreme C-terminus. In the monoclinic form, seven helices of 
the TPR domain (helix-turn-helix) are joined to the PPIase domain by a linker, 30 
residues long (Figure 6.3A). In the tetragonal crystal form only the first four helices 
of the TPR domain are visible in electron density. The two helices of the second TPR 
motif stretch to form an extended helix (Figure 6.3B). This structure may represent a 
folding intermediate potentially illustrating the large scale movements possible upon 
binding of a partner protein including Hsp90 (Taylor et al., 2001). The MIEEVD 
recognition site lies on the hydrophobic groove formed by the first helices of all the 
TPR repeats. 
6.1.3 The TPR-containing immunophilins help Hsp90 assemble with 
nuclear receptors 
In many signal transduction pathways including the assembly pathways of the 
oestrogen receptor (Nair et al., 1996), numerous so-called client proteins are 
regulated by Hsp90 (Pratt and Toft, 2003). Hsp90 requires modulation by co-
chaperones to fully function. The relationship between Hsp90 and steroid receptors 
has been extensively studied. With the binding of Hsp90 to a steroid receptor alone, 
Hsp90 is unable to turn the receptor into its transformed state when a hormone can 
bind stably (Scheibel et al., 1998), co-chaperones are required for full activity. A 
model of steroid receptor/lHsp90 heterocomplex assembly has been proposed 
utilising all available data from this well studied system. Nevertheless, the 
mechanistic interactions of the multi-protein machinery still remain to be answered. 
Steroid receptor assembly pathway - The multi-protein complex system has a 
minimal requirement for the following five proteins (Hsp40, Hsp70, Hsp90, Hop, 
and p23). The sequence of events can be broken down into 3 stages, early (step 1), 
intermediate (step 2), and late complex assembly (step 3) as described in Figure 6.5. 
The spontaneous formation of a Hsp90IHsp7O/Hsp4OfHop complex called the 
foldosome (Hutchison et al., 1994) occurs early. The foldosome complex binds to the 
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ligand-binding domain (LBD) of a steroid receptor. In an ATP-dependent manner, 
Hsp90 then transforms the receptor conformation to its active form (step 2). The 
ligand, in this case the steroid hormone, is therefore able to access the steroid-
binding site resulting in initiation of transcription. 
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Figure 6.5. Steroid recepior1Hsp90 assembly process. The process can be subdivided 
into three broad stages. First stage, five essential proteins assembly themselves into 
a foldosome. Incorporation of the steroid receptor then follows (second stage), in 
which the Joldosome complex captures the receptor which is then transformed into 
its active conformation. The subsequent binding to the hormone recruits another 
protein (p23) and releases the former components (Hop and Hsp70). The 
receptor/chaperone heterocomnplex then moves into nucleus (final stage) allowing 
initiation and regulation qt transcription. Diagram based on Figure 3 (Pratt and 
Toft, 2003). SR: steroid receptor, 1mm: zmnmunophilins. 
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Normally, steroid receptors bound by the Hsp90 heterocomplex machinery are 
transferred from the cytoplasm into the nucleus. Therefore, the steroid 
receptor•Hsp90 heterocomplex needs to be stabilised for hormone action. At this 
stage, p23 binds Hsp90 and stabilises the intermediate hetero-complex in the 
presence of ATP. The exact detail of the subsequent steps involving the release of 
Hsp70 and Hop from the intermediate complex are as yet unclear. Dissociation of 
Hop leaves the TPR acceptor site on Hsp90 free to bind to the TPR domain from an 
immunophilin. It is proposed that the role of the immunophilins in the final complex 
assembly is to facilitate the movement of steroid receptors into the nucleus (Owen-
Grillo et al., 1996). 
6.1.4 The search for a role for C. elegans FKBP48 
The sequencing of the C. elegans genome was completed in 1998. FKBP48 
was the only large TPR containing FKBP (and immunophilin) found in this 
organism. From analysis of full sequence alignments, CeFKBP48 has 44% identity to 
hFKBP51. The TPR domain of FKBP48 shows 37% identity to that of FKBP51 and 
22% to that of Cyp40. A reasonable working hypothesis was therefore proposed, that 
due to their degree of homology FKBP48 and the Hsp90 from C. elegans could 
interact. In the present study, the role of CeFKBP48 was addressed. The interaction 
of FKBP48 with Hsp90 was observed and compared with that of Cyp40 as a positive 
control. The following sections will focus on each technique utilised in this series of 
experiments. 
6.2 CHROMATOGRAPHIC-BASED INVESTIGATIONS OF TPR DOMAIN 
INTERACTIONS WITH HSP90 
This section will discuss the experimental approaches taken to investigate the 
potential interaction between Hsp90 and two TPR proteins, FKBP48 from C. elegans 
Elm 
and bovine Cyp40. Three fragments of FKBP48 were isolated in this work. Full 
length FKBP48 (FL) was the intact protein as predicted from sequence analysis. The 
fragment of FKBP48 lacking final 30 C-terminal residues was called 630. The third 
fragment purified comprises largely the two FKBP domains present in FKBP48 (with 
a few additional residues from the predicted linker region) and was designated ST for 
ShorT as illustrated in Figure 6.6. 
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Figure 6.6. Three ,fragments of FKBP48 from C. elegans obtained after purification. 
A) A representative domain organisation showing different domain compositions of 
each fragment: the ST fragment residues 1-237, the (530 fragment residues 1-430, 
and the FL residues 1-431. B) The full sequence of FKBP48 shown in black with a 
sequence highlight of the other two (the 530 fragment blue solid underlined and the 
STfrag,nent (orange broken underlined). 
6.2.1 Experimental procedures 
Co-iinrnunoprecipitation (Co-IP) - The Co-IP studies in this work were 
carried out to examine whether CeHsp90 and CeFKBP48 (the 830 fragment) could 
be detected together in co-immunoprecipitates. Using an Hsp90 antibody previously 
used to characterise such interactions, (David et al., 2003), the physical association 
of CeHsp90 and the 630 fragment from FKBP48 was examined. The preparation of 
protein complexes was carried out by mixing components at a 1:1 M ratio and 
incubating both target proteins overnight at 4°C. Mouse monoclonal anti-Hsp90 
antibody was diluted to a final concentration of 4 .tg/ml in 150 tl complex solution, 
250 .tl 2XIP buffer (30 mM NaCI, 20 mM Tris pH 7.4, 2 mM EDTA, 2 mM EGTA 
pH 8.0, 0.4 mM sodium orthovanadate, 2% triton X-100, and 1% IGEPAL CA-630), 
and 100tl distilled water. The antigen mixture was incubated overnight with 
agitation at 4°C. To pull out the antibody-antigen complexes, slurry of protein A 
beads (200 il) was added. The protein beads were further incubated for 3 hours at 
4°C. The immune complexes with protein A were precipitated by centrifugation at 
9,200 x g for 2 minutes. The supernatant, designated with S, was stored at -20°C 
until use. The pellet of beads (P) was washed with 1X1P buffer 3 times and stored at 
-20°C until use. The experiment was also set up in parallel at room temperature 
(25°C) to address the effect of temperature on protein complex formation. The 
complex mixture was incubated at room temperature for 30 minutes; otherwise the 
protocol as described above was followed. All the samples were saved and analysed 
by SDS-PAGE. 
Western blot - The protein was blotted onto a nitrocellulose membrane using 
a semi-dry blotter and an appropriate buffer system as outlined in the manufactures 
instructions (BioRad). Briefly, the membranes and SDS gels were soaked in transfer 
buffer (25mM Tris, 190mM glycine, and 20% methanol). The "blotting sandwich" 
was assembled as per instructions. The transfer of proteins from gel to the membrane 
was achieved using 15 mV for 30 minutes. The membranes were then soaked in 
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blocking buffer to block non-specific sites (PBST, 0.5% milk powder) for 1 hour at 
room temperature and incubated overnight at 4°C with the mouse monoclonal anti-
Hsp90 antibody (1:1000). The blot was then washed and incubated with the 
secondary antibody alkaline phosphatase conjugation (goat anti-mouse IgG whole 
molcule:alkaline phosphatase). The blot was washed 3 times in PBST (137 MM 
NaCl, 0.27 mM KC1, 1 mM Na2HPO4, 0.2 mM KH2PO4, 0.1% Tween 20) and 
developed by the addition of 1:5 of the chromogenic substrate BCIPINBT (5-bromo-
4-chloro-3-indolyl phosphate/nitrobluetetrazolium) that react with the conjugated 
alkaline phosphatase on the secondary antibody to produce a brown/purple 
precipitate. 
A direct comparison of Hsp90 binding to FKBP48 was made with that of the binding 
seen with Cyp40. The experimental setup was as described for the previous series. In 
this case of trials, Cyp40 antibody (4 j.tg/ml final concentration) was used instead as 
the primary antibody. The separation of antigen-antibody complexes, in this case, 
was by Protein G Sepharose. 
Gel filtration chromatography - A Sephacryl S-300 HR column (Amersham) 
was set up to run on the BioCad system by Mrs. Sandra Bruce. The column then was 
equilibrated with 1 column volume of running buffer (50 niM Tris, 150 mM KC1, 5 
MM MgC12 pH 7.5) at 0.5 ml/min. The mixture of CeHsp90/CeFKBP48 was 
prepared at 30°C for 30 minutes. One ml of the mixture was applied to the column 
(flow rate as above). All eluent fractions were automatically collected in 1 ml 
aliquots. The peak fractions were analysed by SDS-PAGE. 
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6.2.2. Results and discussion 
Co-immunoprecipitations of Hsp90 and FKBP48 - CeHsp90 co-
immunoprecipitations with CeFKBP48 using AC88, the mouse antibody raised 
against Hsp90 (mouse IgG 1 anti-Hsp90 monoclonal antibody), were examined as 
shown in Figure 6.7. The protein-antibody complex was isolated using Protein A to 
pull-down the antibody. Two protein bands at approximately 82 and 48 kDa (arrows 
1 and 2 on top panels), equivalent to CeHsp90 and CeFKBP48 respectively, are 
shown in the co-precipitate (P) samples (lanes 9 and 15 on the top left and top right 
panels respectively). To identify these bands, immunoblots with appropriate 
antibodies were carried out. Both the Hsp90 and FKBP48 have a hexa-His tag and 
theoretically should be detectable by western blotting followed by staining with an 
anti-His antibody. FKBP48 is clearly visualised on lane 15 (lower right panel); 
however, Hsp90 is barely detectable (not seen on the same lane, same panel). This 
could result from low sensitivity of Hsp90 to Anti-His antibody (compared to 
FKBP48) and low amounts of Hsp90 precipitated. Using the Hsp90 antibody, AC88 
raised against mouse, a weak band of 82 kDa was detected (hardly seen as arrowed 
on lane 9, lower left panel). Therefore, results from co-IP investigations seem unclear 
to determine the interaction between CeFKBP48 and CeHsps90. The two bands of 
target proteins seen from the co-EP precipitates (lanes 9 and 15 of top panels) could 
result from unspecific binding to Protein A. On the basis of the co-EP results it is not 
clear that a complex between CeFKBP48 and CeHsp90 can be formed. 
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Figure 6.7. Determination of interactions between CeFKBP48 and CeHsp90 using 
co-immunoprecipitation. The formation abilities to ftmn complexes between both 
proteins are investigated using Western blot: with anti-Hsp90 antibody (lower left 
panel), with anti-His antibody (lower right panel). Experiments show both obserVed 
proteins (CeHsp90 seen at 82 kDa. arrow 1, and CeFKBP48 seen at 48 kDa, arrow 
2, with respect to the markers) exist in the same precipitate (lane 9, to!) left, and lane 
15, (0/) right). The Hsp90 band (lane 9, lower left, arrow 1) is present at a low level 
whilst the hand corresponding to FKBP48 can he clearly seen (lane 15, lower right, 
arrow 2). T: total protein sample, S: co-/P supernalant. P: co-/P precipitate, S90, S48. 
and Sc: co-/P supernatant of on/v Hsp90, on/v FKBP48, and complex mixture. P 90. 
P48, and Pc: co-/P precipitate of only Hsp90, only FKBP48, and complex mnixture. 
15% SDS gels were used. 
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Co-immunoprecipitations of bCyp40 to CeHsp90 - The potential binding 
interaction between bCyp40 and CeHsp90 was investigated to compare the 
interaction of CeHsp90 with another TPR-containing protein. Cyp40, as described 
earlier in this Chapter (section 6.1.2) belongs to the Cyclophilin subfamily, and in 
this instance the experiments are also cross-species (C. elegans and Bos Taurus). 
Figure 6.8 shows the bidirectional trials at different temperatures (4° and 30°C). Two 
protein bands at approximately 82 and 40 kDa (arrows 1 and 2 on top panels), 
equivalent to CeHsp90 and bCyp40 respectively, are shown in the co-precipitate (P) 
samples (lanes 12 and 24 on the top left and top right panels respectively). These two 
bands were further blotted with Hsp90 antibody (lower left panel of A) and Cyp40 
antibody (lower right panel of A). However, clear results could not be seen as the 
previous case. From the co-IP precipitate samples, only one of target proteins 
specifically bound and was detected as visualised on the immunoblot experiments 
(lower left and right panels of A). Therefore, appearance of Hsp90 and Cyp40 in the 
























Cntrl Hsp90 Cyp40 Cmplx 
	
Cntrl 	HspgO Cyp40 Cmplx 
TSP S PTSPTSP 
	
TS P T S P T S P T S P 
M 1 2 3 4 5 6 7 8 910 1112 
	







83 kDa - 
62 kDa - 
48 kDa - 
83 kDa - 
62 kDa - 
48 kDa - 
2 
2 
B) 30°C 	Cntrl Hsp9O Cyp40 CmpIx 	 Cntrl 	HspgO Cyp40 Cmplx 
T S P T S PT S P T S P 
	
TS P T S P T S P T S P 
M 1' 2' 3' 4' 5' 6' 7' 8'9'10'11 12 
	
13'14'M 15' 1 6'17'18'19'20'21'22'23'24' 
Figure 6.8. Deier,ni,zation of interactions between bCvp40 and CeHsp90. A) At 4°C 
with Hsp90 antibody (left) and cvp40 antibody (right). B) At 30 CC with Hsp90 
antibody (left), with Cvp40 antibody (right). Protein hands seen on the positions of 
arrows I and 2 in A) and B) are identified as Hsp90 (arrow 1) and Cvp40 (arrow 2) 
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with respect to the markers. Formation of Hsp90 and Cyp40 complexes seemed 
undetectable (last lanes of each lower panel). In addition, complex formation could 
be temperature-dependent. More intensity of both protein bands at 30°C, lane 24', 
top panel in co-immunoprecipitation experiments, B) can be seen compare to that at 
4°C in lane 24, top panel in A). T: total protein sample, S: IP supernatant, P: IP 
precipitate; Sc: IP supernatant of complex mixture, Pc: IP precipitate of complex 
mixture. 10% SDS gels were used 
The temperature dependence of TPR interactions with Hsp90 was addressed. This 
finding was supported by previous reports (Denis et al., 1988; Meshinchi et al., 
1990). Complex formation occurred preferentially at high temperature (30°C). As 
seen in Figures 6.8A and 6.8B the proportional intensity of the complexes at 30°C 
(lane 24') is greater than that seen at 4°C (lane 24). Temperature, therefore, is an 
important factor in Hsp90-TPR interactions. 
Inconclusive co-11P results of bCyp40 and CeHsp90 suggested further investigations 
were required to probe the existence of possible interactions. 
Gel filtration chromatography - Three chromatograms from individual runs 
of Hsp90, FKBP48, and the complex mixture were overlaid (Figure 6.9). The peaks 
observed from the runs of Hsp90 and FKBP48 alone are referred to as controls as 
they represent the proteins in their native, uncomplexed states. The chromatogram of 
the protein mixture indicates a large peak eluting very early with the void volume 
suggesting aggregate formation corresponding to a molecular weight of 420 kDa. At 
55 ml and 75 ml the eluted peaks are equivalent to Hsp90 and FKBP48 
corresponding to markers of 400 and 66 kDa respectively when compared to the 
control. Gel filtration could not be used to fully characterise the complex because of 
aggregation and other effects. Whilst FKBP48 elutes at a position equivalent to its 
anticipated molecular weight, Hsp90 elutes at a position indicative of aggregate 
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Figure 6.9. A chromatogra,n of Hsp90-FKBP48 mixture (orange) overlaid with those 
of H.sp9O (blue) and FKBP48 (green) on their own. Proteins were mixed up with 1:1 
M ratio and incubated at 30°C for 30 minutes before sample loading to the column. 
6.3 CHARACTERISATION OF THE INTERACTION BETWEEN LARGE 
IMMUNOPHILINS AND HSP90 USING SURFACE PLASMON RESONANCE 
(SPR) 
To characterise the affinity of FKBP48 interactions with Hsp90. surface 
plasmon resonance studies were undertaken. The biosensors. equipment, and relevant 
accessories used in this work were supplied by BlAcore (Uppsala. Sweden). The 
particular systems used are dependent upon an optical phenomenon termed surface 
plasmon resonance (SPR) (Malrnqvist and Karlsson. 1997). The principle includes 
biomolecular adsorption and interaction at the solid surface (Jonsson et al.. 1991). 
: 
6.3.1 An overview of SPR technology 
At the centre of the BlAcore process is an interaction chip surface that is 
specifically designed for protein adsorption. The output signal is dependent upon 
changes in the refractive index at the surface as proteins bind transiently. Basic 
knowledge of the interaction surface and data measurement, including 
immobilisation techniques is previously described in Chapter 2, section 2.3.2.8. 
Briefly, the chip surface is prepared ready for ligand immobilisation. Anayte is 
subsequently delivered to the ligand-immobilised surface. Association and 
dissociation of ligand-analyte is observed as a change in response units. The surface 
is finally regenerated to remove remaining analyte still bound to the chip surface 
after the dissociation phase of the experiment. 
6.3.2 Materials and methods of affinity interactions 
Materials - Full-length C. elegans Hsp90 (CeHsp90) and the C-terminal 
domain of human Hsp90 (hHsp90-530_724) were employed as ligand molecules. 
This Hsp90 C-domain from human contains the residues essential for TPR protein 
binding. Three fragments of FKBP48 were used as analytes. Full length FKBP48 
(FL) was the intact protein as predicted from sequence analysis. The fragment of 
FKBP48 lacking 30 C-terminal residues was called 630. The third fragment purified 
comprised largely the two FKBP domains present in FKBP48 (with a few additional 
residues from the predicted linker region) and was designated ST for ShorT as 
illustrated in Figure 6.6. The measurements of binding were on the basis of real-time 
BIA technology developed by BlAcore AB, Sweden. The coupling kit, sensor chips 
CM5 (research grade), and HSB-EP running buffer (10 mM F1EPES, 150 mM NaCl, 
0.1 mM EDTA, 0.005% surfactant P20 pH 7.5) were also manufactured by BlAcore. 
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B/A core experiments - There were three main steps of operation, 
immobilisation. association and dissociation, and regeneration. 
Pre -concen (ration and jinmobilisation of Hsp90 - The pre-concentration 
technique was used to determine the proper conditions for immobilisation of each of 
the ligand proteins to the sensor chip. The ligand, for example CeHsp90. was diluted 
in a range of buffers, of varying pH (10 mM acetate pH 4.5. 5.5. 6.0. and 7.0) to 
select optimal immobilisation conditions. The following trials were carried out on the 
unactivated surface of a CM5 chip. An example of the pre-concentration of CeHsp90 
is shown below in Figure 6.10. Using equivalent amounts of protein, at pH 4.5 
CeHsp90 showed the highest level of interaction with the dextran surface. The C-
terminal domain of human Hsp90 showed optimal immobilisation with the 
unactivated CM5 surface at pH 4.0 (data not shown). The ligand molecules were then 
permanently coupled onto the chip surface by standard amine coupling chemistry, 
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Figure 6.10. Pre-concentration sensorgrain offull length CeHsp90. The protein was 
injected onto an zinactivated CM5 dext ran surface. The baseline during this was 
observed to be at about 18,800 RU. The first two injections with acetate buffer pH 
7.0 and 6.0 consecutive/v provided troughs which meant low levels of ligand 
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coupling. The third peak showed the most effect obtained from acetate buffer at pH 
4.5. Peak 4 shows the effect of buffer at pH 5.5. pH 4.5 was chosen for the 
experiment as it gave the optimum results. 
The immobilisation densities of ligand are broadly classified as low, medium, and 
high level according to manufacturer's guidance. The purpose of the proposed 
experiment (affinity, concentration, kinetics, low-molecular weight (LMW) binding, 
or specificity) dictates the extent of ligand immobilisation required. The order of 
applications in terms of immobilisation level (highest to lowest) required to obtain an 
acceptable signal is concentration > LMW-binding> specificity> affinity > kinetics. 
In this study, affinity and kinetics measurements were performed; therefore, a low 
level was chosen. 
A continuous flow of running buffer at 5 j.tl/min was applied to the dextran surfaces 
of both flow cells until a steady baseline was obtained. One flow cell was used as a 
reference to determine the level of non-specific background binding. The other was 
used to measure the specific binding level. The dextran matrices were modified by a 
mixture of N-ethyl-N' -(3-diethyaminopropyl)-carbodiimide (IEDC) and N-
hydroxysuccinimide (NHS). This modification integrated N-hydroxysuccinimide 
esters onto the carboxymethyl groups on the dextran, allowing the capture of the 
ligand through free amines as can be seen in Figure 2.8. Hsp90 was then injected to 
the system over the activated surface of the "experimental" flow cell. The unbound 
Hsp90 molecules were washed off after coupling. Finally, the free activated ester 
groups remaining on the dextran surfaces were deactivated by the high ionic strength 
buffer, ethanolamine pH 8.5. 
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Immobilisation of human Hsp90-530_ 724 on a CM5 chip - Human Hsp90 
was immobilised onto a CM5 chip (Figure 6.11). By amine-specific coupling 
technique hHsp90-530 was covalently coupled at p1-I 4.0 to the carboxylated dextran 
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Figure 6.11. Iminobilisation sensorgranz of hHsp90-530_724 at pH 4.0 via the 7 
stages of amine coupling technique. 5 jig/mI of the protein was injected to Fc2 used 
as a measurement flow cell. The immobilisation level was estimated at 10,600 RU. 
Running buffer at 10 ullinin was passed over both measurement and reference 
cells to establish a baseline value (in response units) for the unactivated chip 
surface. 
Chip surface activation. EDC'/NHS was applied to both flow cell surfiices. 
ED/NHS ,nodified the carboxvmethvl groups to N-hydroxvsuccinimide esters. 
(EDC: 1 -ethvl-3(3-dimethvaminopropvl)-carbodiimide hydrochloride, NHS = N-
ljdrox'succin imicle. 
Baseline fbr activated chip surface. The activation produced slight/v increased 
signals (100-200 RU increase). 
hHsp90-530_724 coupling. 5 pg/mI of the protein was injected to Fc2 only. Using 
the coupling pH determined froni the pre-concentration experiment, the fragments of 
hHsp90 molecules were cot'alentiv linked to the dextran matrix. 
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Washing of unbound ligand molecules. 
Chip surface deactivation. The excessive reactive groups were also removed by 
IM et/wnolamnzne hydrochloride pH 8.5. This ,nini,nised experimental error arising 
from non-specific binding to the matrix •surfiice. 
Determination of im,nohthsation level (10,6000 RU). To do so, the number of 
response units at this stage was calculated by subtracting the value obtained from 
stage 3 
Immobilisation of CeHsp90 on a CM5 chip - CeHsp90 was coupled at pH 4.5 
onto another CM5 matrix surface by the same coupling technique described above. 
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Figure 6.12. Immnohilisation sensorgram of full length CeHsp90 at pH 4.5. Two flow 
cells (Fc) ivere referred to a measurement how cell (Fcl) and a reference flow cell 
(Fc2). The s'ensorgramn for the measurement cell is shown in red, the refrrence cell in 
green. The seven stages of the amine coupling procedure were carried out as 
described in Figure 6.11. The im,nobilisation level was 12,000 RU. 
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Interaction of CeFKBP48 and immobilised hHsp90-530_724 - 10 iM of 
each FKBP48 (FL, 630, and ST) fragment was prepared and placed into the sample 
rack of the automated BIAcore3000. An appropriate programme was written for the 
machine to apply each of the three samples in turn. Each analyte was passed over the 
immobilised chip surface at 10 tlJmin with HBS-EP running buffer. The dissociation 
phase occurred after the fixed period of sample flow over the chip surface, when the 
analyte is replaced by running buffer. The net arbitrary response units of interactions 
and dissociation were taken by subtracting the response units of specific binding 
from the ones of non-specific binding. 
Interaction of CeFKBP48 and immobilised CeHsp90 - The three construct 
lengths of CeFKBP48 were prepared at the same concentration, 10 jtM for example. 
The samples were manually loaded to the sample loop (the BlAcore X is a semi-
automated system; each sample must be injected into the flow cell manually and 
individually). The injections of analytes into the flow channel across the immobilised 
surface with HBS-EP running buffer were then automatically performed at 10 
.tl/min. The protein association was observed for 220 seconds at each injection cycle. 
After the automatic stop injection, the dissociation was also observed. 
Regeneration - A long pulse of 10mM glycinelHCl pH 2.5 was applied to 
regenerate the chip of immobilised C-terminal human Hsp90, whilst 4M NaCl was 
used in the case of immobilised CeHsp90. 
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SPR experiments performed are summarized in table 6.1. 
The total Binding Experimental conditions 
amounts of measure 
ligands -ments 
flowed 
> Analyte conc. E g g 
over achip 
. 	>.. 
c . (pM) .9 . 
CM5 




0.025 tg x 10 	10 	10 300 200 10mM 
hHsp90-530 glycine 
pH 2.5 
X - 	0.005- 	- 180 200 10mM 
0.1 glycine 
pH 2.5 
0.025 xg x 10 	10 	10 220 200 4M 
CeHsp90 NaCl 














Table 61. A summary of the reagents used in binding studies of CeFKBP48 with 
Hsp90 using BIA core technology. 
6.3.3 Results of affinity interactions and discussion 
The interactions between CeFKBP48 and Hsp90 were investigated using real 
time SPR studies. The SPR signals detected correlated with the amounts of complex 
formed and subsequently dissociated. At the beginning of a sensorgram, the slope of 
the curve is steep during the initial interaction phase. Eventually reaching a plateau 
which shows that equilibrium had been reached. Upon depletion of analyte from the 
system, the dissociation phase of the experiment can be observed. On relative similar 
immobilisation levels of hHsp90 and CeHsp90, comparisons between the three 
different fragment lengths showed that the CeFKBP48 interacted with hHsp90-530 
much more tightly than with full length CeHsp90. 
The interactions of CeFKBP48 to hHsp90-530_724 domain - At the same 
concentrations of each CeFKBP48 construct, the 830 fragment produced the greatest 
SPR signal as shown in Figure 6.13. An interaction with the FL fragment could also 
be detected. However it was much relative smaller than that seen with the 830 
fragment. The ST fragment showed no interaction at all. It was concluded that the 
interactions seen were indeed mediated through the TPR domain as both FL and 630 
fragments contained the TPR region, whilst the ST did not. This finding confirmed 
that TPR domains are an absolute requirement for Hsp90 binding as reported earlier 
(Owen-Grillo et al., 1996; Ratajczak and Carello, 1996). 
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Figure 6.13. Binding of three CeFKBP48 fragments to immobilised hHsp90-530. 10 
,uA'I of each frag,nent was injected and diffused through the B/A core 3000 system. 
Among the three fragments of CeFKBP48, the 830 fragment showed the strongest 
interaction to hHsp9O-530 followed by .tiill  length with the STfragmnent showing no 
interaction. 
The interactions of CeFKBP48 to j1111 length CeHsp90 - It was found that 
CeFKBP48 also showed some interaction with full length CeHsp90. However, the 
830 fragment produced a greater signal than the full length CeFKBP48. The ST 
fragment once again showed no interaction. The overall level of binding was rather 
low as can he seen in Figure 6.14. The maximum signal in response units was about 
160 RU for the interaction between the 830 fragment and the immobilised full length 
Hsp90 from C. elegans (approximately 58% relatively lower than that between the 
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Figure 6.14. Binding sensorgrams of CeFKBP48 to CeHsp90. 10 PM of each 
fragment was injected and diffused through the BIA core X system. Among the three 
fragments of CeFKBP48, the 830 fragment shows the strongest interaction signal to 
CeHsp90. The full length protein also shows some interaction. The ST fragment once 
again shows no interaction. 
By the same technique of chip loading, the immobilisation level of full length 
Cel-Isp90 (12,000 RU) was approximately equal to that of the C-terminal domain of 
hHsp90-530_724 (10.600 RU). With the larger molecular weight of the full length 
Hsp90 (2-fold larger), the reduction seen in the signal in this case could come from 
steric hindrance which effects the binding availability of CeHsp90. Therefore the 
signals of the interactions between FKBP48 and CeHsp90 were lower than those of 
FKBP48 and hHsp90, the C-terminal domain. 
Interaction of Cvp40 to hHsp90-530_724 - To observe the binding affinity 
with another large immunophilin, the interaction of Cyp4O and the C-terminal human 
Hsp90 fragment was examined. The series of experiments investigating the affinity 
of bovine Cyp4O to hHsp90-530_724 was carried out by Jacqueline Dornan, 








immobilised on the CM5 dextran surface (10.800 RU coupled). Binding sensorgrams 
suggested that the interaction of Cyp40 and hHsp90-530-724 was strong. The 
interaction of 1 tM of Hsp90-530_724 to the immobilised Cyp40 provided a large 
binding signal of 1,000 RU (Figure 6.15). 
RU 
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Figure 6.15. Binding sensorgrwns of bCyp40 to hHsp90-530 fragments. A range 01' 
concentrations of hHsp90-530-724 (1 nM to 100 ,uM) were used in jmnmobilised 
Cvp40 binding studies. 
These results are suggestive of a hierarchy of binding affinities between the two 
proteins, with human I-Isp90 preferentially binding Cyp40 over FKBP48. Table 6.2 
summarises response units resulting from interactions between three fragments of C. 
elegans FKBP48 and Hsp90s. 
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Immobilised ligand on 
a CM5 chip 
Response Units 
C. elegans FKBP48 
Full length 530 fragment ST fragment 
Human Hsp90_530-724 180 1,140 0 
C. elegans Hsp90 50 160 0 
Table 6.2. A summary of interactions between C. elegans FKBP48 and Hsp90s 
expressed as the SPR signals in the arbitrary response units. 
The Hsp90 binding capability of truncated CeFKBP48 compared with full 
length CeFKBP48 - Interactions between FKBP48 (the FL and 830 fragments) and 
Hsp90 (full length CeHsp90 and C-terminal domain of hHsp90-530_724) were 
observed using real-time BlAcore studies as discussed in the previous section. Both 
fragments of FKBP48 exhibited significantly different affinities for both Hsp90 
fragments tested. 630, the truncated form of FKBP48, showed higher affinity 
according to SPR signals detected (Figures 6.13 and 6.14). The 30 fragment of 
FKBP48 lacks the final 30 residues from the C-terminal CeFKBP48, having been 
identified as a breakdown product observed during the purification of full length 
protein as described in Chapters 3 (section 3.3.4) and 4 (section 4.3.2). This fragment 
can be purified to greater than 80% purity and is stable in storage of 20 mM Tris, 50 
mM NaCl, 1 mM DTT, pH 7.4 for approximately one week. The results from SPR 
studies suggest that deletion of this region from the protein enhanced its TPR 
interactions to Hsp90. This finding is in agreement with an earlier report by the 
Smith group (Cheung-Flynn et al., 2003). They found that the optimal binding of 
large immunophilins and Hsp90 requires the existence of the core TPR domains as 
well as the C-terminal amino acids from Hsp90. They also addressed the question of 
which residues outwith those of the TPR domains of FKBP5 1 and FKBP52 are 
essential for full Hsp90 binding. With 30 amino acids extended from the core TPR 
domains (residues 404-430 of FKBP51 and residues 406-432 of FKBP52), both 
proteins showed enhanced binding to Hsp90. Beyond this position which was an 
additional 30 amino acids to the end of C-terminus, FKBP51 (residues 431-457) 
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achieved the full binding. In contrast. FKBP52 (residues 433-459) exhibited reduced 
binding to Hsp90. Like FKBP52. CeFKBP48 without the final 30 amino acids at the 
C-terminus exhibited greater affinity to Hsp90. 
Callehaut et al., 1992, proposed the C-terminal region of FKBP52 (residues 406-420) 
is a putative calmodulin-binding domain (Callebaut et al.. 1992). Analysis of the C-
terminal sequences beyond the core TPR domain of FKBP48 (residues 402-431) 
compared to those of FKBP51 (residues 431-457). FKBP52 (residues 433-459), and 
Cyp40 (residues 341-370) shows some degree of homology with 18%, 11%, and 
10% respectively (Figure 6.16). Residues 431-457 of FKBPS 1 were not visible in the 
electron density of the X-ray structure recently solved (Sinars et al.. 2003). The role 
of this region in FKBPs remains unclear, in particular the effect of the presence of 
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Figure 6.16. Sequence a/i gn,nent of the 30 final C-terminal residues of CeFKBP48 
against Cvp40 and FKBP5I152 with 10%, 189k and 11% sequence identity 
respective/v. This region in Cvp40 has been proposed to be a ca/modulin-binding 
domain as well as in FKBP52. Residues with blue, lowercase letters are weak/v 
conserved (not over 50%). A position with no conserved residue (black) is 
represented by a dot. 
Iin,nohilised CeHsp90 against iminobilised hHsp90-530_724 - FKBP48 
showed different binding levels to the 2 fragments of Hsp90. FKBP48 interacted 
more strongly with the C-terminal domain of hHsp90-530_724 than the full length 
CeHsp90. Two reasons are likely to explain the differences. Firstly. the standard 
amine coupling procedure used to attach the ligand to the chip surface would result 
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in the protein being randomly orientated upon the dextran surface of the chip, as 
coupling can occur through any available amine. As described earlier, equivalent 
amounts of CeHsp90 and hHsp90 were coupled to the chip surface (Figures 6.13 and 
6.14). It would have been reasonable therefore to assume that the resulting signals 
produced should have been broadly equivalent. Therefore the relative proportion of 
correctly orientated CeHsp90 on the matrix may have been lower than that for the 
human fragment, despite the equivalent loading. Apart from such technical 
limitations, self-hindrance could inhibit the accessibility of TPR domains. The 
additional domains of the full length C. elegans Hsp90 may inhibit accessibility of 
the TPR domains, due to the coupling orientation. Secondly, species preference 
might influence the interaction between proteins. Although Hsp90 is highly 
conserved from bacteria through man (76% sequence identity of CeHsp90 against 
hHsp90), overall protein conformations are likely to be different. The C-terminal 
domain of human Hsp90 might adopt a particular fold that facilitates and stabilises 
complex formation. 
6.3.4 Methods of kinetic experiments 
Evaluation of kinetic parameters of FKBP48/Hsp9O interactions was carried 
out using the SPR technique. Accurate determination of interaction kinetics can be 
accomplished on real-time studies using low amounts of ligands coupled and high 
flow rates of analyte delivery. 
Binding affinity of FKBP48 to immobilised hHsp90-530 - Kinetic 
measurements were also carried out by varying the concentrations of the 830 
fragment (5-100 nM). A series of analyte concentrations were automatically injected 
at 5 gl/min for 180 seconds interaction time. The chip surface was regenerated 
automatically after each cycle. The kinetic parameters were calculated using the 
SigmaPlot software. 
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Binding affinity of FKBP48 to immobilised CeHsp90 - A range of 830 
fragment concentrations (0.5-21 riM) was manually injected through the system. The 
kinetic values were directly derived from the sensorgrams. In a mixture of these two 
proteins, the forward reaction of ligand (L):analyte (A) formation was initially 
dominant as described in Chapter 2, equation 2.3: 
ka  
L+A ____ LA 
kd 
Where L = ligand (Hsp90), A = analyte (FKBP48), ka = association rate constant, 
and kd = dissociation rate constant. The concentration of complexes rapidly 
accumulated until reaching the equilibrium state. The reaction subsequently reversed 
which resulted in the breakdown of the complex. To determine the nature of the 
reaction (how fast the interactants came together and how fast the resulting complex 
dissociated), kinetic constants were analysed. 
6.3.5 Results of determination equilibrium constant and discussion 
Equilibrium constants of the CeFKBP48 to hHsp90-530_724 binding 
interaction - The overlaid sensorgrams of 830 fragment kinetic characterisation to 
hHsp90-530 are represented in Figure 6.17. At each analyte concentration, the 
binding subsequently reached the equilibrium state where the complex formation rate 
was equal to the breakdown rate. The binding dissociation rate then became 
dominant. The dissociation constant (KD) of the 630 fragment and the C-terminal 
hHsp90-530 was determined from the average equilibrium response values Re q 
plotted versus the protein concentration injected (Figure 6.18). The titration curve 
was subsequently fit to a one-site binding model using SigmaPlot with the following 
equation: 
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Rel l = 	(R um [A])! (K! ) + [A]) 
where R eq = equilibrium response value. K0 = the dissociation constant. [A] = 
concentration of the analyte (the 830 fragment), and Rii ax = the maximal response 
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Figure 6.17. The sensorgrams representing the concentration series experiment frr 
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Figure 6.18. A plot of concentrations of the 830 fragment (5-100 nM) against the 
average equilibrium response units (Req). The kinetic constants were determined as 
followings; KD = 6 M and RM = 2 x 10" RU. 
Equilibrium constants of CeFKBP48 to CeHsp90 interaction - Kinetic 
measurements of the binding of 830 fragment to CeHsp90 were also carried out on 
BlAcore X system. The overlaid sensorgrams of this experiment are shown in Figure 
6.19. The dissociation constant of the 30 fragment and the full length CeHsp90 was 
determined (Figure 6.20) in the same described previously. The following constants 
were evaluated with KD = 8.3 tM and RMax = 182 RU. 
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Figure 6.19. The sensorgrams representing the concentration series experiment for 
CeFKBP48 (the (5-0 fragment) affinity toJi1ll length CeHsp90. 
Figure 6.20. A plot of concentrations of the 530 frag,nent (0.5-2] ,LilvI) against the 
average equilibrium response units (R eq). The kinetic constants were determined as 
followings: K, = 8.3 01 and Rf(JX = 182 RU. 
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Table 6.3 compares the equilibrium constants of the 530 fragment of 
CeFKBP48 for Hsp90-530_724 from human against full length Hsp90 from C. 
elegans. The KD of FKBP48 for human Hsp90 fragment is high with the estimate of 
6 M. This can be explained that the range of FKBP48 concentrations (5-100 nM) 
used in this study fell into the initial linear slope of the curve (Figure 6.18) thus 
providing the high estimated KD. Whist FKBP48 concentrations (0.5-21 j.tM) used in 
case of C. elegans Hsp90 led to a saturation state of interaction judged by the curve 
shape (Figure 6.20). Therefore the obtained estimated KD for C. elegans Hsp90 is 
more realistic. 
Equilibrium Constants 
KD 	KA (M') 	RM ax (RU) 
hHsp90-530_724 	6 M 	0.2 	2x 1011 
CeHsp9O 	 8.3 gM 	0.12 x 106 	182 
Table 6.3. A comparison of equilibrium parameters of CeFKBP48 to Hsp90s. 
Estimated equilibrium values of CeFKBP48 - The immobilisation levels of 
both Hsp90s seem too high for the accurate analysis. It was only possible to 
determine approximate equilibrium values. However, the estimates were analysed 
from equilibrium values. In the case of coupled CeHsp90, the association was not 
observed at high concentration of FKBP48 (>15 tM). At higher concentrations of 
FKBP48 the interactions did not reach the equilibrium states as judged by the shape 
of the sensorgram traces. 
6.4 CHARACTERISATION OF THE INTERACTION BETWEEN LARGE 
IMMUNOPHILINS AND HSP90 PEPTIDES USING NUCLEAR MAGNETIC 
RESONANCE (NMR) SPECTROSCOPY 
The aim of this section is to investigate the interaction between the target 
protein (CeFKBP48) and its specific ligand (the TPR recognition peptide, MIEEVD, 
the C-terminal 5 residues of Hsp90) in vitro. The SPR studies showed the physical 
interactions between the target proteins previously in Chapter 6, section 6.3.3. This 
section will illustrate the observations of protein-ligand interactions. NAM 
spectroscopy is a useful technique to provide more insight into the specific 
interactions in terms of changes in proton resonances. NIMIR studies were carried out 
to observe the specific intermolecular binding. All NMR measurements including 
peptide titrations with Cyp40 described in this section were carried out by Dr. Julia 
Richardson. 
NMR spectra of peptides in complex with CeFKBP48 were compared to 
those of free peptides. Interactions between complexes of FKBP48 and the given 
peptides (see below) can be observed from changes in the peptide spectra. Proton 
chemical shifts and line widths were considered as the key indicators to quantify the 
structural changes. The shifts of resonances are considered by changes at the 
chemical level of interactants. The peak broadening could be related to the motions 
of the protons in the system after reaching the excited state. In addition, the rate of 
molecular process (e.g. chemical exchange) can be measured from the spectral 
appearance as slow, intermediate, or fast exchange occurred over the time scale of 
the experiment. 
6.4.1 NMR spectroscopy techniques 
Sample preparation - Peptides MEEVD and GDEDASRMIEEVD, the C-
terminal 5 and 12 residues of human Hsp903, were a kind gift from Dr. Derek 
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Macmillan, School of Chemistry, University of Edinburgh. Purified 830 fragment 
and full length CeFKBP48 were prepared as described earlier in section 2.2.3.3. The 
proteins were exchanged into PBS buffer and concentrated up to at least 60 mg/ml. 
Each peptide was dissolved in PBS containing 90% H 20 and 10% deuterium oxide 
(1)20) to a concentration of 1 mlvi. 
Instrument set-up - The following adjustments needed to be achieved before 
spectrum recording of spectra. First, a sample probe was tuned to eliminate polarity 
and dielectric constant variation of the lock solvent. Radiofrequency pulse length 
was calibrated to the suitable length to provide a 90° pulse. Magnetic field was 
shimmed to reach a homogeneous as state as possible. 
Protein titration - Protein titrations were applied to both peptides. Two sets 
of step-wise titration designs were carried out in parallel; 0-90 .tM of full length and 
0-75 p.M of the truncated form of FKBP48. In both experimental sets 2.5 p.1 of each 
protein at 60 mg/ml was added to the peptides at each titration step. 
Spectral analysis - The interactions were analysed by observing the changes 
in the spectra for each peptide. Each free peptide was scanned as the template 
spectrum. The key measurable indicators used for analysis were the position of peak 
centre (e.g. chemical shift in ppm) and the line width on a frequency scale. 
6.4.2 Results of NMR and discussion 
Both peptides were dissolved in PBS buffer containing 90% H 20 and 10% 
D20 to a final concentration of 1 mM. The spectra of 5mer and 12mer C-terminal 
peptides of Hsp90 were recorded in the absence of FKBP48 and Cyp40, see spectra 
labelled 0 p.M in Figures 6.21, 6.23 and 6.25. Table 6.4 illustrates the assignments of 
chemical shift for both peptides in free forms. Spectra of the Smer titrated with 630 
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FKBP48, full length FKBP48 and Cyp40 are given in Figures 6.21, 6.23, and 6.27, 
respectively. Spectra of the 12mer titrated with 830 is given in Figure 6.25. 
5mer 
Chemical shift assignments 
Chemical shift 	12mer Chemical shift 
- - GNH 8.36 
- - D NH 8.32/8.39 
- - ENH 8.38 
- - D NH 8.32/8.39 
- - ANH 8.26 
- - SNH 8.30 
- - RNH 8.08 
M NH 8.33 M NH 8.30 
E NH 8.51 E NH 8.55 
E NH 8.43 E NH 8.42 
VNH 8.17 VNH 8.17 
D NH 7.98 D NH 8.02 
• Mel 0.95 V Mel 0.95 
• Me2 0.92 V Me2 0.92 
Table 6.4. Proton chemical shift assignments of the observed residues of the certain 
peptides both amide (NH) and methyl (Me) groups. 
The changes in 5mer peptide resonances titrated with the 830 fragment - For 
the titration experiments, FKBP48 (both full length and the 830 fragment) was added 
to the peptides in steps of 15 jiM to a final concentration of 75 and 90 jiM (in cases 
of the 830 fragment and full length respectively). Broadening and shifting of certain 
peaks were observed in the resonance spectra of both the 5mer and the 12mer upon 
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step-wise addition of both. Peak broadenings can be affected by relaxation properties 
of protons and the chemical shift alters as the peptide is in a different chemical 
environment, e.g. unbound and bound. Figures 6.21 and 6.23 represent a series of 
multiple alignments of all spectra in each experiment. With the 830 fragment titrated, 
the resonances of the 5mer (MEEVD) shift and broaden as seen in Figure 6.23. 
Methionine (M5), valine (V 2), and aspartate (D1) peaks became broadened at the 
titration of 30 pM the 830 fragment. The glutamate peak (E3) shifts upfield by a 
maximum of 0.02 ppm as can be seen in Figure 6.22A. In addition, the two peaks of 
methyl valines (VM e I and VM e2) are obviously broadening by a maximum of 5.8 and 
2.2 Hz respectively (Figure 6.22B) and shifted upfield as the concentrations of 
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Figure 6.21. Concentration dependence of 'H spectra of 5mer peptide (MEEVD) 
with step-wise addition of the 630 fragment of FKBP48 at the amide region (A) and 
the methyl region (B). 
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Figure 6.22. Histogram representatives of' Smer spectral changes in A) chemical 
shifts and B) line widths in a step titration of 15 iM up to a final concentration of 75 
,iM of the 830 fragment of CeFKBP48. 
The changes in 5mer peptide resonances titrcired with the full length C. 
elegans FKBP48 - Compared to the full length FKBP48 titrated, the pattern of 
change of the 5mer spectra is similar hut more pronounced (Figure 6.23). For 
example. at 30 .tM of full length FKBP48 the resonance of glutamate (E3) moves 
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(maximum of 0.06 ppm) and broadens (maximum of 7 Hz) more than that with the 
truncated protein titrated at the same concentration (maximum of 0.02 ppm and 2 
Hz). The most changes of peptide spectra were observed from the amide glutamate 
(E3 ) shifted upfield (maximum of 0.056 ppm) and the aspartate (D 1 ) (maximum of 
0.038 ppm) as illustrated in Figure 6.24. 
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Figure 6.23. Concentration dependence of 'H spectra of 5mer peptide (MEEVD) 
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Figure 6.24. Histogram representatives of 5ner spectral changes in A) chemical 
shifts and B) line widths in a step titration of 15 uA'1 up to a final concentration of 90 









The changes in 12mer peptide resonances titrated with the 830 fragment - 
Changes in the 12mer spectra on increasing protein concentrations were also 
observed. The peptide resonances (Figure 6.25) are gradually changed with titrations 
of the 830 fragment. The 830 fragment seems to have a little effect on the C-terminal 
MEEVD residues of the 12mer peptide (GDEDASRMEEVD). The additional 
residues at the N-terminus tend to participate in the interactions. The resonance of 
the N-terminal serine, for example, shifts upfield (0.02 ppm) and appears broadened 
(12 Hz) (Figure 6.26). This is suggestive of possible, additional interactions of other 
C-terminal residues of Hsp90, beyond the final MEEVD, with TPR. 
[30 fragment] 
I 	I 	 I 	II 
A) 	EEM 5Av2 
I I 	
R D1 Me 
I 	I 	I 	I 	I 	I  
oil 20 pM 
B) 	 V Me1V Me2 
ii 	I 	I 	 I 	 I 
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Figure 6.25. Concentration dependence of 'H spectra of 12mer peptide 
(GDEDASRMEEVD) with step-wise addition of the 830 fragment of FKBP48 at the 
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Figure 6.26. Histogram representatives of 12mer spectral changes in A) chemical 
shifts and B) line widths in a step titration of 37.5 ,ui4vl up to a final concentration of 
75 ,uM of the 530 fragment of CeFKBP48. 
Both 630 FKBP48 and full length FKBP48 include all the key residues of TPR 
binding, however, they induce different changes upon the MEEVD peptide spectra. 
The truncated protein. 830 FKBP48, formed by limited proteolysis of FKBP48, 
could result in protein with a significantly altered conformation when compared to 
that of the full length protein. Potentially therefore the truncated protein could 
present an altered binding surface to the peptides resulting in differences seen with 
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the interactions. The effects of another TPR containing protein, Cyp40, were also 
investigated. 
The changes in 5mer peptide resonances titrated with Cyp40 - The spectra 
recorded to follow the titration of MIEEVD with Cyp40 in steps of 10 jiM to a final 
concentration of 60 j.tM revealed sizeable changes in both the amide and methyl 
regions. These changes were more pronounced than those recorded for MIEEVD 
titrated with FKBP48. For example, 5mer titrations with Cyp40 show the methyl 
valine (VMe2) shifted by their proximity to an aromatic ring (Phe 234) and broadened 
as seen in Figure 6.27. This is in good agreement with the results of the SPR studies. 
However, there was no upfield ring-current shift of VMe2 in the case of FKBP48 
titration. This may be because the equivalent replacement of L265 in FKBP48. The 
influences of individual residues on the binding interactions will be discussed in 
greater detail, including a discussion of modelled interactions (Section 7.3.8). 
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[Cyp4O] 
8.6 	8.4 	8.2 	8.0 	7.8 	1.2 	1.1 	1.0 	0.9 	0.8 	0.7 
ppm 
Figure 6.27. Concentration dependence of 'H spectra of 5mer peptide (MEEVD) 
with step-wise addition of Cyp40 at the amide region (A) and the methyl region (B). 
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6.5 INVESTIGATION OF FKBP48 STRUCTURE USING SMALL ANGLE X-
RAY SCATTERING (SAXS) 
This section will describe the determination of preliminary structure of 
FKBP48 in solution using SAXS technique. 
6.5.1 SAXS experiments 
Full length FKBP48 was prepared as described earlier in Chapter 3, section 
3.2.4. SAXS measurements were carried out at the beamline SRS station 2.1 by Miri 
Hirshberg and her colleagues, Synchrotron Radiation Source (SRS) laboratory, 
Daresbury. Fourier transformation of the data obtained was applied to estimate the 
scattering characteristics of the target protein. Using the programme GASBOR, the 
shape of FKBP48 was reconstructed based upon the protein template, FKBP5 1 (PDB 
code 1KT1). 
6.5.2 Results of SAXS 
Analysis of SAXS data - The scattering data as can be seen in Figure 6.28A 
represents the set of experimental scattering intensity iexp(S) of the protein at different 
scattering angles (s). The experimental dataset is then processed to restore the ideal 
intensity i(s) shown as the data in the curved line. The relationship between 
scattering intensity I(s) and the pair distribution function of the protein p(r) was 
determined using Fourier transformation. Figure 6.28B shows the histogram of 
distance between all pairs of points of the protein. The maximum diameter D, is 
110.0 A which refers to the longest distance between two points on the molecular 
envelope. The degree of sphericity/nonsphercity of the protein sample is 
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Figure 6.28. The SAXS prqfile of FKBP48 (A) and the distance distribution fimction 
(B). The experimental scattering intensity is fitted to the model curve by non-linear 
regression and transformed to the distance distribution function. 








Figure 6.29. Shape determination of FKBP48 from C. elegans. A docking model of 
FKBP48 (A) is based directly on FKBP5I residues 54-385 (B). The1a/)e of 
FKBP48 reconstructed fro,n the SAXS data is similar to the SAXS shapes, with the C-
terminal TPR domain at an angle to the two FKBP domains. 
The restored envelope of FKBP48 is displayed along with the atomic structure of 
FKBP5I deposited in Protein Data Bank (IKT1) (Sinars et al.. 2003). FKBP51 was 
shown to be monomeric in the crystal structure and shows high sequence homology 
to FKBP48. The shape of reconstruction remains stable which finally provided 
successive reconstruction runs with the similar shapes. The molecular envelope of 
FKBP48 is rather well occupied by the overall X-ray structure of FKBP51, 
particularly the domain FKBP 2 as shown in Figure 6.29A. The size of TPR domains 
of both FKBP51 and the SAXS shape seems equal whilst the FKBP1 domain of 
FKBP48 from the SAXS shape appears more elongated than that of FKBP5 1. 
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6.6 CONCLUSION 
The findings in this chapter described the existence of the interactions of 
Hsp90 and FKBP48 in C. elegans. Results from co-immunoprecipitation and gel 
filtration were inconclusive; however, the interactions could be verified using other 
techniques. By SPR studies, the significant differences in interaction abilities 
between the three fragments of FKBP48 to Hsp90 could be quantified. The truncated 
630 fragment performed best in interactions to Hsp90 followed by the full length 
FKBP48 (Figures 6.13 and 6.14). The ST fragment was unable to show any binding 
to Hsp90 presumably because it lacks the TPR domain. This supports the possibility 
that the interaction is mediated by the TPR domain. Overall the signals (in response 
units) from the experimental series of CeFKBP48 and CeHsp90 were much lower 
than those seen with the human Hsp90. This implies that CeFKBP48 formed a tighter 
complex to hHsp90-530 domain rather than to full length CeHsp90 however this is of 
no real biological significance. In addition, FKBP48 interactions to Hsp90 were 
found across species (C. elegans to human) at the same relative strength. By NIVIR 
techniques, aspects of interactions were defined in terms of specific residues 
involved in non-bonded interaction. Spectral changes of the synthetic peptides 
equivalent to the terminal C-terminal residues of Hsp90 (residues 720-724 of human 
Hsp90 and residues 688-702 of C. elegans Hsp90) became more pronounced after 
the titrations of FKBP48 at 30 pM. The full length FKBP48 bound to the 5mer 
peptide slightly better than its breakdown fragment. Peptide residues E 3 , V2, and D 1 
appear to be involved in peptide-FKBP48 interactions, see Figures 6.21, 6.23 and 
6.25. The changes in the 12mer spectra confined mostly to the final 5 residues 
(MEEVD) suggest that it is only these residues involved in TPR interactions. 
Changes in the spectra of the 5mer titrated with Cyp40 were detected at a lower 
concentration (10 pM). The relative strength of binding seemed to contradict that 
found by the SPR investigations. SPR and NMR results show that Cyp40 binds more 
strongly to Hsp90 than does FKBP48. These results will be used in Chapter 7 to 
develop detailed molecular modes of Hsp90-immunophilin interactions. 
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TPR DOMAINS IN C. ELEGANS 
7.1 INTRODUCTION 
This chapter describes the approaches taken to analyse in depth the repertoire 
of TPR containing proteins in C. elegans. This involved a detailed search of the C. 
elegans genome to identify all proteins having a TPR motif together with the 
generation of a model of the structure of FKBP48. FKBP48 is the only large TPR 
containing immunophilin found in C. elegans and apparently interacts only weakly 
with Hsp90, the protein originally proposed as a potential binding partner. 
Interactions of the C. elegans TPR containing protein FKBP48 (described earlier in 
Chapter 6) with Hsp90 were compared with those of the known Hsp90 co-chaperone 
protein Cyclophilin 40. Site-directed mutagenesis studies by Ward et al., of Cyp40 
interacting with Hsp90 revealed 10 residues from the TPR domain of Cyp40 to be 
important, five of which were essential for TPRJHsp9O recognition (Ward et al., 
2002). The amino acid sequence of each C. elegans TPR repeat was aligned to 
determine the overall degree of conservation of the residues key to Hsp90 
recognition. Due perhaps to its inherently unstable nature in solution, extensive 
crystallisation trials of FKBP48 were unsuccessful, therefore molecular modelling 
was the approach taken in an attempt to provide further insight into possible modes 
of interaction between FKBP48 and its proposed protein partners. Three-dimensional 
(31)) models of FKBP48 and both potential partner proteins were produced, 
interaction between TPR containing proteins and Hsp90. Three-dimensional models 
of FKBP48 and two potential Hsp90 binding partners were produced. The 
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interactions between FKBP48 and the final five C-terminal residues of Hsp90 were 
also modelled. 
7.1.1 Genome sequence of C. elegans 
A C. elegans model system - The nematode C. elegans, belonging to the 
Secernentea class of the Metazoa kingdom is a widely used as a model organism. It 
was the first multi-cellular organism to have its genome completely sequenced, 
results becoming widely available in 1998. The project revealed that C. elegans 
contains approximately 20,400 genes of which some 40% share significant similarity 
to predicted proteins found in other organisms (Mannhaupt et al., 2003). Therefore, 
the genetic information of this organism can be used as a resource for comparison 
and interpretation of other genomes. To date, the results from sequencing have been 
annotated with any other relevant information and have been made freely available 
from a number of databases such as WormBase, http://www.wormbase.org  (Harris et 
al., 2004). This database is a very comprehensive and accessible resource and 
features the complete genome sequences of C. elegans together with information on 
other features including mutant phenotypes/genetic markers/genetic map 
information, the developmental lineage of the worm, connectivity of the nervous 
system, gene expression described at the level of single cells, links to bibliographic 
resources and a massive number of genomic analyses such as RNA interference 
(RNA) screens. Additionally, genome sequencing data from the closely related 
species C. brig gsae have been incorporated into this database allowing comparative 
analysis to be made between the two organisms. 
7.1.2 Functions of TPR-containing proteins in C. elegans 
TPR repeats in C. elegans - As in other multi-cellular organisms, a number 
of different repetitive protein repeats are found in C. elegans making up 
approximately 2.7% of the whole genome. Several families of protein repeats are 
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found including the helical TPR repeat family. Some background of the other helical 
repeat proteins is included in Chapter 1, section 1.3.2. TPR repeats have been found 
in many species ranging from bacteria to eukaryotes. Incorporation of TPR repeats 
promotes a number of diverse molecular functions in a wide range of host proteins. 
TPR proteins have been shown to be involved in a range of biological processes 
including cell cycle regulation, transcriptional control, and mitochondrial and 
peroxisomal protein transport. For example, the C. elegans peroxisome receptor 5 
(PEX5) imports peroxisomal targeting signal 1 (PST1) proteins. The targeting signal 
partly comprises the tripeptide SKL, which interacts with the TPR domain of PEX5 
resulting in the import of the target proteins into the peroxisome (Gurvitz et al., 
2001). Peroxisomes are the intracellular organelles for many cellular reactions such 
as 13-oxidation of fatty acids (Kanau et al., 1995). This chapter will focus on those 
TPR containing proteins found associated with Hsp90 and will discuss in detail how 
the interactions are mediated through TPR domains. Other helical repeat proteins are 
also described in greater detail in Chapter 1, section 1.3.2. 
TPR proteins as Hsp co-chaperones - In the steroid receptor assembly 
pathway (as previously detailed in Chapter 6, section 6.1.4) TPR-containing proteins 
including TPR immunophilins recognise the terminal pentapeptide MIEEVD of 
Hsp90 resulting in the recruitment of Hsp90 to a pre-existing receptor-Hsp70 
complex. In this work, the interaction between FKBP48, the only TPR containing 
immunophilin in C. elegans with Hsp90 was characterised as relatively weak when 
compared with that seen between bovine Cyp 40 and Hsp90 (as previously described 
in Chapter 6, sections 6.3.3 and 6.4.2). As a result of this somewhat unexpected 
finding, a search for new C. elegans TPR protein(s) which could act as a binding 
partner for Hsp90 was undertaken and is described in detail in the following section 
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7.2 MATERIALS AND METHODS 
7.2.1 A search for TPR-containing proteins in C. elegans 
A search for TPR -containing proteins in C. elegans using SMART - SMART 
[Simple Modular Architecture Research Tool (SMART, http://smart.embl-
heidelberg.de )] is a database web tool for identification and annotation of protein 
domains (Letunic et al., 2004). Extensive annotation and comprehensive sources of 
information are provided for each domain. The database can be interrogated in a 
number of ways, in this example the goals were very tightly defined therefore the 
request was submitted to the database using a keyword search "TPR domain" 
combined with species specificity "C. elegans" to return only TPR containing 
proteins found in this organism. 
7.2.2 Sequence alignment of TPR-containing proteins in C. elegans 
Sequence alignment - An alignment of all the resulting individual 34 amino 
acid TPR repeats from all the proteins found was carried out using CLUSTAL X 
(Thompson et al., 1997). 
7.2.3 Modelling protein structures 
Defining suitable templates for modelling - The structures of FKBP48 and 
the proteins identified from sequence analysis as potential binding partners for Hsp90 
were modelled using SWISS-MODEL (http://swissmodel.expasy.org ). This is an 
automated internet-based server for comparative modelling of 3D protein structures 
(Schwede et al., 2003). A structure of a homologous protein is required for the 
modelling process and can be user defined or automatically selected by the 
programme from the sequence of the target protein in the "First Approach Mode" of 
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the interface. The queries received were then processed by the SWISS-MODEL 
server. Results were returned via e-mail. 
Target-template alignment - SWISS-MODEL produced a structural 
alignment of the target protein sequence and template structures by superposing onto 
the template structures using a least square algorithm and discarding incompatible 
templates. 
Visualisation of modelled structures - The molecular graphics programmes 
SIBYL, version 6.9 (Tripos, Inc.) and INSIGHT II version 2000.1 (Acceryls, Inc.) 
were used to display and analyse the output of SwissModel. 
7.2.4 Modelled interactions between the TPR domains of target 
proteins and the final five residues of Hsp90 
Comparison of target proteins and Hop - To model the interaction between 
the TPR domain of the target proteins (FKBP48 and the putative Hsp90 binding 
proteins) with the MEEVD final peptides of Hsp90, the X-ray structure of Hop 
TPR2A in complex with MEEVD (Scheufler et al., 2000) was selected as a template. 
The coordinates of Hop TPR2A from the PDB database (PDB code 1ELR) and 
FKBP48 as derived from SwissModel were retrieved. Coordinates of both structures 
were fitted using the programme INSIGHT II. Using the superimpose mode, similar 
residues from both structures were superimposed onto one another. 
Target-template alignment - The programme MultAlin an internet-accessible 
web tool for sequence alignment, was used to align the TPR domain sequences of 
proteins of interest (Corpet, 1988). 
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Superimposition of TPR domains - The coordinates of TPR domains of the 
following proteins (Cyp40, Hop, FKBP51, FKBP52, and FKBP48) were 
superimposed using MultiProt (Shatsky et al., 2002). Thanks to Mr. D. Soares 
Biocomputing Research Unit (BRU), ISMIB, University of Edinburgh for his help 
and advice on using MultiProt. 
Electrostatic Surfaces - Electrostatic potential surfaces of the proteins of 
interest were calculated using the programme GRASP (Graphical Representation and 
Analysis of Surface Properties) (Nicholls et al., 1991). This programme reads PDB 
files/Delphi potential maps/Delphi charge files/Delphi radius files, computes 
surfaces/surface areas/volumes, and provides high resolution display of solvent 
accessible surfaces/electrostatic potential mapped to surfaces. 
7.3 RESULTS AND DISCUSSION 
7.3.1 Sequence alignment and analysis of TPR-containing proteins in 
C. elegans 
In C. elegans, 41 TPR-containing proteins were predicted by the SMART 
server, including FKBP48 (Accession number 045418). Table 7.1 summarises all 41 
proteins categorised into eight groups according to the number of TPR repeats 
contained. Domain architectures of individual proteins are also shown. All the 
different identified domains are symbolised as bubblograms described in Table 7.1. 
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Table 7. 1. A su,nmarv of TPR-containing proteins froni C. elegans. Most of the 
domains were predicted by the SMART database, the exceptions being one FKBP 
domain protein and two TPR repeat proteins predicted by Pfamn. All domain 
architectures were taken from the SMART database. RNA 1 results and indications of 
protein homologues were obtained from WormBase. 
No. 	Accession 
of nurnlwr 
'l'PR 	Sw .ssProt 
Protein (description) RNA 1 
J)htnOtVpc 
2 	Q9GRZ2 - 	 4- 	- 	 ff Embryonic 
defect 
Y59A8B.6 protein (Y59A8B.6 gene) similar to 
U5 snRNP-associated 102 kDa protein from M. 
mnusculus which is involved in mRNA splicing 
(Makarova et al., 2(()4) 
3 	045418 -H= HH Morphology defect 
FKBP48 (jkb-6 gene) similar to FK506-binding 
protein 4 (FKBP52) from human which acts as 
Hsp9() co-chaperones (Scammell et al., 2003) 
045786 	____ 	____ 	 Wild type 
morphology 
T12D8.8 protein (T12D8.8 gene) similar to HSP 
associated protein like from A. thaliana which 
regulates ATPase activity of Hsp70 (Velten et 
al., 2(.()2) 
076630 	 Growth defect 
Hypothetical 	protein 	(Y57G7A.10a). 	a 
homologue of Protein KIAA() 103 from M. 
,nusculus, an uncharacterised conserved protein 
(NCBI KOG5*) 
Q20683 	- - H 	 Wild type morphology 
F52H3.5 protein (F52H3.5 gene) similar to 
cDNA sequence BCO2 1608 from human 
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Q21746 	 Wild type 
morphology 
Hypothetical protein (R05F9.I0 gene) similar to 
a small glutamine-rich TPR-containing protein 
from B. rerio which is involved in cell division 
(Winnefeld et al., 2(()4) 
Q2254 	- -_______________ 	 Movement 
defect  
Hypothetical protein (T19A5.1 gene) similar to 
tetratricopeptide repeat domain 17 from human 
Q86DM5 	 Reproductive 
defect 
Hypothetical protein Y57G7A. 10 (Y57G7A. /Oa 
gene). a homologue of Protein KIAAO 103 from 
M. Inusculus 
Q817G4 	 Wild type 
	
. . 	. 	 morphology 
Hypothetical protein F54C I .5a (F54T1 .5a gene) 
similar to Hypothetical TPR from M. inusculus 
Q9BKR2 	 - 	 Unspecified 
Hypothetical protein Y47A7.1 (Y47A7.1 gene) 
similar to dsRNA virus protection family 
member, 	contains 	8 	copies 	of 	the 
tetratricopeptide (TPR) domain from S. 
cerevislue which is involved in translation 
repressor activity (Ohtake and Wickner. 1995) 
Q9BMU2 	 Unspecified 
Hsp70-interacting protein (Hypothetical protein) 
(chn-I gene) similar to STII homology and U- 
Box containing protein I from M. nuscuIus 
which is thought to participate in the cellular 
stress response to the accumulation of unfolded 
and misfolded proteins (Hatakeyama et al.. 2004) 
P91240 	 + . 	 Morphology defect  
Signal recognition particle 72 kDa protein 
homologue (SRP72) (FO8D/2.I gene) similar to 
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SRP72 from human. Signal-recognition-particle 
assembly has a crucial role in targeting secretory 
proteins to the rough endoplasmic reticulum 
membrane. SRP72 binds the 7S RNA only in 
presence of SRP68. This rihonucleoprotein 
complex might interact directly with the docking 
protein in the ER membrane and possibly 
participate in the elongation arrest function (by 
similarity) 
Q09519 	- 	 -H+-- --- 	Embryonic 
defect 
D202 1.1 protein (D2021.1 gene) similar to 
ENSANGP000000()6566 (Fragment) from A. 
ganihzae sir PEST 
Q09536 	 Reproductive 
defect 
FIOB5.6 protein (enth-27 gene) similar to 
Anaphase promoting complexes subunit 6 
(APC6) from M. ,nusculus which is involved in 
the progression of cell division (Page and Hieter, 
1999) 
Q18426 	- I ±:f.f. 	 Growth defect 
C34C6.6 protein (I)rx-5 gene) similar to 
peroxisome receptor I from human which is 
involved in metabolic pathways in peroxisomes 
e.g. 3 oxidation of fatty acids (Thieringer et al., 
2003) 
Q21592 	-k-H 	 Embryonic defect 
M7.2 protein (kic- I gene) similar to kinesin light 
chain from C. elegans which interacts with 
dynein and drives intracellular transport along 
microtubules (Ligon et al., 2004) 
Q93178 	 Wildtype 
morphology 
K09A9.6 protein (K09A9.6 gene) similar to 
Asparty l( asparaginyl) 	3-hydroxylase 	from 
human which hydroxylates aspartic or 
asparagines residue in certain epidermal growth 
factor-like domains (Jia et al.. 1994) 
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5 
Q9N4()7 	 Wild type 
morphology 
Hypothetical protein (Y39A3CR.3 gene) similar 
to TPR protein 7 like-I from human 
P41842 	 - 	T I 	 Embryonic 
defect 
Hypothetical protein T201312.1 in chromosome 
III (T20B12.I gene) similar to a hypothetical 
protein from M. ,nu.sculus 
C18C4 lOa 	 - 	 Unspecified 
Kinesin Light Chain (KLC) (k1c-2 gene) similar 
to KLC-1 protein from R. norvegicus which 
interacts with dynein and drives intracellular 
transport along microtuhules (Ligon et al.. 2004) 
CI8C4.10c 	 Unspecified 
Kinesin Light Chain (KLC) (k1c-2 gene) similar 
to KLC-1 protein from R. norvegicus which 
interacts with dynein and drives intracellular 
transport along microtubules (Ligon et al.. 20()4) 
: Q09485 	 Wild type 
morphology 
Hypothetical protein (rpv-1 gene) similar to 43 
kDa receptor-associated protein of the synapse 
(RAPSYN) from T. ca1itrnica which is required 
for clustering of acetylcholine receptors at the 
neuromuscular junction (Rodova et al., 2(X)4) 
Q 1929 	-H----+!F-•=+ f-H 	Morphology defect 
Hypothetical protein (mat-3 gene) similar to Cell 
division cycle protein 23 homologue (Anaphase 
promoting complexes subunit 8) (APC8) from 
M. nuscu1us which is involved in cell division 
progression (Shakes et al.. 2003) 
Q8T4K4 	 - -- 	 Embryonic 
defect 
MAT-I protein required for metaphase-to- 
anaphase I of cell cycle (Golden et al.. 2000) 
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Q8WTL6 	 Wild type 
	
I 	 morphology 
Hypothetical protein Y50D7A.4 (Y5OD7A.4 
gene) NMDA receptor-regulated gene I 
(Fragment) from B. rerio which has electrical 
activity required for normal neuronal 
development (Sugiura et al.. 2001) 
Q95PV7 	 - 	 - 	 Growth defect 
ZK856.13 protein (ZK856.13 gene) similar to 
Splice isoform I of Q9Y5Q9 General 
transcription factor 3C polypeptide 3 from 
human which is required for initiation of RNA 
polymerase III (Hsieh et al.. 1999) 
Q9N593 	- . 	 Embryonic 
defect 
Hypothetical protein (mat-I gene) similar to 
CDC 27 from B. rerio which is required for 
metaphase-to-anaphase I of cell cycle (Golden et 
al.. 2(X)0) 
P46822 	--J 	 Unspecified 
Kinesin Light Chain (KLC) (k1c-2 gene) similar 
to KLC-1 protein from R. norvegicus which 
interacts with dynein and drives intracellular 
transport along microtubules (Ligon et al., 2004) 
6 	016259 	i4HH 
Hypothetical protein (R09E12.3 gene) similar to 
Stress- induced-phosphoprotein I from human 
which is a Hsp co-chaperone recruiting Hsp90 to 
the pre-existing steroid receptor-Hsp70 
complexes (Chen and Smith, 1998) 
P91189 
C55136.2 protein (dnj-7 gene) similar to DnaJ 
(Hsp4O) homologue. subfamily C, member 3 
from X. luevis which is though to guide Hsp7() 
proteins to specific substrates and control their 
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Wild type Q19955 	
morphology 
Hypothetical protein (ags-3 gene) similar to 
mosaic protein LGN from human which is 
GTPase activator activity 
Q20144 	 fflJjiflp 	 Wild type 
morphology 
Hypothetical protein F38B6.6 (F38B6.6 gene) 
similar to the gene F32D1.3 product from C. 
elegcins 
Q7ZI 46 	L. + 	f Wild type morphology 
Hypothetical protein ZK32.7 (ZK328. 7a gene) 
similar to FLJ 11457 protein from human 
Q95QH3  
Hypothetical protein (ags-3 gene) similar to the 







Hypothetical 	protein 	T25F10.5 	(bbs-S 	gene) 
similar to TTC8 protein (fragment) from B. rerio 
which is involved in ciliogenosis of basal body, 
short cylindrical array of microtubules and other 






Y54EIOBL.4 protein (dnj-28 gene) similar to 
DnaJ (Hsp4O) homologue, subfamily C, member 
3 from B. rerio which is though to guide Hsp70 
proteins to specific substrates and control their 
binding to substrates by control of their ATPase 
cycle 
Q9N4Z9 	 H: - 	 Unspecified 
Hypothetical protein (OSM-5) (os,n-5 gene) 
similar to transgene insert site 737 from M. 
niusculus. insertional mutation causing 
polycystic kidney disease which is required for 
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the production of cilia in sensory neurons 
Q0356() 	 -. - 	
Embryonic 
defect 
Hypothetical protein B0464.2 in chromosome III 
(B0464.2 gene) similar to flybase gene name is 
CG2469-PA from D. ,,,ela,'a,s'ter 
8 	016296 	1 fl-H fl- 	 Wild type 
morphology 
F32D1 .3 protein (F32D1.3 gene) similar to the 
gene CBG23627 product from C. briggsae 
Q20255 	 - 	 1. 	Wild type 
morphology 
Hypothetical protein ZK328.7 in chromosome 111 
(ZK328.7a gene) similar to FLJI 1457 protein 
from human 
12 	018158 	-- _7• --. 	- 	---f-- -f-+— 	Wild type 
morphology 
UDP-N-acetylglucosamine--peptide 	N- 
acetylgiucosaminyltransferase (EC 2.4.1 .-) (0-
GlcNAc) (OGT) (ogt-I gene) similar to putative 
0-linked GlcNAc transferase (0-linked N-acetyl 
glucosaminestransferase) from A. thaliana. 
Cytoplasmic UDP-GlcNAc used by OGT is 
synthesised through the hexosamine pathway: in 
hyperglycemia, abnormally high glucose flux 
through 	this 	pathway 	promotes 	insulin 
resistance, and hexosarnine biosynthesis may 
therefore be a glucose sensor: 0-GlcNAc 
modification of an SpI activation domain 
inhibits its transcriptional activity, and the 
glycosylation state of SpI is correlated with its 
ability to activate genes involved in diabetes 
Total 	 41 
KOGs are a eukarvote-specific version of the Conserved Orthologous Groups original/N , 
devised hi' Roman Taiusov, Eugene Koonin and others (at NCBI) fhr microbial genomes. 
KOGs are defined bY a triangle of reciprocal best BlastP hits between domains of eukarvotic 
proteins from at least high/v divergent species (i.e., species that diverged no later than the 
Cambrian Era) such as C. elegans. D. mne/anogaster, and H. sapiens. 
( 
TPR tetratricopeptide repeat. ST11 .vlre.s's induced (Heat shock chaperonin-binding 
motif), Itransinembreane segment If- FKBP din identified by PFAM. iu 
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Dna] molecular chaperone homology domain, 	RING finger, 	TPR repeal 
identified by Pfani. Iff 	a doinam family that is part of the cupin meial/oenzvine 
supeijwmlv. 	LGA motif putative GEFs specific for G-alpha GTPases, 	I 
aspartvl/Asparaginvl heta-hvdroxvlas'e domain identified by Pfamn, 4uto > modified 
RING finger domain, PRPI splicing factor, N-terminal domain identified by 
Itthn. HAT HAT (HalfA-TPR) repeals) 
Location of frequency of TPR occurrences - The complete repertoire of TPR-
proteins from C. elegans was identified from the genomic sequence. The histogram 
in Figure 7.1 shows the distribution of lengths of tandem peptide repeats found in C. 
elegans. As can be seen from the domain representations of all the proteins, TPR 
repeats are found as a cluster of tandem repeats throughout the whole length of the 
protein. The most prevalent are proteins with 3 tandem repeats (11 out of 41 TPR 
proteins) as shown above in Table 7. 1. The maximum number TPR repeats found is 
12, seen in only one protein, 0-GIcNAc protein (accession. number 018158). 
Results from BLASTP searches against a number of databases (S WALL, SwissProt, 
TrEMBL, ENSEMBL, FLYBASE, WormPrep, etc.) are also included and shown 
matches with homologues from other species. including C. elegans. Additionally, 
relevant information about RNA j analyses, sub-cellular localisation, and protein 
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Figure 7. 1. TPR tandem distribution in C. elegans. The x-axis represents the number 
of TPR repeats in any given protein: the y-axis represents the percentage of all TPR-
containing proteins with that number of repeats. Analysis of the SMART non-
redundant database identified 206 TPR motifs from the 41 proteins in C. elegans. 
TPR domain was identified hr the SMART Webserver Version 4.0 (Letunic et al., 
2004). 
The effect of RNA, on TPR-containing proteins in C. elegans - Using RNA 1 
technology, loss-of-function information for the genes encoding a number of TPR-
containing proteins has been established. Using this particularly powerful technique, 
a variety of defects can be detected from the screens of 35 proteins including 
phenotypic deformities (19 with wild type morphology. 3 with morphology defects) 
and malfunctions (3 with growth defects. 2 with reproductive defects, 7 with 
embryonic development defects, and I with a movement defect). Six proteins were 
screened with unspecified defect. The amount of information available on both sub-
cellular localisation and molecular function of target proteins grows rapidly and is 
incorporated into a number of C. elegans databases, providing a very useful, freely 
available resource. Although only 10 of 41 proteins have well characterised 
functions, functions for a number of the remaining proteins can be hypothesised 
based on the degree of homology to functionally assigned proteins from other 
species. TPR containing proteins in C. elegans are thought to be involved in a wide 
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variety of functions including Hsp co-chaperones (e.g. 045418 and 045786), or 
function in a number of processes including subsynaptic localisation (e.g. 009519), 
axonal transportation (e.g. C18C4.10a, C18C4.10b) and pre-mRNA processing (e.g. 
Q9GRZ2). 
Summary of the biological and molecular functions of C. elegans TPR-
containing proteins - It has been established that there are a wide variety of proteins 
with which the 41 TPR-containing proteins interact. As discussed earlier, protein-
protein interactions are commonly mediated through the TPR domain leading to the 
formation of multi-protein complexes. The TPR proteins from C. elegans can be 
functionally classified by their interaction partners and include 17% with the Hsp90 
multi-protein molecular chaperone complex, 12% with the anaphase-promoting 
complex, 9% with protein transport complex, and 2% with the transcription 
activation/repression complex. However of the 41 proteins from C. elegans 14 have 
as yet no experimentally confirmed function. For example, Y59A8B.6 protein 
(Accession number Q9GRZ2) contains three distinct domains; the N-terminal PRP1 
splicing factor domain (residues 22-182), RNA processing protein (HAT helix) and 
the C-terminal TPR domain (residues 702-735). The Blast search of this protein 
revealed a number of similar protein sequences with a range of e-values between 
0.079-5.2e-270. The best match for Y59A8B.6 protein is US snRNP-associated 102 
kDa protein, a mouse homologue. There are another six homologues found in other 
species (data from the WormBase), RIKEN cDNA 1190003A07 gene from M. 
musculus, US snRNP-associated 102 kDa protein from human, Flybase gene named 
CG6841-PA from D. melanogaster, splicing factor, component of the U41U6-U5 
snRNP complex from S. cerivisae, gene CBG09283 from C. brig gsae, and gene 
M03F8.3 from C. elegans. The N-terminal part of the PRP1 splicing factor is 
involved in mRNA splicing (and possibly also poly(A) RNA nuclear export and cell 
cycle progression) (Urushiyama et al., 1996). The HAT (Half-A-TPR) repeat is 
found in several RNA processing proteins. This repeat is structurally and 
sequentially thought to be similar to TPRs (Preker and Keller, 1998). 
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7.3.2 Sequence analysis of the 206 TPR repeat motifs from C. 
elegans 
From the 41 TPR-containing proteins in C. elegans shown in Table 7. 1, 
sequences for 206 TPR repeat motifs were retrieved from the SMART database and 
used in a multiple sequence alignment to determine a C. elegans consensus sequence 
for this motif. All sequences of the 206 TPR repeats were collected and saved as a 
txt file. Individual TPR repeats were identified by their SwissProt accession numbers 
followed by the number of the TPR repeats from the protein sequences. The data file 
of all sequences was uploaded to the CLUSTAL X programme (version 1.83). The 
resultant alignment contained the sequences of STI1 and Cyp40 as templates and is 
shown in Figure 7.2. The frequency with which each residue occurred at each of the 
34 possible positions was revealed as can be seen in Figure 7.3A. Additionally, 
residues at positions 4, 7, 8, 11, 20, 24, 27, and 32 previously shown to be important 
in fold recognition were subjected to detailed further analysis (Figure 7.3B). 
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Q95PV7_'TPR2 AIA'1QIA'P 34 
Q23049 RA IEAIACVA 34 
Q9BYR2_'I'PRl TRVFCFIAL 	ETT 	-N 	FTNSYY 	KMTIDESN - 34 
P9i24O_'i'PR L;I}'?YVLQR---MV.kEALAI-KVAANHPE-- 34 
Q09485_'I'PR2. 34 
P41842_'IPR? 34  
FBP48Ce'rPRl 
LC? FNAYCA WK- - -LENFEE 	C -RCVSLQEH- 
A}QAELPCT4LQ --- KQNLYLNY4KRAEEVLEYE- 34 
Q09_85_1PR cLILyHLsLN --- KQsLVrAYE-ct'EAsLAVEul- 34 
Q23049_'I'PR6 SESLV}1LCILYHR- - -EGYIr.EAR.  34 
Q9N4Z9_I'PR2 IvILNNIrIpvR__ _MQSE:LAI 	 - FDHCVEENPNF - 34 
Q95PV7_'IPR4 LYSLENM 	-QFiLL LA1E2s -FIWVLILP1H- 34 
Q9N407_'I'-PR2 34 
Q9BKR2_'I'PR2 LSA LI V.VLCLE --- HOMINE S SF:V -LEIKYNPQN- 34 
Q9N4Z9_TPR4 VALFNIG 	KA-- -QNLEALEF-FIYLHQILLNN- 34 
Cyp40bov_'rPR1 SEtLYNIC1 	F FY- - - 34 
0i6296_'1PR4 AAFNYGPLL - --- SGNFHVAIEN-FELALYLQQPI-3- 34 
Q817034 'IPR2 A)VIIIJ.CIt:Y__-ECNyEEALFY-FNEAIEF SOY Q- 34 
Q095I9_'IPRi 34 
Q09536_'1PRi PkLNITIAESF---LLIC-fl[AL5LDN'r'r- 34 
Q19294_TPR4 ifi 	YCLQ4LI- -- 	IPAThLF'Y -QEAKCKPHL- 34 
Q95PV7_'i'PRl LEA14LGANVLAA --- RQ1U'rLA1EI _LREITIKQE*YH - 34 
02025_'1'PR7 EKCL14LAC1 IN-- - Ni1'LQAVTF -LDLVFKNCNC - 34 
ruler 1 ....... 10 ........ 20 ........ 2.0 ......... 
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S'1'I_  human _'IPR3 K 	SRF3.LEF --- LN PEEYJ -*EEQ WEANN - 34 
Y5CID7A. 4_'P-PRl CE L21*'C LILIT - - -MCKLQE.QEC-VRRCLVSDLPS- 2.4 
Q8W'JL6_'ItPR1 CE 	J.MYCLILNO- - - llGKL ,~EA f2r.C-YRRGLVSDLRS- 34 
Q19955_'I'PRl CTKL'FQECEL FR---MQFJEYC ILL - LYP2LEVC CL- 34 
Q9QH3_'I'PR1 CTKL1ECERLFR---MQ4EFCIEL -LV}2LEV 	EL- 34 
Y 0Dm. 4_'1PR2 VCHVFC LI QF'I'---  EflLEIYA -YYRALMLEYLN - 34 
Q8W'IL6_'IPR2 TCH'JFC LI'2F'r --- El 	LE.IYi -11 - 34 
016296_'rPR7 *AXCAILHL___NQ4ELALVE-EIALILDPTS- 34 
Qi8426_'l'PR4 FJ.PYNLCI3CliQ --- LSSE1Ll<-LSALELQYCC- 34 
Q20144_'l'PR3 AITAV  2.4 
P41842_'1'PR2 IRABRSLQ}3LLU --- t*FEEK-LRRSLELQPIQ- 34 
Q8'I4K4_'1'PR2 IffiJi  34 
Q9N93_'1PR2 AYkYTLLCHELDT --- QDELEYAJ4C-FRSALLLSPRL- 34 
Q09519_ 'lPR4 S JUN TLDGELTEF 	Qt:LEC-FA14LN1WV- 34 
Q21746_''PR3 srACPNG LAY s: --- QNR EBA7E-'YF}2LELEPNQ- 34 
SI_hujan_PRG ).YA3IGNS! FF---EE 	YLAIHF -!1wsLAE}'rP- 34 
016259_7PR3 34 
Q09536_'rPR4 VDMJE 	LC!AV- --  LONIt:K$EF -FIWALAIDPFN- 34 
Q19294_'l'PR 34 
016296_'l'PR5 V'r?LQNIAL7EFH - - - NQN1NSLLF -J'ALHLLP•TH- 34 
016296_'l'PRE Lt:SLQCIANLLQ2---1QN1ESETF--RKVMEAPNS- 34 
P91189 ''_PR y 	PI0RCNILLV---GELE3JEkt -FNIVLNWSN- 34  
Q9N3EO'l'PR2 AG'PJLVLLK- --MCQLER 	3.E -FRYLIDSA3Q- 34 
Q19294_'lPR3 AALLICHEFME --- 	 }WCVS-RRMEIDP2E- 34 
Q0360_'rPR2 ADLVCIGBC FAY. - - -MQMt:EM'T-RANEIEPYN - 34 
C7p4IJ_bov_'l'PR2 LSCV LNIGJ.CY LK- --MSDW?CAVLS -CLEA.LEIL)PSN- 34 
Q19955_'1PR5 PA!ANIJ.NCAL- --KSN1PLAIE -KLNLAIEI- 34 
Q95QH3 TPR5 riF_Aiut 	 c-19 	- --KSN1PLJI Qb -FL APT LAIE I- 34 




Q86DM_'I'PR1 NRVLYLYLE,___''EH1QELCI-TERLVEDEPNN- 34 
P91240_fItPRl WALELP3VFYY---QENLI-iLYLLflBSEL- 34 
Q817C-4_'ItPRI 34 
Q9N4Z9_'1PR6 34 
S'I'I_  human _'lPR8 34 
O16259_'l'PR AlL 	,N 	CLTV---LEF1.LL[ -CtTCIRLDS}<F- 34 
S'I'I_huiitan_'lPR2 CLY NF2.AAV- - -FCLYAYEL -OlIVDLKPL- 34 
P9i189_ltPR4 ASLY 	IF.YCLEE---RQELYYZ'.IHt -}1RISKLSILS- 34 
Q9N3E0_PR4 ASLY IzF:yc 	k--- EDKVYSAIBL -Wl{A.A}LSSEI- 34 
P91189_'ItPR6 IL CEFEAIL ---DEEIESAIEL -'2KIEVNPLH- 34 
Q9N3E0_'PR7 VEILIF:.EUI1A- --DEE t:L?L_EKAEEWDSSN_ 34 
Q21746_'r-PR2 -vFcN 	AA:F:---LEQ EL.AIL-cR'lALALDPSY- 33 
'150D7A. 4_'lPR3  S4 
Q8WPLE_'I'PR3 VA}1ETRANLLM[: --- LEQPE 	ENV -RALIERNPLS - 34 
045786_PPR2 AlLH:YNVLIY---LYRPVAAI.kE'-CDFAIE.INPES- 34 
P91189j1PR2 jQAIYFT.A TLA--- MGP.GF'AAI -,., r  -LERVLELKPEF- 34 
Q9N3E0_'1PR2 QAIFF?21tL- --FcRsvPCL:L -I>TVL5LKPEF- 34 
Q20255_'I'PRS PGFCZYL. FY LI'- - -kFRLFJCI-CKVLLLNPQY- 34 
Y50D7A. 4 TPR5 vrCV.LC EVYRR- - - F'CI--.%?LLI~.LYC-UTECEr)REPTB- 34 
Q8W'1LE_'PPR5 VTGJALc:EvYRF- - - YGI'.VLLALYC - uTECELREP'rH- 2.4 
Q8'14K4_'lPR5 APIFHLLAFVlFR- --MCF HLALLI-SWA3.ELDPRG- 34 
Q9N`593 TPR5 AFIFHLL.PVRR --- MON HLALLN-SWAAELDPR- 34 




LYF:F:Q- __L} 	LQLJ..t -LFKAQE lAPEL - 34 
FYBP48_Ce_fIkPR3 V}ALYFFTALLT - --MNEVRLMF'L -FEKIVEVEPEN - 34 
Q7Z146_ ''PRE 34 
Q20255_ ''PRE WHAL SRVVELF:R- - -NGEQ 	EI'-LDRAYEVNPPC - 34 
FKBP48_Ce_'I'PR2 ITCAY LNLS LVCEK- - -QNEQLECIY -CDKVLEXPQN - 34 
03560_'rPR4 LACLCMH --- RIEIEEAIYC-FL)TVHFRLPNN- 34 
Q7Z146_'PPRI SLY LIFSV FYF---RNENLE.AIF 	-LAL-IPRE 34 
Q20255_'I'PRI SLThLIFSI' FYV---RIENLEItIl 	-LKMALQ-IPRF 34 
07662.0_'1'FR2 PEAWLLSELFLL---ENDVAKAVHC-LEECVLISPLN- 34 
Q86DM5_'1PR2 PEAWLQLEELFLL --- ENDVAl<VHC-LEECVLISPLN- 34 
ruler 1 ....... 10 ........20 ........30 ......... 
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Q2254_'TPR1 PLFHYVQR!4FLL --- LIVLYI-LDA1CKDPNN- 34 
Q19294_ItPR1 pMIIrYIAACSNA---Rt:AISN-FEDVRKADPYR- 34 
Q95PV7_'I'PR2. 34 
Q9QRZ2_'IPR1 I PL I LLVRLEEF- - - &G Q  IVF?.FVE -LEKARLRNPEN - 34 
Q9BMTJ2'1'PR3 VKPLYFLQNVF LQ--- S FY SEAl SC - LSKL'fVI - 34 
Q03560'I'PRI VLPLIVIN --- }YTAIY- 	 -YAIRQCRWT - 34 
09536 TPR2 AE G V'AFHILPT- - -EE0SiSC-FA5KLTI<S- 34 
Q0360_'1'PR 	EMLNIVGAL!XiS --- 	 QEKAE}-FJYERLEEQ- 34 
P41842_'I'PRI LEMLCV ILCY0- - -LQEFAETL-RLIEQKPNE- 34 
Q03560_'ItPR3 AEAFMGPChHA --- QQPLA1F -Tr Q AR- QAN1E- 34 
023049_'1'PR4 PELFLNIGLCCNA --- 	 QFt:FALSSILRA0ST('ITt-- 34 
Q23049_'I'PR2 v'rML'r 	4ARVQEA-- -LGEYtE svFL-yRvLr).EsNN 34 
OGID 	LYYV 'rELAHR2FO- - -SN VEAEFY -NLVFQSDPNN- 34 
Q93178_I'-PRi FF11 LLFALNL yE- - - F QEEA}jEL -FDHVIAVYPAS - 34 
Q93178_'1'PR3 LNLCPAISFVM --- 	 YELAPTv-LKIWLA1DPNH - 34 
Q 9N3E 0_'IPRE ?G-TI FR LWD QCIRE --- WNiGEAI 00 -CTRVLE ME SL - 34 
Q817G4_1'PRS SLAYSIALYFc --- RD!tSALYL -ISEIINR'VI<t- 34 
9N4Z9_'I'PR7 SKE!NUSOLPR --- 'r4 QRIFEL -R0 IURKFPQI - 34 
ruler 	i ....... 10........ 20 .,..,.,. SO 
Figure 7.2. An alignment of individual TPR repeat sequences fro,n 41 proteins in the 
C. ele guns genome. Each TPR repeal is identified by its SwissProt accession number 
followed by the sequential number of each TPR repeat. The alignment also contains 
the sequences of the template motifs (ST1I_TPRI-9 and Gyp40_TPRJ-3). The 
alignment was produced using CLUSTAL X (Thompson et al., 1997). Colouring 
scheme is specified as followings; orange fr GIP/S/[', red for H/K/R, blue fbr 
F/W/Y, green for i/JIM/V. 
The ibid recognition of TPR - Sequence analysis was carried out to survey in 
depth the amino acid composition of each of the C. elegans TPR protein motifs. 
Figure 7.3 illustrates the amino acid most prevalent at each position of the TPR 
repeat. Overall, alanine and leucine residues are predominant in this species as can be 
seen in Figure 7.3A. These small hydrophobic residues are required to fit within the 
overall geometry of the TPR fold, allowing the tight turn between motifs to be stable 
(Figure 7.313). The TPR fold is defined by the structure of the consensus sequence 
onto which functionally specific residues can be inserted, promoting targeted 
recognition of different partner proteins. The original consensus amino acids defined 
by Sikorski were used as a reference; (W at position 4. L at position 7, G at position 
8. Y at position 11. A at position 20. F at position 24. A at position 27. and P at 
position 32) (Sikorski et al., 1990) and are illustrated in Figure 7.3C. In C. elegans 
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these eight residues, as determined from the above sequence analysis are L, L, A, Y, 
A, Y, A, and P (Figure 7.3C). Three residues differ from those of the original 
consensus sequence predicted from yeast (Sikorski et al., 1990). The analysis of C. 
elegans sequences presented in Figures 7.2 and 7.3 shows a consensus of L4, A8, 
and Y24 in contrast to the original suggested TPR motif (based on structures) with 
W4, G8, and F24. The remaining five residues of the TPR fold consensus sequence 
are conserved with leucine at position 7, glycine at position 8, alanine at position 20, 
alanine at position 27, and proline at position 32. 
Hsp90 recognition of TPR - Previous analysis and site-directed mutagenesis 
studies revealed residues key to the interaction between TPR protein and Hsp90 
(Ward et al., 2002). K227, N231, N278, K308, and R312 of Cyp40 were crucial for 
Hsp90 binding. These key residues are located on the first helix of three consecutive 
TPR repeats which form a binding groove. Mutation of any one of these five residues 
effectively eliminated any Cyp40-Hsp9O interaction. These five key residues 
correspond to K5 and N9 of TPR repeat 1, N6 of TPR repeat 2, and K2 and R5 of 
TPR repeat 3 within the 34 amino acid consensus sequence and are illustrated with 
red dots in Figure 7.3A. Conservation of C. elegans TPR sequences at these five 
positions was also analysed and revealed no degree of conservation among the 206 
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W 4 L7 G8 Y11 	A20 F24 A27 P32 
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Helix At 	 Helix Bi 
* 	* 	 * 
L4 L7 A8 Y1 1 	A20 Y24 A27 P32 
1 (_______ 	_______ 	34 
Helix Ai 	 Helix Bi 
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A 	RG Y A Y A 	E 
* * * * * 
Figure 7.3. The amino acid composition at each of the 34 positions for all C. elegans 
TPR repeats. A) The previous alignment (Figure 7.2) of each 34-amino-acid was 
submitted to the internet-based WebLogo programme which summnarises the 
frequency with which individual residues appear at any given position in the 
sequence in graphical orni. The top letters at 34 positions represent the amino acids 
which appear most Ire quentiv. Blue diamonds represent positions of consensus 
sequences. Red clots indicate positions of key residues fbr H.sp90 binding. B) A helix-
turn-helix arrangement of a TPR repeat of CeFKBP48 showing close packing 
between the helices. Side chains in blue are highlighted to present the consensus 
positions. Coloured balls highlight residues involved in tight packing. C) Scheme of 
secondary structure arrangement of 34 amino acids in a TPR motif showing the 
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original consensus sequence (above) against the consensus sequence of TPR motifs 
in C. elegans (below) as observed in this work. Blue stars represent conserved 
residues of TPR consensus between yeast and C. elegans. 
Figure 7.4 shows the divergence of the C. elegans TPR from that of the yeast 
sequence at the eight consensus positions (position 4, 7, 8, 11, 20, 24, 27 and 32). 
The 8 histograms show that C. elegans TPR sequences exhibit a strong preference 
for particular amino acids at these positions. For example, at position 4, leucine 
(27%) is selected rather than tyrosine (17%) or tryptophans (15%) possibly to 
stabilise the turn of helix Ai and Bi. Strong preferences are clearly seen at positions 
7, 20, 24, 27, and 32 in the occurrence of L (48%), A (88%), Y (38%), A (62%), and 
P (50%). Preferences are found at positions 4, 8, and 11 in the occurrence of L (27%) 
with Y (17%), A (47%) with G (43%), and L (29%) with F (19%) respectively. The 
highly conserved residues L7, G/A8, A20, and A27, which are also conserved in the 
original yeast motif, are likely to be the key structural determinants of the helix-turn-
helix motif and are required to allow tight packing of the two adjacent helices 
(Figure 7.3B). Remaining residues at positions 12, 13, 22, and 23 show a great 
degree of variability, perhaps providing variable specificity of interaction with 
individual target proteins. 
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Figure 7.4. Distribution of TPR sequence in C. c/c gans at the consensus positions 
defined by Sikorski. The original TPR consensus sequence (W4, L7, G8, Y11, A20, 
F24, A27, and P32) was identified from yeast. in this work, the degree of 
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conservation of these residues from the TPR motifs present in C. elegans was 
compared and contrasted with those of the yeast sequence. The most prevalent 
residues within this sequence of 34 are L4, L7, G8, Lii, A20, Y24, A27, and P32. 
7.3.3 Discovery of two C. elegans proteins that interact with Hsp90 
Defining the reference sequences for survey of new C. elegans TPR protein(s) 
likely to bind Hsp90 - Site-directed mutagenesis studies of Cy40 to probe 
Cyp40/Hsp9O interactions identified the residues important in this interaction. The 
equivalent residues in the C. elegans TPR containing sequences: K and N at 
positions 5 and 9 of TPR repeat 1, N at position 6 of TPR repeat 2, K and R at 
positions 2 and 5 of TPR repeat 3 illustrated in Figure 7.2 were used as a reference. 
Only C. elegans sequences containing consecutive TPR repeats were surveyed. 
Defining the criteria for protein candidate(s) - The sequences of all TPR 
repeats were aligned against those of the templates (Cyp40 and 5T1) to determine 
the overall degree of conservation of the residues key to Hsp90 recognition (Figure 
7.2). The residues of all C. elegans TPRs were compared and contrasted with the 
reference. Full conservation of all the five key residues was set as 100%. The 
percentage cut-off used throughout this survey was 80%. The FKBP48IHsp9O 
interactions have been characterised as illustrated in Chapter 6, sections 6.3.3 and 
6.4.2. Four out of five equivalent FKBP48 TPR residues crucial for Hsp90 binding 
(80%) in FKBP48 were conserved. Therefore it was assumed that any TPR repeat 
showing a degree of conservation over 80% satisfied the criteria and was likely a 
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Figure 7.5. Diagram representing the positions of the key TPR residues ftr Hsp90 
binding as characterised by site-directed inutagenesis (Ward ci at.. 2002). A) All the 
positions are located on the first he/ices of each TPR repeat. The table summarises 
the conservation of these five key residues in other C. etc gans TPR proteins that 
could potentially be Hsp90 partners. B) X-ray structure of the TPR domain 2A from 
Hop in complex with the Hsp90 peptide MEEVD (PDB code IELR) shows the 
interaction site at where the key residues thr Hsp90 binding are located (Seheujier et 
at., 2000). 
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Discovery of two putative Hsp90 binding proteins - The occurrence of the 
five key Hsp90 recognition residues on the three consecutive repeats of individual 
proteins was examined. Data analysis was evaluated in terms of percentage similarity 
at these five positions, as described in Figure 7.5A. It was found that amongst the 41 
proteins strong conservation of these key residues was seen in three proteins, 
FKBP48 (accession number 045418) (80% identity), hypothetical protein encoded 
by R09E12.3 gene (accession number 016259) (100% identity), and hypothetical 
protein encoded by R05F9.10 gene (accession number Q21746) (100% identity). The 
table in Figure 7.5 summarises the results for each of these 5 residues in the target 
proteins. Of the five key residues, four are conserved in the FKBP48 TPR repeats, 
(K5, T9, N6, K2, and R5). The TPR domains of the two putative proteins contain full 
equivalents of the five key residues (KS, N9, N6, K2, and R5 in 016259 TPR 
domain 1 and K5, N9, N6, K2, and R5 in 016259 TPR domain 2 and K5, N9, N6, 
K2, and R5 in the TPR domain of Q21746). The rest of 41 proteins show low percent 
identities in range of 20%-40% (data not shown), which did not satisfy the criteria. 
Therefore these proteins were not considered as likely Hsp90 binding partners using 
the criteria as set in this work. 
BLAST searches using the complete sequences of both putative Hsp90 
binding proteins (016259 and Q21746) against all non-redundant GenBank CDS 
translations, RefSeq Proteins, PDB, SwissProt, FIR, and PRF databases revealed 
high sequence similarities to stress-induced-phosphoprotein 1 (STI1) and small 
glutamine-rich tctratricopeptide (SGT) protein from C. elegans respectively. Both 
STI1 and SGT proteins play an important role in protein-protein interactions. The 
STII protein is a heat shock protein co-chaperone that binds to both Hsp70 and 
Hsp90 and recruits Hsp90 to pre-existing steroid receptor-Hsp70 complexes (Chen 
and Smith, 1998). The highly conserved SGT protein accumulates to high levels in 
human cell lines during cell division (Winnefeld et al., 2004). The most conserved 
region is the central region of 3 TPR repeats (Kordes et al., 1998). To predict the 
molecular nature of the possible interactions of the two proteins with Hsp90, 
molecular models of each of the proteins were constructed using a number of TPR 
domain proteins as templates. The structure of FKBP48 was similarly modelled, to 
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compare and contrast the interactions between the TPR domains of these three 
proteins with the Hsp90 MEEVD region. The modelling of the structures will be 
described in greater detail in the following section. 
7.3.4 Modelling of C. elegans FKBP48 
The structure of CeFKBP48 was constructed to gain an insight into its 
structure to allow comparison with the preliminary structural result from the SAXS 
experiment discussed earlier in Chapter 6, section 6.5.2. The SWISS-MODEL 
package from http://swissmodel.expasy.ch  was used to derive all the modelled 
structures and was described in greater detail in Chapter 2. 
Fold identification and template selection - The results of the final FKBP48 
model returned by SWISS-MODEL contained the coordinates as a PDB file. 
Additionally, the sequences of known 3D structures were examined and an overall 
alignment between target sequence and template structures with percentage identity 
generated, as can be seen in Figure 7.6. FKBP48 sequence was threaded in the 
ExPDB template library extracted from PDB database for template searching. The 
templates showing over 25% sequence identity with the target sequence were 
automatically selected for inclusion in the modelling process. In this work, therefore, 
68 out of 69 templates found were used. 
-256- 




43.62 % identity 
lktOA.pdb 
40.47 % identity 
lrot_.pdb 
60.7 % identity 
lrou.pdb 
60.7 % identity 
lnlaA.pdb 
58.5 % identity 
lnlaB.pdb 
58.5 % identity 
lyat_.pdb 
50 % identity 
lfkl_.pdb 
51.9 % identity 
lfkk_.pdb 
51.9 % identity 
lfkj_.pdb 
51 % identity 
la7xA.pdb 
51 % identity 
lfkr_.pdb 
51 % identity 
lfkiA.pdb 
51 % identity 
lj4iA.pdb 
51 % identity 
lihgA.pdb 
20.3 % identity 
ljvwA.pdb 
40.4 % identity 
lnaOB.pdb 
28.2 % identity 
lnaOA.pdb 
28.2 % identity 
Figure 7.6. PDB structures used to model CeFKBP48 modelling results from SWISS-
MODEL. 
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Target-template alignment - The SWISS-MODEL server also produced the 
overall target-template alignment as seen in Figure 7.6 which showed remote 
relationships. Once templates have been selected, the alignment of target sequence 
with the template structure was produced by MultAlin 
(http://prodes.toulous.inra.frlMultAlin ). Although a number of closely related protein 
sequences (with over 40% sequence identity) were selected as multiple templates, an 
optimal alignment of the target sequence with only those of IKTO and IKTI was 
carried out (Figure 7.7). From the alignment overview, it was assumed that an overall 
structure of FKBP48 could be similar to those of these two proteins. 1KTO and IKT1 
code for the same protein, FKBP51 from two different species (Homo sapiens, IKTO 
and Saimiri boliviensis, 1KT1), therefore an alignment could provide an insight into 
the degree of conservation of residues between different species. 
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I 	10 	21' 	36 	40 	50 	61) 	70 
FKBP51_H.sapiens 41ITDEGRKNNEESPTHTVHEIJGE(IITSI'KR 	I PV N LET! flIhUKYK:K S KI 
	
FKBP51_S.holivensis t11T0E6HKNSR6NPHHTVREJGEIIVTS V R I PV H [ET IlIhOR V 	N K H K' IJSS 
FKBP52_H.sapiens HTREEMKHT[56HQSHPLP11I 6VU ISP Q E 	V RI I TFfl MIhUR F T U L I I1SS 
FK8P48_C.elegans 	 1SfiI KID iTPK 6 E KI 0 VVKTTITTI( 	V I E I 	Ihh 
Consensus t..e.......... 	 . 	........ njlid.. . 	1 
71 	80 	90 	100 	110 	120 	130 	140 
I --------+---------+---------+ ------+---------+---------+ ----- I 
FKBP51_H.sapiens H N P VI SLhKI,UVTKRUI1I6VIIIIIKK6ITCHLLCKPI fl SO LI JSNI1T! Fl lIUL LOFKGU 
FKBP51-S.bolivensis H N P Vs SI K1h'JKAUIIIGIPTIlKXhI TCHLLCKP[ 11 AT L 	SN H FFEVELLOFKIiU 
FKBP52_H.sapiens L K K S DL!K ;IKfiU[iIRiI1iflKV6FCHITCKPI YOrSO P PH H vrrvri FIFKGF 
FKBP48C.elegans R 6 0 S HI R'Pl IKGIIL)LGVIIIIITKII HEFTIRSEIY6Y6DHi P 	66 	It I VII FI1ISHI 
Consensus . • • s .1iklV1KaU1Iig!ATPIkkhI ch.t.ckpYaYh.& p ." .11 II f:fkgI 
141 	150 	160 	170 	180 	190 	200 	210 
I --------+---------+---------+---------+ --------- +--------- +--------- I 
FKBP51H.sapiens 	LFE__l6JIPRTKRK1E6YSNIH[GfiTEIHLERC6GRl1' DC; , Vfi T''(J 1 PjNOP'IfJ1'KHLEK 
FKOP51_S.bolivensis LLE__ 6 1) RTKRR[GVSH GAP QIHLE RCGGRV [IC VII T 	I HUh I I K!LEK 
FKDP52_H.sapiens 	LTE[[ GuIlRIUTRE6YHI(h 6111 EVHLEYVKDKL 00 LR E I LUL V L P lOP 
FKBP48_C.elegans ISPDRTILPTIIVEISKNSF'HIITSKI-AHCVITYQGT[ VII VN H 	S EGLE V RLRR 
Consensus 	i.e. .uli,iRri...egjs.INga. 	 d. 	v. • e • dl . . 'r'rl.r 
211 	220 	230 	240 	250 	260 	270 	280 
I --------+---------+---------+---- -----+--------- +--------- +--------- I 
FKBP51-H.sapiens II RE QCILYL-6PRr6 EH6KPKFG EP4HE IrEVTi PSFUI<RKES 
I DTK 	UHHIV KiIV 
FKBPSLS.bolivensis hRE UCILHL-EIPRG EHGKPKFG EP'II1E I 1 EVT' PSI FFHKIS 	01K URHIV1 I Kh IV 
FK8P52...H.sapiens III KG HSIVYL-KPS Hr iSVGKEKFQ PPrrE. KTELH S 	AKIS 	NSE 	USTIVI [Rh I V 
FKRP48...C.elegans FL)L6' KSKIEIRGHKTlNSPPA6SHPVN'Ti El TIE E VPHT THE AHKUHP IlRhIPI 
Consensus n .g • si..1.p. . 	..k.kf.ppP4tPeI • e.. 	 •. 	qa.iv rlIv 
281 	290 	300 	310 	320 	330 	340 	350 
I --------+---------+---------+------ ---+--------- +--------- +--------- I 
FKHP5I_H.sapiens 	EKG KYl1UlVIQYGKIVSUI I Ill VGLSEKESKHS SFLLHHFI NI RI1CYLL LREYTKI1 IC 9HIGLD 
FKBP51_S.bolivensis EKG KYV0VIQY6KIVSUI I III VGLSEKESKHSE SFLLHIIFi HI HNCYL LREVTKH EC 	H GLU 
FKBP52H.sapiens 	EKE KYKQ11.0TKKIVSUl I Vi SSFSNEERQKO HLRLRSHI P41 HIICHLr LURISHO ES Ill ft [LU 
1K0P4812.elegans 10K NLKL YHKYKRREEVL I VI KSTDPEKIIHER TILHGRY[ III SI VCS1 QHFQLEC KU hr V [TK 
Consensus •fk. kkq..qYkkivsuI FyI  .s.s.ee......llaa.IPIIahc.lri.e...a e.1 0 al eld  
351 	360 	370 	380 	396 	400 	410 	420 
I --------+---------+---------+--- ------ +--------- +--------- +--------- I 
FKIJP51...H.sapiens SAHEIGI YPRG[hQi LPIHIFESIIKGO 	'.'LfVH 	RE 1511 QKKRKEHNF RRI II 	KKFII 
FKRP51_S.bolivensis SANE' U 	RUE 0 LIINI FESKGD I VN RL JEll QKKHK[HNE- RRT ii KKFFI 
FKDP52_H.sapiens SHIrE 6 R 6 1 H HVH11FEI RHO 	I LV 	KT LHV QQRIRRQLH[LKKL II 	ERLO 
FKRP48.C.elegans PGPV' H 	KHT L Thh VRD IIKL tl V yE AU IIV RNTIREONERUKKR K HYIS 
Consensus s.e' rge . • n.'fe.' • .dh I 1 v 	•. i.v q..ireqneR*kk. a 	.k.a 
421 	430 	440 	450 	460 
I --------+------ --- +--------- +--------- I 
FKDP51_H. sapiens F H EEHNKHPIGKKTSEGVTNEKGTDSUHHEEEKPEGHV 
FKBP51S.bolivensis I H [EONKHIISKKTSEGVTN[KLTRSHRVEEEKPE6HV 
FKHP52_H. sapiens F N HKHERSSGUHPTOI[IIK[EUKSNTHGSUSQVETEA 
FKBP48_C.elegans Ti I DL PTNTVEDEDEIVHSTS6SSTSNR 
Consensus e.L• ..a.....d........e......a......e... 
Figure 7.7. An alignment o/' FKBP48 against FKBP5I152. The levels of homology 
between CeFKBP48, SbFKBP5J, and /iFKBP51/hFKBP52 are 38%, 38% and 41% 
respective/v. In the COflSCfl5US lines, residues with red, uppercase, letters are high/v 
conserved (90%). Residues with blue, lowercase letters are weak/v conserved (not 
over 50%). A position with no conserved residue (black) is represented b' a dot. !fr 
I and V residues, $for L and M residues, %for F and Y residues, and #for B, D, E, 
N, Q. Z. 
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7.3.5 Modelling of the hypothetical protein (accession number 
016259) 
The SWISS-MODEL server identified 8 known 3D structures (PDB codes 
1ELRA, 1A17, 1ELWA, 1ELWB, 1NAOA, 1NAOB, 1KT1A and 1KTOA) as the 
possible templates for the above protein. Sequence identities of templates to the 
target sequence were in the range 38-52%. Two regions of the target protein were 
modelled separately. Modelling of region 1 (residues 1-132) equivalent to the N-
terminal TPR domain, named TPR domain 1 in this work, was carried out using the 
templates 1ELRA, 1NAOA, 1NAOB, 1NA3A, and 1NA3B. Region 2, named TPR 
domain 2 (residues 133-268), was constructed using the templates 1A17, 1ELWA, 
1ELWB, 1KTOA, and 1KT1A. Figure 7.8 shows alignments of both 016259 TPR 
domains against their respective template sequences templates. 
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1 	10 	20 	30 	40 	50 	60 	70 	 80 
I _+ _+ -+ -+ -+ -+ -+ - I 
1ELR:H 	GKULKEK 	0H 1(1< 	1 LKH 	K 	T1TYITUflRVYEK60TNKCR LCI IIiI1 VGRi HREOY 
016259 t1TDHI11EK'; lififi 7 1 OK 	K HYII I SJITFVNNKRflVY' EEKK1 HECYUFCIJ lIVE V6RE TR80Y 
lHHn:H 6HM0P6NSEulUYlt 04HYYl , QGio, F 1EV 	L 	NAEflUYNL6IHKQG11YDEAILYYQ1I,LE L0Pt4N ---- 
INHO:B GF1IIDPGHS1IERUYE4L iHHYYI:061 Li I i['.IEY I ILL t [if NHHERMVHL6NHl TKQGDTDERIFYYQI(IIL[ LOPNN 
1N83:fl 6HIIOP6NSHEHUVHL t,NHYYI QGHIIIEEsIEVYU)(HLELDPNNOEHIIYHL6NR iKO6DYDERhl YYQKHU LOPHII----
1P1H3: B GR11DP6HSII[HMYHI t,HRYYKUGIIYI E5IIEVYUl FlU I 11I'HHREHIIYHUiNH T i KQGUYOEHI( YVUKIIU LDPNN ---- 
Consensus gandpgnsFseau9l IHayVKqgD*eRieY FI1F I 0InHaeauH1gnaY kqgddeai 999 *KiIIE 1dpn.... 
81 	90 	100 	110 	120 	130 136 
I --------+---------+---------+---------+---- -----+----- I 
IELR:H P01 K YRPI SYF EKYI(DHIHFYP1KSLHEHPTP0V1I(KCQUHEKIIKEQERL 
016259 KLI K MSPR HFQ •NDLSLHVUUFHRSLSEFRUPELVKKYKELEKULKHAEPL 
1NA(o:H --- F MVIII AYY GDYDERIEYYQKRLE--LDPNNRERKUDLGNRKQKQG 
11480:0 --- E IIYNL RYY :6OVDEHI[YYQKALE--LDPNPIHEHKUOLGHHKQKQ6 
11483:8 --- F KUDE AKO iG 
11483:8 --- F KOOL AKO 6 
Consensus •.. e •.J a.q -g .... a ....... 1 ..... p................... 
 
241 	250 	260 	270 	280 	290 	300 	310 	320 
I --------+---------+---------+---------+---------+ --------- +--------- +--------- I 
1H17: RDEPPHOGHLKRHEELPTUANDVFKRKDYENIKFSUH E-------------LNPSNRIY--Y 
IKTO:H LIYEVTLKSFEKHKESU[I10TKE1(LE0flHIV [KGTVVFK66KYIIQ VIQ 61(1 SIILEI1EY6LSEKESKRSESFLLHAF 
11(11:8 LIVEVTLKSFEKHKESIIEMDTKEKLEQURIVI E1(GTVYFKGGKYVQ VIQ6K1SIILEMEYGLSEKESKHSESFLLHHI 
016259 LVKKV--KELEKULKHHERLHVINPEL HOLE INK6HEYFI(K6DVPT MPH HERK ------------- RDPEPIHIL--Y 
IELU:fl 	 I1EOVHEUEKGNKHLSV6HIDD LQCSEFIIK ------------- LUPHHHVLY 
1ELM:R IIEOVNEUEKGNKHLSV6I4IOOULUCYSERIK ------------- LDPHHHVL--T 
Consensus ................. e ....... eqa.e1lekgn.9fk.g...s...TseaIk ............. ldp.n..1.. 
321 	330 	340 	350 	360 	370 	380 	390 	400 
I --------+---------+---------+---------+-------- -+--------- +--------- +--------- I 
i817: 	GHRSLHYLRTECYGY1ILGOHTRRIEI OKKYI TV RHASNMR: 6KFPHHLRD TVVI(VKPH KDHKIIKYUECNKIVKQ 
1KT0:II Ll1LHh1CYLKLRETKHVECC0KHUiI 0581W LV RGEHOLL IIEFESKGD KVLEVNPQ KRHRLUISMCQKKHKE 
1KT1:A LNLHl1CYLKLRETKllVECC0KHtGI DSRHE LYR6EFIQLL NEFESK60 KVLEVHPQ KHFIPLUIFMCUKKAKE 
016259 SIIRRF1CLTKLIIEI QRIsLDDCOTCIR DSKFI YIsi(HFICLVR REMSKIsURH ORLUVOPS EEHREGVKNCLRSNOE 
IELII:H SHRSRfiYFIKKG0QKFtYED6CKTVO KPD146 YSKIIHHLEF HRFEEHKPTTI EGLKHERN PULKEGLQHMEHR 
1ELU:B SHRSHHYHKKGO(QKHYEOGCKTVO KPOM6I YSRKAHBLEFE NRFEEHKRTYF EGLKHERN PULKEGLOHIIEHR 
Consensus sHrsaa.k...qkIl.ed..k... d .... y.kaaa1..n.fe.1lkr.E..1kv.P. ..akeg.qnc...... 
401 	410 	420 	430 	440 	450 	460463 
I --------+---------+---------+--------- 4 I 
1R17: 	---KIiFEPHIAGDEHKRSVVflSLDIESI1TIEDEYSGPKI 
1KTO :8 HNER__OPRIYHHMFKKFHEQDRKEERHKRMGI(KTSEGVTHEK6TOSQHMEEEKPEGHV 






Figure 7.8. Sequence alignment off. elegans 016259. A) TPR domain 1 (Y'016259 
against IELRA = Hop TPR2A domain, chain A, INAOA = designed protein CTPR3, 
chain A, JNAOB = designed protein CTPR3, chain B, INA3A = designed protein 
CTPR2, chain A, and INA3B = designed protein CTP2, chain B. B) TPR domain 2 of 
016259 against 1A17 = protein phosphatase 5, IELWA = Hop TPR1 domain, chain 
A, IELWB = Hop TPR2A domain, chain B, IKTOA = human FKBP51, and JKTJA = 
FKBP5I from Saimiri boliviensis. In the consensus lines, residues with red, 
uppercase letters are high/v conserved (90%). Residues with blue, lowercase letters 
are weak/v conserved (not over 50%). A position with no conserved residue (black) 
is represented by a dot. !for I and V residues, $for L and M residues, %for F and Y 
residues, and #for B, D, E, N, Q, Z. 
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7.3.6 Modelling of the hypothetical protein (accession number 
021746) 
Three known structures were used to model the structure of Q21476 TPR 
domain (residues 92-246). The target sequence showed the identity levels to these 
following templates, 32% identity with protein phosphatase 5 (PDB code 1A17), 
33% identity to Hop TPR2A domain chain B (PDB code 1ELWB), and 33% identity 
to Hop TPR2A domain chain A (PDB code 1ELWA). Figure 7.9 shows an alignment 
of Q21746 sequence against the templates. 
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1ELU : B 
Consensus 
81 	90 	100 	110 	120 	130 	140 	150 	160 
I -------- +---------+---------+---------+---------+---------+--- ------ +--------- I 
1817:.. RDEPPHOhiRLKRHETUAHElYFKAK 'i' N IKFSQHFE 'PS H Y ll SL l,RTEE -'GYLG 
021746 FKSAEGLPE6ESHLPTPSUSDISURHKII.EEGHOLMKRS F H VOKNA K P-R P Y C fill CRLEQDL ID 
	
1ELU:1l 	 IIEQYHEI KEKGNKHLSV6 1 U LUC SE K PH H L S 511 HKKGLJ UK YE 
IELII:8 IIEUVHE( KEK6NKHLSV6 I r LOC SE K PH H L S SO HKKGD UK YE 
Consensus ................ p.d .... qaIele.gHd..ka. •-. •q.sik -p.. y . 	a 	• r.P ........ 
161 	170 	180 	190 	200 	210 	220 	230 	240 
I --------+---------+---------+---------+---------+---------+------ ---+--------- I 
1H17:_ AIRHIE DKKYI GYY' RHHSNIIRL6K RA LRU ETVVKVKPH KIJA PIKYQECllKIVKQKHFERHIH6DEHKRSVVD 
021746 CRTQLR DPSYSIRMG IIGLHYSCQNP IN HER KKRLELFPN ESY NNLKIA DKLKELESSRPRPllHNPLHGIIG 
1ELU:H GCKTVIJ KPDUG GYS KHHOLEFLNR CE KRT EEGLKHEHN PUL EGLUNM HR 
1ELU:B 	EICKTVD KPDU6 GYS K000LEFLNP FE KRT EE6LKHEHN PUL EGIUNPI HR 
Consensus V a.. dp,'. 	. • ia ... lnr e 	• r e..lk.epn ... ..lq ..... k ..... . ... g......... 
241 	250 	260 	270 	280 	290 	300 	310 	320 





Consensus ............... P ................................................................ 
321 	330 	338 






Figure 7.9. An amino acid sequence alignment of C. elegans Q21746 hypothetical 
protein with its templates, JELWA= Hop TPR2A domain chain A, /ELWB = Hop 
TPR2A domain chain B, and ]A]7= PP5. In the consensus lines, residues with red, 
uppercase letters are highly conserved (90%). Residues with blue, lowercase letters 
are weak/v conserved (not over 50%). A position with no conserved residue (black) 
is represented by a dot. !for I and V residues, $fr L and M residues, % for F and Y 
residues, and #for B, D, E, N, Q, Z. 










7.3.7 The overall architecture of FKBP48 from C. elegans 
The overall structure of FKBP48 is similar to that of FKBP51 (Sinars et al., 
2003) and FKBP52 (Wu et al.. 2004) from human. The modelled structure of 
FKBP48 comprises two FKBP domains at the N-terminus (residues 24-118 and 141-
234) and one TPR domain at the C-terminus (residues 254-407) as illustrated in 
Figure 7.10. The FKBP domain folds with five anti-parallel 13  strands wraparound a 
central cc helix. Three TPR repeats and an additional long C-terminal helix (residues 
381-407) are included in each of these Hsp90-binding TPR domain. 
Figure 7.10. A structural comparison of the CeFKBP48 model (green) with 
hFKBP51 (PDB code IKTO, magenta), and hFKBP52 (PDB codes JQJC and JP5Q, 
orange). A) The overall structures of the three given proteins adopt two N-terminal 
FKBP domains (residues 24-118 and 141-234 in FKBP48, residues 41-135 and 156-
248 in FKBP5I, residues 40-134 and 157-249 in FKBP52) with one following TPR 
domain including the final C-terminal long helix (residues 254-407 in FKBP48, 
residues 268-412 in FKBP5I, residues 270-427 in FKBP52). B) Representation of 
clot surtaces surrounding the structures of FKBP48151152 rendered by ribbons. 
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j Aw? 






Figure 7. 1 1 represents charge distribution of the overall structure of FKBP48. Both 
the FKBP domains and the outer binding groove of TPR domain compose negatively 
charged surfaces shown in red as can be seen in Figure 7.IOB. The inner binding 
groove of TPR domain mainly forms a positively charged surface shown in blue 
(Figure 7. 10A). 
A) Front view 	 B) Back view 
Suriu Paiti 	'5.J 	5, 
Figure 7.11. An electrostatic surface representation of the modelled structure qt 
FKBP48 from C. elegans, A) front view and B) back view. A dotted circle highlights 
the inner groove which is a putative Hsp90 binding site. Distribution of charged 
surface ranges from negauivelv to positively charged seen in red and blue 
respectively. The figure was prepared using GRASP (Nicholls et al., 1991). 
The TPR domain of FKBP48 is structurally similar to that of Cyp40. Hop, 
FKBP5 1. and FKBP52 which are Hsp90 binding domains. The TPR motif contains 
three repeats with two helices each. The six helices (designated A l , B 1 . A2 , B 2 , A. 
and B) form a helix-turn-helix structure. The final long helix at the C-terminal end 
(designated C) extends from the core domain (helices A l - B3) with different angles. 
Figure 7.12 represents superposition of the TPRs of the aforementioned proteins 
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which are comparatively well superposed with their core domain backbones whilst 
Figure 7.13 represents the charged surfaces of their inner groove. 
N-terminus 
riinus 
Figure 7.12. Stereo view of superimposition of TPR domain of cyp40 (magenta), 
Hop TPR2A (cyan), FKBP51 (yellow), FKBP52 (blue), and FKBP48 (red). All the 
TPRs were superimposed using MultiProt (Shatskv et al., 2002) 












Surface Potential IMO 	-5.000 	0,000 	5.00U' 	>-( 
Figure 7.13. A representation of electrostatic potential surfaces of A) Hop TPR2A, 
B) Cvp40, C) FKBP5I, D) FKBP52. and E) FKBP48. Distribution of charged 
surface ranges .troin  negative/N , to positive/v charged seen in red and blue 
respectively. The Figure was prepared using GRASP (Nicholls et al.. 1991). 
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7.3.8 The TPR modelled structures of 016259 and 021746 
Structures of 016259 TPR domains - The hypothetical protein 016259 coded 
by R09E12. 3 gene has a predicted molecular weight at 37 kDa (320 amino acids 
long). It composes two consecutive N-terminal TPR domains (TPR1 residues 5-113 
and TPR2 residues 140-241) and one stress-induced (STI) 1 domain (residues 269-
308) at the C-terminus as illustrated in Figure 7.14B. Using the SWISS-MODEL 
modeller server, 3D models of the two candidates were generated as previously 
described. Figures 7.14A and 7.14C show structural models of both 016259 TPR 
domains. The models reveal the similarity of the core domain fold with different 
angles of final helices. In addition, positively and negatively charged distributions on 
both domain surfaces are different. The core TPR domains (circled) of both appear to 
be positive, whilst the final helix of TPR domain 2 seems more negative than that of 



















Surf ce Potential 111111010-4-ON 	0.000 	5' 
Figure 7.14. Model structures of 016259 TPR domains .from C. elegans. A) and C) 
Ribbon (left) and electrostatic potential surface (right) representatives of 016259 
TPR domains land 2 respectively. B) A buhb/ogramn represents domain organisation 
of this protein comprising three separate domains, two of which are TPR domains 
and one of which is stress-induced domain involved in mediation of heat shock 
response of Hsp 70. 
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Structure of Q21746 TPR domain - Q21746, a hypothetical protein with 
molecular weight at 36 kDa (337 amino acids) is encoded by R05F9.I0 gene. It has 
been proposed to possess one TPR domain as can be seen in Figure 7.1513 (residues 
105-205). A 3D model of the TPR domain illustrated in Figure 7.15A shows the six 
helices of three TPR repeats and an extra final long helix at the C-terminus. The 
surface of the core TPR domain (circled) is shown with positive charges. The extra 
helix is rich in hydrophobic residues at its extremity. 
96 
	




L I , 
1% 	Iry 
 I INI 
 
 
Surface Potential 	_ 	-S.lIX) 	01000 
Figure 7.15. Model structure of Q21746frag,nentfroni C. elegans (residues 96-230). 
A) Ribbon (above) and electrostatic potential surftice (below) representative of 
Q21746 TPR domain. B) A bubblogran of domain organisation showing one 
characterised region as a TPR domain. 
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7.3.9 TPR interactions with the peptide MEEVD 
Similarities and differences in TPR/Hsp90 binding residues - A site-directed 
mutagenesis study of Cyp40 interacting with Hsp90 revealed 10 residues from the 
TPR domain of Cyp40 to be important, five of which were essential for TPRIHsp90 
recognition as highlighted in black in Figure 7.16 (Ward et al., 2002). The amino 
acid sequences of each TPR repeat of C. elegans FKBP48, 016259, and Q21746 
were aligned with Cyp40 and other well characterised TPRJHsp90 binding proteins 
to determine the overall degree of conservation of the residues key to Hsp90 
recognition. Sequence alignment between each TPR repeat of these proteins indicates 
the key residues for MEEVD recognition are highly conserved (Figure 7.16, residues 
in black). The residue at position 9 is not as well conserved, with a threonine in 
FKBP48151152 TPR repeats and an asparagine in all other sequences. Residues 
involved in Cyp40/Hsp9O interaction but not directly in association with TPRIHsp9O 
recognition (shown in blue) show low degree of conservation. Site-directed 
mutagenesis studies of Cyp40 suggest the importance of ten residues for 
Cyp40fHsp9O interactions with five residues essential for TPRIHsp9O recognition. 
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hSTI_TPR7 : K N F 
016259_TPR4 : K N F 
hSTI_TPR1 : K N L 
hSTI_TPR4 K N Y 
016259_TPR1 : K N '1 
Q21746TPR1 K N M 
hFKBP51_TPR1 K T F 
hFKBP52_TPR1 : K T F1IJ 
CeFKBP48_TPR1 K T L 	( L 
bCyp40_TPR1 K N F 
hSTITPR8 K N TK 
016259_TPR5 : 	 I N TK 
hSTI_TPR2 : 	 V N 
hSTI_TPR5 T N FE 
016259_TPR2 : 	 T N FE 
Q21746TPR2 : 	 V N CR 
hFKBP51_TPR2 A N LK 
hFKBP52_TPR2 A OM LI LK 
CeFKBP48_TPR2 : 	 G N SK 
bCyp40_TPR2 S N LK 
hSTI_TPR9 K R V 
016259_TPR6 : 	 K R A 
hSTI_TPR3 : 	 K R T 
hSTI_TPR6 : 	 K R F 
016259_TPR3 : 	 K R W 
Q21746TPR3 : 	 K R A 
hFKBP51_TPR3 : 	 K R D 
hFKBP52_TPR3 : 711 El D 
CeFKBP48_TPR3 : 	 K R L 
bCyp40_TPR3 : 	 K R D 
Figure 7.16. Alignment of TPR repeals of TPR containing proteins that are Hsp90 
partner proteins, including the two putative proteins from C. elegans 016259 and 
Q21746. Three consecutive TPR repeats are present in pink (TPR 1), green (TPR 2), 
and purple (TPR 3). Residues highlighted in black are critical for TPR1Hsp90 
recognition (Ward et al., 2002). Residues shown in blue are additional residues 
associated with the overall Cvp40/Hsp9O interaction. Residues in red represent 
highly conserved residues. T'to residues, N40 and M43 (highlighted in red boxes), 
,nav interact with the C-terminal pentapeptide (MEEVD) of Hsp90 (Wu ci al., 2004). 
100 
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C) 
Interaction models between TPR domains aiul the C-terminal residues 
MEEVD of Hsp9O - Intermolecular interactions between TPR domains of interest 
proteins and the final C-terminal residues of Hsp90. MEEVD, were modelled based 
on the X-ray structure of Hop TPR2A domain complexed with the MEEVD peptide 
at resolution of 1.9 A (PDB code 1ELR) (Scheufler et al., 2000). The TPR domains 
of FKBP48, 016259, and Q21746 were coordinated with the reference. The peptide 
was then manually docked into the putative binding grooves (Figure 7.17). 
Figure 7.17. A representation of intermolecular interaction surfaces between TPR 
domains and the conserved residues of Hsp9O, MEEVD. A) TPR domain of FKBP48 
(magenta) and the peptide MEEVD. B) TPR domain of Q21746 (orange) and the 
peptide MEEVD. C) TPR domain I of 016259 (cyan) and the peptide MEEVD. D) 
TPR domain 2 of 016259 (red) and the peptide MEEVD. Side chain residues of each 
TPR protein are sJu)v'1l in white. 
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Figures 7.18 to 7.21 show the intermolecular interactions between the TPR domains 
of FKBP48. 016259 and Q21746 proteins and the docked MEEVD peptides at 
higher resolution. 




Figure 7.18. Model structure of the Hsp90 MEEVD peptide onto the FKBP48 TPR 
domain. A representation of intermolecular interaction: a stick represents FKBP48 
residues, and a stick and hail represents the pen tapeptide (MEEVD). Hydrogen 
bonds shown in black clash lines are for,ned by Lvs 258, Asn 308, and Lvs 338 with 
the final aspartate of the peptide (Asp 5). Negative/) ,  charged groups of the peptic/c 
form salt bridges with Lvs  258, Lys 338, and Arg 342. The va/inc and methionine 
side chains sit deep in hydrophobic pockets. 
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Figure 7.19. Model structure of the Hsp90 MEEVD peptide onto the 016259 TPR 
domain 1. A representation of intermolecular interaction; a stick represents 016259 
TPRJ residues, and a slick and ball represents the penla/)epflde (MEEVD). The key 
residues fr Hsp90 binding are conserved (Lys 9, Asti 13, Asti 44, Lvs 81, and Arg 8). 
Hydrogen bonds are shown in black dash lines. Negatively charged groups of the 
peptide form salt bridges with Lvs 9 and Arg 85. The hydrogen bond is also frr,ned 
between Glu 51 and the ,nethionine residue of the peptic/c. 
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- 
Figure 7.20. Model structure of the Hsp90 MEEVD peptide onto the 016259 TPR 
domain 2. A representation of intermolecular interaction: a stick represents 016529 
TPR2 residues, and a stick and ball represents the pen tapeptide (MEEVD). The key 
residues in Hsp90 binding are all conserved (Lys 144, Asti 148, Asti 179, Lvs 209, 
and Arg 213 equivalent to Lvs 12, Asti 16, Asti 47, Lvs 77, and Arg 8 in the model). 
In addition, the TPR2 domain has rwo additional residues conserved (Phe 151 and 
Lys 186 equivalent to Phe 19 and Lys 82 in the model) that are predicted as the 
interaction stabilisers. Hydrogen bonds are also shown in black dash lines. 
NegativelY charged groups of the peptide form salt bridges with L%s 12, Lys 77, and 
Arg 81. The va/inc and methionine side chains sit deep in hydrophobic pockets. 





Figure 7.21. Model structure of the Hsp90 MEEVD peptide onto the Q21746 TPR 
domain. A representation of intermolecular interaction: a stick represents Q21746 
residues, and a stick and ball represents the pentapeptide (MEEVD). Compared with 
Ratajczak five residues which are critical for Hsp90 binding also appear conserved 
(Lys 109, Asn 113, As,i 143, Lvs 173, and Arg 177 equivalent to Lvs 18, Asn 22, Asn 
52, Lvs 82, and Arg 86). Whereas the other five residues associated or the binding 
are diffrrent. Hydrogen bonds are shown in black dash lines which can be seen. 
Negative/v charged groups of the peptide form salt bridges with A rg 69, Lvs 82, and 
Arg 86. The hydrogen bond is also formed between Cvs 51 and the aspartare residue 
of the peptide. 
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7.4 CONCLUSION 
Consensus sequences of TPR fold in C. elegans - The consensus motif 
presented here from an analysis of C. elegans sequences is 14, L7, A8, Yl 1, A20, 
Y24, A27, and P32 (Figure 7.3C) which differs in 3 positions from the original 
consensus sequence defined by Sikorski: W4, L7, G8, Yll, A20, F24, A27, and P32 
(Sikorski et al., 1990). These residues are likely to be important in maintaining the 
structural integrity of the TPR fold in a helix-turn-helix arrangement. Small 
hydrophobic residues present at positions 8, 20, and 27 (G, A, and A) located at the 
closet inter-helix contact between helices allow the helical tight packing of the motif. 
Large hydrophobic residues are present at positions 4, 7, 11, and 24 (L, L, L, and Y) 
along the helical inner faces to interlock both helices. Proline is present at position 32 
with its side chain projecting away from the turn to stabilise the turn of helix B and 
the next helix A. In addition, the presence of proline at this position prevents an 
extended formation of the helix B. 
No conservation of key residues required for Hsp90 binding in C. elegans - 
In spite of well conserved TPR consensus for the core structure, no conservation of 
residues important in Hsp90 binding was found. This may suggest diversity of 
biological functions amongst C. elegans TPR containing proteins. 
Prediction of FKBP48 structure - The overall architecture of the modelled 
structure of FKBP48 is similar to those of FKBP51 and FKBP52. However there are 
some differences in overall orientations between these three proteins. Using the 
second N-terminal FKBP domain as a reference, the overall orientation of FKBP48 is 
relatively more similar to that of FKBP51, rather than to FKBP52. The TPR of 
FKBP48 superimposes well onto that of FKBP5 1 (Figure 7.10) which corresponds 
with the SAXS result shown previously in section 6.5.2. The accuracy of the model 
however is yet to be evaluated. 
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FKBP48 TPR interaction with the final C-terminal residues of Hsp90 - Like 
other Hsp90 co-chaperones containing TPR repeats, the interaction of FKBP48 with 
Hsp90 has been characterised in this work. Compared with the previous work from 
Ratajczak et al., four of five essential residues in the five essential residues for 
binding are conserved (K258, T262, N308, K338, and R342 in FKBP48 and K227, 
N231, N278, K308, and R312 in Cyp40). In contrast, only one of the five residues 
required for efficient TPRJHsp90 association is conserved in CeFKBP48: K315, 
equivalent to K285 in Cyp40. The remaining residues are replaced in CeFKBP48 by 
L265, G304 and L359 (equivalent to F234, S274, D329 in Cyp40) and there is no 
equivalent residue in CeFKBP48 to L284 in Cyp40. Thus, strong hydrophobic 
interactions between L284 and M 5 and between F234 and both M 5 and V2 in the 
Cyp40JM1EEVD complex will not form. Moreover, in the CeFKBP48IHsp9O 
complex, there is no equivalent salt bridge formed between D329 and R313 (L359 
and K343 in the CeFKBP48 sequence). This could explain the weak interaction 
between CeFKBP48 and Hsp90 found in this work. 
Discovery of the putative Hsp90 binding partners containing TPR domains - 
Sequence analysis in the nematode C. elegans led to the discovery of two potential 
proteins, 016259 and Q21746, which might also play a role in Hsp90 binding. In 
addition to FKBP48 it is proposed the two new proteins are potential Hsp90 binding 
partners. With complete conservation of all the key Hsp90 binding sequences (K, N 
in helix A l of TPR repeat 1, N in helix A2 of TPR repeat 2, and K, R in helix A 3 of 
TPR repeat 3 as illustrated in Figure 7.22) they are predicted to have similar modes 
of Hsp90 interactions as Cyp40 in terms of charge interactions. Therefore, with this 
hypothesis, these two TPR-containing proteins from C. elegans have been implicated 
in steroid receptor function via Hsp90 association. 
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Figure 7.22. Structure of TPR domain comprising three TPR repeals (he/ices A 13 
and B13) and a final C-terminal helix (helix C). All critical residues with green side 
chains for Hsp90 binding are highlighted. 
The modelled interactions of 016259 and Q21746 TPR domains and Hsp90 MEEVD 
have been mapped out. The conserved peptides seem to bury well in the putative 
binding grooves (Figure 7.17). 016259 is hypothesised to be a multiple TPR 
domain-containing protein. With high similarity to stress-induced phosphoprotein 1. 
TPR domain 1 of 016259 is thought to be able to interact with Hsp70 whilst TPR 
domain 2 may interact with Hsp90 (Prapapanich et al., 1996). The TPR domain of 
Q21746 exhibits high similarity with small glutathione rich tetratri cope ptide (SGT) 
and may interact with Hsc70 (Tobahen et al., 2001). The interaction of rat SGT with 
heat shock cognate protein 70 (Hsc70) was characterised (Liu et al., 1999). Yeast 
two hybrid studies suggest SGT may interact with Hsp90. Deletion of SGT TPR 
domains showed the lack of binding to Hsc70. The possible interfaces between TPR 
domains of the two proposed proteins and Hsp90 MEEVD are shown with formation 
of hydrogen bonds and hydrophobic interactions. 
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SUMMARY AND FUTURE WORK 
The work described in this thesis involved biochemical characterisation and 
structural studies of a selection of FKBPs from various species: FKBP22 from N. 
crassa, FKBP 12/29/48 from C. elegans, and FKBP7 1 from A. thaliana. This chapter 
provides a brief summary of results to date and concludes with some suggestions for 
the future direction of each project. 
8.1 N. crassa FKBP22 
The preliminary structure of FKBP22 - A partial structure of FKBP22 from 
N. crassa (the N-terminal domain, residues 21-129) was determined. Molecular 
replacement was used, using the structure of FKBP12 as the search model. The 
overall domain structure is similar to that of the typical FK506-binding protein 
(FKBP). The protein exhibits PPIase activity with a kca/Km of 3.9 x 106  M 1 s' (Suc-
Ala-Leu-Pro-Phe-pNA as a substrate). A preliminary crystal packing analysis 
showed a well ordered arrangement of FKBP domains suggestive of dimer 
formation. This correlates with dynamic light scattering results that also suggest the 
protein may exist as a dimer in solution. 
The C-terminal domain - Despite the N-terminal FKBP domain packing well, 
no ordered structure of the C-terminal domain was visible in electron density map. 
Analysis of the C-terminal sequences (residues 136-217) revealed a highly biased 
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amino acid composition (12-23% occurrence of alanine, glutamate, lysine, and valine 
against 0% of phenylalanine, glycine, isoleucine, leucine, proline, and arginine). The 
prevalence of these hydrophobic, acidic, and basic residues might be compatible with 
the C-terminal domain comprising largely an amphipathic helix. 
Future work - Mass spectrometry data suggest the protein is intact, although 
the C-terminal domain is not visible in the electron density. Several approaches 
might help address the problem. These could include further optimisation of 
crystallisation conditions with different additives or different ligands hopefully 
producing better quality protein crystals and higher resolution X-ray data. Structural 
predictions suggest the formation of a long flexible C-terminal helix which could 
hinder crystallisation. To overcome this, site-directed mutagenesis could be carried 
out to produce FKBP22 truncation mutants with different lengths from the C-
terminus followed crystallisation trials. 
8.2 C. elegans FKBP12, C. elegans FKBP29, and A. thaliana FKBP71 
Problematic protein production - Production of crystallographic quantities of 
FKBP12/29/71 was problematic during this work. Although tagged FKBP12 and 
FKBP29 from C. elegans were highly expressed, low yields of the purified proteins 
were obtained after cleavage of the MBP fusion protein. A number of approaches 
could be taken to try and address these problems and might include the use of 
different expression vector systems e.g. other different promoters or fusion tags. 
FKBP71 from A. thaliana, like FKBP48, was inherently unstable, resulting in the 
formation of peptide fragments. This was compounded by poor overexpression levels 
of protein. Due to the difficulties outlined above, no further studies on these three 
proteins were carried out. 
Future work - To enable useful structural studies on these proteins the 
amount available, the degree of solubility and the stability of the proteins would have 
to be improved. Two possible approaches could be carried out: the use of expression 
vectors with different fusion proteins and also expression in different cell systems 
e.g. yeast or mammalian cells. 
8.3 C. elegans FKBP48 
Hsp90 recognition of FKBP48 - FKBP48, one of eight FKBPs found in C. 
elegans, is abundantly expressed in neuronal cells. Structural prediction from the 
FKBP48 sequence revealed three separate domains: two of N-terminal FKBP 
domains and one C-terminal TPR domain. In this work overexpressed, purified 
FKBP48 was found to readily degrade into two fragments, the 830 (missing 
approximately final 30 C-terminal residues) and the short (missing the TPR domain). 
In mammals, the interactions between Hsp90 and a number of its TPR containing co-
chaperone proteins including immunophilins (Hop, PP5, Cyp40, and FKBP5 1/52) 
have been investigated. As the only large immunophilin present in the in C. elegans 
genome, a reasonable supposition was that CeFKBP48 would interact with Hsp90. 
Interactions of FKBP48 and Hsp90 have been demonstrated in this thesis. SPR 
experiments of the three fragments of CeFKBP48 showed that the interactions of 
interest was mediated via the additional C-terminal TPR domain of CeFKBP48 as 
illustrated in Chapter 6, section 6.3.3. Two out of three fragments of FKBP48 (full 
length and the 30) showed some degree of interaction with immobilised Hsp90. No 
interaction between the short fragment and Hsp90 was detectable, confirming that 
the TPR domain of CeFKBP48 mediates the interaction with Hsp90. 
TPR recognition of Hsp90 - Previous studies proposed that the recognition 
region of Hsp90 is localised to the extreme C-terminal residues, MEEVD. 1 H NfvlR 
protein-peptide titration experiments confirmed the interactions of interest. A pattern 
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of peak shifting and broadening similar to that seen with Cyp40 was observed in the 
1 H spectra of the peptide. This implies that the peptide is binding to these two TPR 
containing proteins in the same orientation. However, a higher concentration of 
FKBP48 (30 .tM) than Cyp40 (<10 .tM) was required to observe these changes and 
the effect on some resonances was less pronounced. Titration of CeFKBP48 (full 
length and the 830 fragment) into a sample of the pentapeptide resulted in shifting 
and broadening of the peptide resonances. The magnitude of the changes increased 
with increasing amounts of the proteins added and were consistent with intermediate 
exchange of the protein and peptide on the NIvIR timescale. The most significant 
changes in peptide spectra were observed from the amide E 3 shifted upfield 
(maximum of 0.056 for both) and D 1  shifted downfield (maximum of 0.02 and 0.018 
respectively). However, there was no up-field ring-current shift of the methyl 
resonances of V 2; this is consistent with the fact that residue F234 is replaced in 
CeFKBP48 by L265, and this residue would not give rise to such an effect. 
The modelled interaction of FKBP48 and the pentapeptide, MEEVD - A 
mutational analysis of the key residues in Cyp40 identified ten residues that mediate 
binding to Hsp90. Five of these residues (K227, N231, N278, K308 and R312) were 
all shown to be essential for TPR/Hsp90 recognition, whereas the other five residues 
(F234, S274, L284, K285 and D329) were required for efficient binding. CeFKBP48 
TPR (residues 254-370) shares 22% sequence homology with Cyp40 TPR (residues 
222-340) and alignment of their sequences indicates that four out of five of the 
residues essential for recognition of the MEEVD motif are conserved in CeFKBP48 
(K258, N308, K338, and R342 in FKBP48 equivalent to K227, N278, K308, and 
R312 in Cyp40). The fifth essential residue, N231 in Cyp40, is replaced by T262 in 
the CeFKBP48 sequence. Thus, several stabilising interactions that N231 formed in 
the Cyp40IIvIEEVD complex may not be form in a CeFKBP48IMIEEVD complex. 
These include strong H-bonds with D0, positioning of a water molecule that contacts 
D 1  and hydrophobic interactions with V2. 
In contrast, only one of the five residues required for efficient TPRIHsp90 
association is conserved in CeFKBP48: K315, equivalent to K285 in Cyp40. The 
remaining residues are replaced in CeFKBP48 by L265, G304 and N370 (equivalent 
to F234, S274, D329 in Cyp40) and there is no equivalent residue in CeFKBP48 to 
L284 in Cyp40. Thus, strong hydrophobic interactions between L284 and M 5 and 
between F234 and both M5 and V2 in the Cyp40JIVIIEEVD complex will not form. 
Moreover, there is no equivalent for the salt-bridge formed between D329 and R313 
(N370 and K343 in the CeFKBP48 sequence). 
Putative TPR containing Hsp90 co-chaperones from C. elegans - A search of 
the C. elegans database for other TPR containing proteins revealed 41 proteins 
including CeFKBP48. Alignment of the TPR motifs within these sequences with 
those of Cyp40 highlighted two hypothetical proteins (accession numbers Q21746 
and 016259) that may be potential binding partners for Hsp90. The five residues 
essential for TPRJHsp9O recognition are fully conserved in both proteins. Q21746 
contains three TPR motifs and 016259 contains six TPR motifs as well as two heat 
shock chaperonin binding motifs or STI domains. Within the second set of TPR 
motifs of 016259 (TPR5 4-6), two of the five residues implicated in efficient TPR-
Hsp90 interactions are also conserved. BLAST searches using the full sequences of 
016259 and Q21746 revealed 93% and 81% sequence identities to C. elegans stress-
induced-phosphoprotein 1 and C. elegans small glutamine rich protein respectively. 
This suggested that both putative proteins may also interact with Hsp90. 
Future work - Results from the FKBP48-Hsp9O co-immunoprecipitation 
experiments were inconclusive. Further analysis of this proposed interaction would 
require different antibodies, ideally optimized for co-]EP experiments and selective for 
Hsp90 in complex, either specific to FKBP48 or more specific to C. elegans Hsp90. 
The different predominant localisation of the proteins would appear to make an 
interaction between the two unlikely, however some in vitro interaction may be 
possible due to non specific interactions between the Hsp90 and the TPR binding 
groove, hence the inconclusive EP results. The inherent instability of C. elegans 
FKBP48 was very problematic, particularly in the series of crystallisation trials. 
Another possible approach would be the construction of co-expression vectors for 
Hsp90 with FKBP48, perhaps resulting in stabilization of the FKBP48. As discussed 
earlier in Chapter 3, section 3.3.4, protein homogeneity is a very important parameter 
to try and control during the crystallisation process, a protein which rapidly degrades 
will result in a number of species of protein being present in the crystallisation drop, 
reducing the likelihood of a successful outcome. Site-directed mutagenesis could be 
used in an attempt to overcome the natural breakdown of the protein. 
The analysis of TPR sequences to identify possible Hsp90 binding proteins has 
provided the basis for a new project. The two proteins (016259 and Q21746) have 
been cloned by Mr. Liam Worrall and Dr. Antony Page. Purification and binding 
experiments are planned. The proteins could be tested for complex formation with 
Hsp9O. 
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